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Abstract 
Microdosimetry has been used for decades to characterise radiation fields using gas de-
tectors with effective volume similar to that of human cells. The tissue-equivalent pro-
portional counter (TEPC) is the gold-standard microdosimetric device, however silicon 
microdosimeters have shown to be a viable replacement which offer many advantages in-
cluding a slimline form factor and submillimeter resolution. This thesis continues the de-
velopment of silicon-on-insulator (SQQ microdosimeters for use in hadron therapy beams 
and mixed radiation fields, designed at the Centre for Medical Radiation Physics (CMRP), 
University of Wollongong, Australia. 
Three new SOI microdosimeters were investigated, including two based on state of the art 
3D silicon technology, utilising deep reactive ion etching. This technology was used to 
provide well-defined sensitive volumes with enhanced charge collection properties, which 
were lacking in previous CMRP microdosimeters. Electrical characterisation was under-
taken as well as scanning electron microscopy and energy-dispersive x-ray spectroscopy, 
revealing the physical and chemical properties of the microscopic detection volumes. Us-
ing the ion beam induced charge collection technique, the spectroscopic response to high 
LET alpha particles was measured and the charge collection geometry mapped. 
Equipped with the knowledge of previous simulations which investigated the tissue equiv-
alence and angnlar dependence of silicon microdosimeters in hadron therapy beams, mea-
surements with each device were performed in a 290 MeV/u 12C ion spread-out Bragg 
peak beam. Microdosimetric spectra were obtained and using the microdosimetric-kinetic 
model, RBE 10 values were derived. Good agreement with previous results obtained using 
a TEPC was observed for most devices. Due to the high spatial resolution of the micro-
iv 
V 
dosimeters which the TEPC lacks, detailed measurements were possible at the end of the 
Bragg peak, where the LET of primary particles changes rapidly. Measurements were 
also performed using mono-energetic 290 MeV/u and 70 MeV 12C ion beams. 
With the development of in-house electronics and remote controlled motion stage, the 
microdosimetric effects of motion were investigated in 290 MeV/u 12C beams produced 
using passive scattering and active delivery. Static microdosimetric spectra were obtained 
and compared to when the detector was undergoing motion representative of the trajec-
tory that a hypothetical organ might undergo during treatment. The impact of motion 
on microdosimetric quantities varied and was dependent on the motion characteristics, 
acquisition location and delivery technology. 
Application in proton therapy was also undertaken with microdosimetric measurements 
performed in-field with beams produced using double scattering and pencil beam scan-
ning techniques. Using the microdosimetric-kinetic model, the RBE distribution along 
the depth of a water phantom deviated from the value ~1.1, which is commonly used in 
proton therapy treatment planning. Radiation protection quantities were also produced 
for out-of-field locations using pencil beam scanning proton fields. 
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Chapter 1 
Introduction 
This chapter provides an overview of the relevant concepts and literature that are discussed 
and investigated in this thesis in the context of charged particle therapy. A number of 
concepts are explored including the physical interactions of charged particles with matter, 
modelling the radiobiological effects of radiation, microdosimetric techniques used to 
characterise radiation fields, as well as an overview of the previous silicon-on-insulator 
(SQQ microdosimeters, and new 3D SOI microdosimeters. 
1.1 Literature Review 
1.1.1 Charged Particle Interactions with Matter 
The term energy deposition is used ubiquitously throughout this thesis to describe the 
interactions of charged particles within microscopic silicon volumes. The purpose of 
utilising solid state detectors for the measurement of radiation is to relate the energy 
deposited within them to interactions that occur within human tissue. This can be relevant 
in countless scenarios from simply characterising a radiation field in a potentially harmful 
environment to predicting biological effects of the charged particles in hadron therapy. 
As such, an understanding of how charged particles interact with matter is necessary and 
presented in this section. 
1 
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1.1.1.1 Electronic Interactions 
Electrons are light charged particles that are subject to Coulomb interactions imposed by 
the medium they traverse. The incident electrons primarily interact with the orbital elec-
trons of the medium. Due to these particles having the same mass, large energy transfers 
are possible which can cause significant deflections during the electrons journey in the 
medium. Inelastic interactions can also occur when the incident electron imparts enough 
energy to raise the energy of the bounded electrons to a higher energy state, or ionise it 
from the target atom completely. If an ionised electron has sufficient energy it can pro-
duce further cascades of electron excitations or ionisations within the medium, depositing 
energy away from the initial collision site - these are known as delta electrons or o-rays. 
The energy loss due to collisional interactions within the medium has been described by 
Bloch in equation 1.1. It can be seen from this equation that the collisional energy loss is 
proportional to the atomic number and electron density, and inversely proportional to the 
square of the electron velocity. As a result, the highest energy loss occurs when very low 
energy electrons interact with high Z materials. 
(
dE) 21r'1eNZ ( mov2E 
- dx col= mov2 In 2l2 (1-/32) 





e = charge of an electron 
N = number density of medium atoms 
Z = atomic number of the medium 
v = velocity of the incident charged particle 
mo = reset mass of an electron 
I = mean ionisation energy of the medium 
/3 = v / c where c is the speed of light 
Electrons also emit radiation when they are accelerated/deflected when undergoing coulom-
bic interactions with the medium nuclei, known as bremsstrahlung or "stopping radia-
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tion". The rate at which the incident electrons lose energy via radiative means has been 
described by Bethe in equation 1.2. Due to the 1 / m2 dependence, Bremsstrahlung is gen-
erally only of significance for very light charged particles, and is greatest for high energy 
electrons interacting in a high Z material. 
-(dE) = NEZ(Z+ l)e
4 
( 41n (~)- ~) 
dx rad 137m5c4 moc2 3 
(1.2) 
where all symbols are defined as per equation 1.1. 
The resultant Bremsstrahlung has the possibility of interacting with the medium at some 
distance from its point of origin, potentially escaping the medium completely in the case 
of high energy incident electrons. The escape of photons has significant implications for 
small volume x-ray and gamma-ray detectors. 
1.1.1.2 Uncharged Hadronic Interactions 
The primary uncharged hadronic particles responsible for depositing energy within media 
relevant to biological tissue are neutrons. Unlike charged particles, they do not undergo 
Coulomb interactions when traversing material. Instead, they interact through a variety of 
different processes that may result in a significant portion escaping the medium, without 
transferring any energy to the medium. Neutrons interact with the nucleus of atoms, not 
the orbital electrons, and these interactions depend on the energy of the particle and the 
composition of the medium. Neutrons can be classified by their kinetic energy, listed in 
table 1. 1. In general, neutrons are always born with high energies, and lose their interac-
tions with surrounding materials, and lose this energy through interactions with surround-
ing materials, differing from both photons and electrons that are often generated at low 
energies. 
Neutrons can interact with matter in a variety of ways, with elastic and inelastic scatter-
ing being the primary mechanisms at higher energies. Elastic interactions occur when the 
neutron scatters off a target nucleus with little to no energy lost, while inelastic scattering 
occurs when the neutron causes the recoiling target nucleus to become excited, resulting 
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Neutron Type Energy 
Cold 0-0.025 eV 
Thermal 0.025 eV 
Epithermal 0.025-0.4 eV 
Cadinium 0.4-0.6eV 
Epicadmium 0.6-1.0 eV 
Slow 1-10 eV 
Resonance 10-300eV 
Intermediate 300eV-1 MeV 
Fast 1-20MeV 
Relativistic 20MeV 
Table 1.1: Neutron classification based on energy[2] 
in the loss of energy through secondary emissions upon dexcitation. The neutron will 
eventually lose most of its energy from these process and before interacting with matter 
through neutron capture, where the target nucleus absorbs the neutron. This often pro-
duces an unstable atom which will eventually decay or undergo fission, emitting daughter 
products in the form of gamma rays or lighter nuclei. A common example of this is the 
1H(n,y)2H reaction, emitting a 2.2 MeV gamma ray which can then be detected using 
conventional spectroscopic detectors ( e.g. Scillnator with PMT, HPGe, etc). Another is 
neutron capture in 10B which can produce a 1.47 MeV a particle and 0.84 MeV lithium 
nucleus, which deposit energy in close proximity to the interaction site. This describes 
the primary mechanism used in boron neutron capture therapy, used in the treatment of 
hypoxic cancers [3]. 
1.1.1.3 Charged Hadronic Interactions 
In contrast, when a charged particle enters a medium, energy loss occurs immediately 
and continuously through Coulomb interactions between the heavy charged particle and 
atomic electrons in the medium. Coulomb forces exerted on these bound electrons may 
be excited to higher energy states, or if transferred sufficient energy, be ejected from their 
atom through ionisation [4]. As mentioned previously, these delta rays can cause further 
cascades of ionisation and energy transfer within the medium. 
Due to the relatively large mass of hadrons compared to electrons, the energy loss through 
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each of these interactions is small, in the order of electron volts. As a result, the paticle 
trajectory is much less affected by these interactions when compared to electrons. How-
ever, these energy losses decrease the charged particle velocity and lengthen the time that 
electrons are acted upon by the Coulomb force. The result is an increasing rate of charged 
particle energy loss as it traverses deeper into the medium. After slowing down, the heavy 
charged particle will begin to attract electrons from the medium, effectively reducing the 
charge of the particle, resulting in increasingly smaller energy losses before eventually 
coming to rest within the medium as a stable atom. 
Stopping Power 
The rate at which a charged particles loses an infinitesimally small amount of energy dE 
occurs through a medium of particular thickness dx is called its stopping power S, defined 
in equation 1.3. Stopping power is more commonly expressed per unit physical density 





m- p dx (1.4) 
For charged hadrons, the semi-empirical Bethe-Block formula describes the energy loss, 
defined in equation 1.5, and takes into account the properties of both the incident particle 
and the medium it is traversing [5]. From this equation, it is clear that the greatest rate of 
energy loss will occur for ions with higher electric charge ( oc z2), and in media with the 
greatest atomic number and density (oc NZ). 
- dE = ( 4n-e
4
z2) NZ [zn ( 2mov2)-ln (1-v2) - v2] (1.5) 
dx mov2 I c2 c2 
where all symbols are defined as per equation 1.1 and z is the integer multiple of electronic 
charge of the incident charged particle. 
Linear Energy Transfer 
The term linear energy transfer (LEn is a more practical quantity used to describe the 
rate at which charged particles deposit energy in media. LET is defined as the amount 
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Figure 1.1: An illustrative example of a Bragg curve generated from 270 MeV/u carbon 
ions. Adapted from [8]. 
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of energy that a charged particle of energy E deposits per unit length within a medium, 
expressed in units of ke V / µm. LET values of interest vary between the order of ~ 10 
keV/µm for typical a-electrons [6], to hundreds and thousands of keV/µm for very low 
energy charged particles used in hadron therapy [7]. 
The Bragg Peak 
The Bragg Curve describes how charged hadrons deposit their energy as a function of 
depth within a medium; it is the key characteristic which differentiates heavy charged 
particles from photons in the context of therapeutic application of radiation. From equa-
tion 1.5, the rate at which energy is lost to matter is inversely proportional to the square of 
the charged particle velocity, 1 / v2. This property plays a crucial role in the way charged 
particles deposit energy in matter, as charged particles are constantly slowing down when 
travelling through the media. 
For an approximately monoenergetic beam of ions, the energy deposition profile is known 
as a pristine Bragg peak. As seen in figure 1.1, the curve can be broken up into three 
distinct regions: 
A. The build-up. The high energy charged ion interacts very mildly with the medium, 
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depositing energy through the generation of o-electrons. Little dose is deposited 
per cm of medium travelled and is often called entrance dose. However, for heavier 
ions, the nuclear process of fragmentation can occur, whereby an incident ion inter-
acts with a nucleus in the medium, causing a nuclear excitation. Upon de-excitation, 
the emission of low-Z fragments can occur, as well as neutrons. One advantage of 
the fragmentation process is the generation of positron-emitting nuclides within 
the medium, providing an interesting method for in-vivo dose verification using 
conventional PET techniques [9]. In addition, heavier high energy ions can also 
produce neutrons by stripping them from medium nuclei [10]. 
B. The Bragg Peak. As the ion slows down, it expends more and more energy to the 
medium as per equation 1.5, depositing a significant portion of its energy within 
a localised volume within the medium, after which it comes to a complete stop. 
In addition, this maximum energy loss is proceeded by the coulombic attraction of 
medium electrons, causing the effective charge of the ion (z in equation 1.5) to de-
crease. For a particular species of ion and medium, the depth of the Bragg peak is 
primarily determined by the initial energy of the incident ion; increasing ion energy 
results in decreased stopping power due to the 1/..Jl dependence, allowing the ions 
to travel farther through a medium. The width of the Bragg peak is primarily de-
termined by a process called straggling, which describes the variation in ion range 
due to the statistical nature of interactions within the medium [5]. If the number of 
interactions and overall energy loss of an ion is higher than others, it will stop ear-
lier within the medium compared to ions that interact less. Generally, the number 
of interactions is proportional to:? jv2, as seen in equation 1.5. Hence, for different 
ion species that the same range, the ions with a higher atomic number will have a 
much sharper Bragg peak, due to less straggling. 
C. The Tail. For lighter hadrons such as protons, little to no dose is deposited after the 
particles stop in the medium, except the relatively small contribution from neutrons 
that have been generated by inelastic reactions with the medium. For heavier ions, 
the fragments and secondary particles that were created at shallower depths can de-
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posit dose away from where they were generated before coming to a complete stop. 
In charged particle therapy, the delocalised energy deposition is of significance, es-
pecially at the distal edge of the Bragg peak, due to the potential to deposit energy 
in healthy critical organs, known as organs at risk (OAR). 
1.1.2 Utilising Hadrons in Charged Particle Therapy 
The treatment of cancer with radiation (radiotherapy) started long ago, with the first med-
ical use of x-rays occurring in 1896 to treat breast cancer [11]. The use of radiation in 
cancer treatment expanded, however the biological impact of radiation was poorly un-
derstood, resulting in adverse effects and poor treatment efficacy. With the advancement 
of power supplies and x-ray tube technology in the 1930s, the production of therapeutic 
beams consisting of up to 200 kV x-rays and electrons was made possible [12]. At the 
same time, Van de Graff and others developed the first particle accelerators that formed 
the basis of producing and accelerating high energy charged particles, although not orig-
inally created for oncology. A linear accelerator that could accelerate electrons up to 4 
MeV was invented in the 1940s, allowing the generation of electron beams and mega-
voltage x-rays for the treatment of deep seated tumours [13]. It was clear at this stage 
that while effect, x-rays characteristics could not be controlled effectively, which allowed 
large dose build-up in healthy tissues. 
Meanwhile, in 1946 Robert Wilson put forward the idea that protons were the simplest and 
most practical means for the external treatment of cancer [14]. Medical physicists around 
the world investigated the plausibility of protons as an advantageous treatment alternative 
and in 1954 the first clinical proton facility was opened at Lawrence Berkeley National 
Lab in the USA [15]. Shortly after, more facilities opened, including the first hospital 
based facility at Loma Linda University Medical Centre in 1970. Whilst proton therapy 
has been extremely widespread, with over 21,000 patients having been treated at Loma 
Linda to date [16], others at the time thought that the low relative biological effectiveness 
of protons ( ~ 1.1) could be improved [17]. The use of heavier charged particles for therapy 
was suggested in the 1960's and 1970's with pi-mesons being clinically tested at the Los 
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Figure 1.2: An illustrative example of the composition of a Spread-out Bragg curve. The 
red spread-out Bragg peak profile is created from the superposition of all other pristine 
Bragg peak profiles. Adapted from [23]. 
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Alamos National Lab and the Paul Scherrer for years after [18]. But this method, as well 
as helium ion therapy and heavier ions such as neon, nitrogen and oxygen, did not come 
to fruition clinically [19]. Heavier ion studies however were undertaken in Germany and 
Japan, showing carbon ions to be effective in obtaining effective treatment outcomes [20]. 
Carbon therapy was first implemented in 1994 at the National Institute of Radiological 
Sciences (NIRS) in Japan. Today, there are 92 proton therapy and 12 carbon therapy 
facilities operating clinically worldwide [21]; a testament to the amazing properties of 
these ions. 
While the Bragg peak profile that these charged particles exhibit is favourable for the 
localised deposition of dose for tumour treatments, it in fact too localised to be used for 
therapeutic purposes in humans [14]. To utilise ions to treat malignant tumours, high 
conformal doses need to be delivered to volumes spanning multiple centimetres. The 
solution to this problem is to create a spread-out Bragg peak dose profile, which is the 
superposition of a combination of Bragg peaks of different ranges/energies. For each 
tumour treatment, depending on the size, location and depth of the tumour, a precisely 
weighted set of different ion energies is required [22]. 
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In practice, the patient is treated using a) passive delivery, which requires the modification 
of a mono-energetic ion beam after it has been generated, or b) active delivery, which 
delivers the treatment using different ion energies which are generated directly from the 
cyclotron/synchrotron with minimal modification. 
1.1.2.1 Passive Delivery of Hadrons 
Passive scattering involves the transformation of a high energy monochromatic pencil 
beam of ions into a variable energy beam, using insertions device downstream from where 
the particle is generated and extracted. As the ions pass through the insertion device, their 
energy is selectively degraded to produce the appropriate variation of energies to achieve 
the desired dose profile within the body. Of course, the ions are also scattered laterally to 
ensure a uniform field over a clinical field size, comparable to that of the treatment site. 
The Heavy Ion Medical Accelerator at Chiba (HIMAC) at NIRS is a notable example 
where passive scattering delivery has been used (many of the results in this thesis are 
obtained at this facility). 
In proton therapy, lateral spreading of the ion beam is often done using a double scattering 
technique. The beam passes through a single scattering foil which results in a wider 
Gaussian beam profile and is then scattered off a second foil which produces a larger 
uniform field. Designs often include composite scattered with contoured to provide a 
field with a flat dose response [24]. In 12C ion therapy, lateral spreading can be achieved 
using beam wobbling. This technique uses two dipole magnets, placed one after another 
along the beam axis and are oriented such that their magnetic fields are orthogonal. An 
alternating current is applied to the magnets, with a phase shift between them [25]. When 
an ion enters the wobbling magnet, its trajectory is altered due to the Lorenz force. The 
time dependent magnetic field causes the ion beam to be spread out over a larger area [26]. 
The ions then enter a scattering material such as tantalum to produce a laterally uniform 
broad beam. In all passive delivery methods, the beam is defined with high-Zjaws, then 
reduced to a size similar to the treatment volume using a patient specific cut-out, before 
entering the body. 
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Depth dose modulation can be achieved using the following insertion devices: 
• A ridge filter is an upstream insertion device that converts an approximately mo-
noenergetic laterally spread ion field and produces a SOBP dose distribution within 
a medium. While there are many types of ridge filters [27, 28], they are all gen-
erally made from a solid bar of low-Z material (e.g. aluminium, brass), machined 
down to produce a set of steps of different thickness. As the ions traverse the differ-
ent thickness of each step, they will exit with different energies. The relative area 
of each step thickness is designed to produce the correct proportion of ions with a 
particular energy in order to produce the desired flat dose response. 
• A modulation wheel follows the same principal as the ridge filter, however the 
wheels are generally made from lower-Z materials with some high-Z to reduce and 
account for scatter across different energy ranges [24]. They are also often only 
used for modulating protons [29]. The wheel is constructed to have a set of radially 
distributed steps of different thickness. The wheel is rotated at constant velocity 
and the pencil beam traverses a static point which lies along the radial sequence 
of steps. Due to this constant rotation, the thickness through which the ions travel 
changes temporally, hence, the relative arc length of each step is made to match the 
appropriate weighting of the pristine Bragg peak required to produce the desired 
flat SOBP. The speed of the wheel is ~ 10 Hz, sufficiently fast to prevent interplay 
effects between the delivery of each pristine Bragg peak due to organ motion. 
• Range shifters involve simplistic range modification by the downstream insertion 
of a set thickness of low-Z material e.g. different thickness sheets or adjustable 
water column. The ions exit the range shifter material with a known lower energy. 
By using an optimised set of absorber thicknesses, the correct set of pristine Bragg 
peaks can be produced to generate the required flat SOBP at a specified depth within 
the patient. 
• A patient specific range compensator (also called a bolus or applicator) is a piece 
of machined low-Z material generally made from polyethylene, lucite or wax. It is 
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placed close to the patient and ensures that there is a highly conformal dose deliv-
ered to the distal edge of the tumour volume. As such, its form is very similar to 
the shape of the tumour. The ions travelling through the thickest parts of the bolus 
will stop proximally within the target volume and the ions travelling through the 
thinnest will stop at the distal edge of the volume. Generally, for each treatment 
angle, there is a unique compensator that needs to be mounted in the beam head, 
which makes this technique quite expensive in terms of fabrication, but also in both 
the therapist's and patient's time. A technique using a single patient-specific com-
pensator has been proposed to increase efficiency and reduce costs which involves 
combining the geometry of the compensators at each angle into a single bolus, and 
using multi-leaf collimators for lateral beam shaping [30]. 
These modulation devices are designed to conform the dose profile to the distal edge of 
the treatment volume, however this naturally affects the proximal distribution as well, of-
ten resulting in poor proximal conformity. In addition, the modification of the beam using 
insertion devices produces neutrons, and for heavy ions, produces fragments. These con-
tribute to the out-of-field dose in treatment delivery which is undesirable and detrimental 
to the treatment [31]. However, passive scattering has been used for decades and has 
proven to be simple and robust. 
1.1.2.2 Active Delivery of Hadrons 
Significant benefits can be obtained when avoiding the modification of the beam and 
utilising the pencil beam directly. Active delivery technology utilises two orthogonal sets 
of magnets to laterally steer a pencil beam over the tumour volume, with depth modulation 
achieved with the generation of specific ion energies directly from the synchrotron. The 
3D tumour geometry is broken up into voxels where the beam is to be delivered. In each 
voxel, the set of ion energies and weightings required to deliver the prescription dose to 
the tumour are determined, with a high degree of both distal and proximal conformity 
[32]. Each energy layer is then delivered one at a time. This is performed using spot 
scanning, where the beam is turned off in between voxels, or using continuous scanning, 
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where the beam remains on during the delivery of each energy layer. 
Due to the high conformity of this treatment modality, it is much more sensitive the in-
terplay effect that occurs due to respiratory motion [33]. The interplay effect describes 
the distortion of the delivered dose profile due to the movement of the treatment volume, 
often when its motion occurs over a period of time that is comparable to that in which the 
beam is delivered. While the treatment of a single energy occurs almost instantaneously, 
the time taken to change energy layers can cause subsequent energy layers to be delivered 
in a different phase of motion. This can result in volumes of tumour and healthy tissue 
that are overdosed and underdosed, as well as a general blurring effect on the dose profile 
[34]. Rescanning is a common mitigation technique that involves delivering the energy 
layers to the tumour volume multiple times at different phases of the motion cycle, effec-
tively averaging the dose distribution and decreasing the risk of large dose discrepancies 
[35]. Recent strategies involve 4DCT tracking and delivering the beam during a particular 
motion phase, having been implemented in both proton therapy [36] and carbon ion ther-
apy [37]. Studies have also been performed to investigate adjusting the lateral position 
and range of the ions in real time, based on the position the target [38]. 
1.1.3 Microdosimetry 
Microdosimetry was developed around 50 years ago and involves the investigation and 
quantification of stochastically deposited energy from radiation within small volumes in 
matter[39]. A motivation for its formation is the fact that different types of radiation will 
interact differently and cause different amounts damage, even with the same absorbed 
dose[40]. Most importantly, it attempts to relate the type of radiation and the way it 
deposits energy within matter to a biological effect or damage. Scales of the order of 
micrometres are considered as these small sizes are comparable to the size of cells where 
DNA is located; destruction of the DNA in cells is the mechanism for cell death and 
treatment success. 
There are two types of microdosimetry: regional and structural. The former uses the 
concept of small volume elements within matter called sites, and is implied when using the 
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term microdosimetry; the latter will not be considered here. Microdosimetry differs from 
conventional dosimetry mainly due the stochastic nature of energy depositions within 
matter and the microscopic nature of the interactions considered. 
1.1.3.1 Specific Energy 
Specific energy z is the stochastic analogue to the quantity used in conventional dosimetry, 
absorbed dose D. Absorbed dose is defined as the average energy de deposited in an 
element of mass dm, defined in equation 1.6. Specific energy is defined as the energy 
deposited e per unit mass m for a single site, defined in equation 1. 7. 








A better, more informative quantity for characterising a particular type of radiation is lin-
eal energy; this stochastic quantity is defined in equation 1.8 where the energy deposited 






The quantity e is the energy deposited along the particles track in one event and [ is the 
mean chord length of the volume being investigated. According to work done by Cauchy, 
the mean chord length for any convex surface in an isotropic radiation field [ 41] can be 
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1.1.3.3 Microdosimetric Distributions 
Bothy and z have their own continuous probability distributions, f(y) and f(z), respec-
tively. The frequency mean lineal energy and specific energy are defined below[39]: 
YF = lo~ yf(y)dy (1.10) ZF = lo~ zf(z)dz (1.11) 
While these distributions are useful, the dose weight distribution d(y) and d(z) for each 
quantity is often used where the relationship between the two distributions are as follows[42]: 
d(y) = yf(y) 
YF 
(1.12) d(z) = zf(z) 
ZF 
(1.13) 
Hence it can be seen that the dose mean lineal energy, defined below, can be expressed in 
terms of the frequency mean lineal energy: 
YD= lo~ yd(y)dy 
= - /J(y)dy 1 lo~ 
YF 0 
1.1.3.4 Microdosimetric Spectra 
(1.14) 
(1.15) 





Due to fact that for a given microdosimetric survey of some radiation, both the values 
of lineal energy y and its distribution f(y) may exist over multiple orders of magnitude, 
it is important to display microdosimetric spectra in a manner that is easy to interpret 
with all information accessible to the reader. As a result, using a linear scale on either 
axis will result in the display of very little information. Using a log-log plot will allow 
the distribution of lineal energy events to be seen, but lacks the ability to be interpreted 
usefully. By using a semi-log representation, where the x-axis represents yin log-scale 
and the y-axis represents y. f (y), the area under the curve in a specific range is proportional 
to the fraction of events in this region. The same property exists when plotting y on the 
x-axis in log-scale and/ f(y) (equation 1.12) on the y-axis to obtain the dose distribution. 
Figure 1.3 shows appropriate representation of this spectra. 
The microdosimetric spectra is generally normalised, such that its integral is equal to YD 
, however this makes comparison of spectra difficult. As such, all yd(y) distributions in 
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Figure 1.3: Left: microdosimetric spectrum with linear representation. Middle: micro-
dosimetric spectrum with semi-log representation. Right: dose distribution with semi-log 
representation[39] 
this thesis have been normalised to unity, in order to facilitate intuitive comparison. 
1.1.4 Estimating the Biological Effect of Radiation 
1d 
16 
The LET for each radiation type and energy varies significantly, resulting in different 
biological effects when interacting with tissue. For example, Co-60 gamma-rays have an 
LET of ~0.2 keV/µm, while heavy ions can have LET of the order of ~1000 keV/µm 
[43]. Physically, the difference in LET will result in vastly different ionisation densities 
of the tissue in which the radiation interactions, resulting in differing amounts of DNA 
damage. As a result, for the same absorbed dose delivered to a volume of tissue, the 
biological effects of the higher LET radiation will be much greater. An example of this 
can be seen in figure 1 .4, showing the vastly different effect of using high LET radiation 
compared to low LET radiation for various cell lines. 
The goal of charged particle therapy is to ideally induce complete cell death within the 
tumour volume while minimising damage done to the surrounding healthy tissue. The 
absorbed dose is the quantity that is physically measured in all facets of radiotherapy to 
determine the appropriate beam parameters to deliver the treatment plan. However, for 
high LET radiation, this measured physical dose must be scaled by some factor which 
takes into account its enhanced biological effect. This quantity is known as the relative 
biological effectiveness (RBE), defined as the ratio of the dose required produce some 
biological effect using a radiation of interest to that using a known reference, often 200 
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Figure 1A: Survival curves for various cell lines using x-rays and carbon ions. Adapted 
from [1]. 






DR,S = Dose delivered with reference radiation to produce cell survival S 
Ds = Dose delivered to produce cell survival S 
The RBE is fundamentally determined through in vitro cell experiments, where specific 
cell lines are irradiated with the radiation of interest at different absorbed doses, and the 
proportion of surviving cells is quantified using techniques such as clonogenic assay [44]. 
This is repeated for the reference radiation and the RBE is determined for a particular 
survival percentage. A common representation used in 12C therapy is the RBE10 , which 
is the ratio of the dose required to achieve 10 % survival. While the RBE heavily depends 
on LET which is determined by radiation type and energy, it also depends on the cell 
line and its current state within its cell cycle, the oxygen concentration, dose rate used 
as well as the treatment fractionation regime [43]. Some of the various models that have 
been developed to describe the biological response to radiation in cells will be described 
below. 
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The Linear Quadratic Model (LQM) 
It has been known since the days of Curie in the early 1900s that radiation caused damage 
to living cellular organisms [ 45], putting forward the hypothesis that this effect increased 
with dose. This was verified through studies in chromosome aberration in the early 40's 
[ 46], with the subsequent development what is known as the linear-quadratic model. This 
was further developed and confirmed with theoretical models which included radiations 
response from single events and multiple events [47]. 
While there are many different approaches to estimating the effects of radiation on tissue, 
the linear-quadratic model is the most fundamental and ubiquitous tool in characterising 
a particular radiation field's effect on cell death. It states that the probability of cell 
surviving exposure to a particular dose of radiation is dependent on two parameters, a 
and /3, as per equation 1.19 [48]. The a parameter describes the cells survival response 
at low doses and is generally reflects the cells response to single radiation events and the 
/3 parameter describes the curvatures of the cells response at higher doses and generally 
reflects the cells response to multiple radiation events. The a/{3 ratio is the quantity often 
used to describe a cell lines response to a particular radiation. An example is shown in 
figure 1.5 of a cell line with varying al f3 ratios. 
where: 
S = Probability of cell survival 
a = LQM a parameter, dependent on cell radiosensitivity 
f3 = LQM /3 parameter, dependent on cell radiosensitivity 
D = Dose delivered to cell 
The Microdosimetric Kinetic Model (MKM) 
(1.19) 
The microdosimetric kinetic model was developed by Hawkins in 1996 [49], used to 
describe the relationship between dose and cell death for radiations of all LET values, 
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Figure 1.5: Illustrative examples of the effect of varying the al{J ratio on a cell's survival 
response to dose. 
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and is extremely similar to the theory of dual radiation action [50]. The model describes 
breaking down a cell into a number of microscopic volumes referred to as domains. Each 
domain is a homogeneous tissue volume in which the contained DNA can be damaged 
(lesions), the extent of which is proportional to the dose deposited within the domain. 
The number of domains that that have received a dose D of a population of domains is 
The model assumes the following: 
• There exists a type of lesion (primary type I) which will kill the cell 
• There exists a type of lesion (primary type II) which may result in being: 
(a) non-repairable resulting in cell death, proportional to nn, 
(b) non-repairable due to combination with another type II event within some 
distance (e.g. double strand break), resulting in cell death, proportional to nb. 
This distance is characteristic of the cell and is dependent on it's cellular cycle 
state, 
( c) repairable, proportional to nn, or 
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( d) remain dormant until after time t, where it results in cell death 
• Type I and II lesions are uniformly distributed in the DNA of domains that received 
doseD 
Based on these assumptions (and many more), Hawkins showed that the survival of a 
population of cells is of the same form as the LQM, however with a and /3 parameters 
dependent on the number of type II lesions, the rate of formation of type II lesions from 
processes dependent nn and nb and the time t, after which these lesions can tum lethal. 
Equation 1.20 shows the general expression which describes the model in terms of cell 
survival. The model is valid for doses less than 125 Gy which is of course is much 
greater than the doses required to kill human cells, of which all this research is founded 
upon. 
s = e-(aD-JlIY) = e-((ao+r/l)D-JlIY) 
where: 
l'.l() = parameter proportional to the number of domains per nucleus 
r = parameter which describes the microscopic dose to the nucleus 
f3 = LQM /3 parameter 
(1.20) 
From the MK model came the modified microdosimetric model (MKM) which further 
modelled the a component in equation 1.20 in terms of quantities that in part could be 
measured with a microdosimeter [51]. The a term was derived in terms a particular cell 
characteristics and microdosimetric quantities, defined in equation 1.21. 
where: 
l'.l() = LQM a parameter 
f3 = LQM /3 parameter 
p = Density of tissue 




y* = Saturation-correction dose-mean lineal energy 
(1.21) 
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The overkilling effect results in a decrease in RBE for particles with LET above ~ 1()() -
150 keV/µm, whereby the desired biological effect has been achieved and increased dose 
is "wasted" [52]. The saturation-corrected dose-mean lineal energy y* takes into account 
this saturation effect and is defined in equation 1.22. 
where: 
y* = rof [1-e-rlro] f(y)dy 
Jyf(y)dy 
(1.22) 
Yo = Factor dependent on cell MK model parameters including nucleus radius Rn, 
domain radius rd and LQM parameter /3 (empirically determined [51]) 
Substituting these terms into the LQM, the cell survival can be expressed as in equation 
1.23. 
(1.23) 
The RBE (equation 1.18) can now be expressed in terms of the survival, dose, /3 and 
modified a parameter. The RBE for 10% survival is expressed in equation 1.24. 
RBErn = D10,R = 2/3D10 
D10 Ja 2 -4{31n(0.1)-a 
where: 
D10,R = Dose delivered with 200 kVp x-rays to produce 10 % survival 
D10 = Dose delivered with radiation of interest to produce 10 % survival 
a = a as per equation 1.21 
f3 = LQM /3 parameter 
(1.24) 
For human salivary gland (HSG) tumour cells, considered to be a reference cell line, 
values of D10,R = 5.0 Gy, f3 = 0.05 Gy- 2, rd= 0.42 µm and Yo = 150 keV/µm have 
been determined for 12C ions [51]. Using this equation, the MKM model allows for the 
estimation of RBE10 for HSG cells based on measurements from a microdosirneter. 
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The Local Effect Model (LEM) 
The Local Effect Model (LEM) describes the biological effects of radiation within cells 
in terms of the local energy deposition and was introduced in 1996 by Scholz and Kraft 
[53]. The model sought to overcome limitations of previous models from Katz and Kiefer 
which described the biological effect only in terms of integral dose within a volume of 
interest, without regard for the fine track structure that was produced at the cellular level 
[54]. In contrast, the LEM hypothesised that the biological effect was dependent on the 
total length of the tracks that were generated within a cell. 
The model assumes a homogeneous distribution of sensitive sites within a cell, that in the 
occurrence of a lethal event within any of them, the cell would die. With the assumption 
that the distribution of lethal events is Poisson and the number of these events N is de-
termined by the dose D deposited within, the survival probability S can be expressed in 
terms of LQM parameters: 
S(D) = e-N(D) 
⇒ N(D) = -ln(S(D)) = aD+f3d2 
(1.25) 
(1.26) 
Since the distribution of sites is assumed to be homogeneous within the cell, the number 
of events per volume of the nucleus within the cell V is constant and dependent on dose, 
expressed as: 
v(D) = N(D) = -ln(S(D)) = aD+ {3D2 
V V V 
(1.27) 
Since the event density is constant with the cell, the average number of lethal events N 
produced from any arbitrary local dose distribution D(x,y,z) can then be expressed in the 
form of a volume integral: 
N = !_ 111-ln(SD(x,y,z))dxdydz 
V X y z 
(1.28) 
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The survival probability can then be expressed as: 
(1.29) 
If the dose distribution can be quantified and the volume of the cell is known, then by using 
the x-ray cell survival curve, the average number of lethal events can be determined. The 
RBE can then be calculated by first determining the dose which produced the calculated 
the cell survival (equation 1.19), then calculating RBE using equation 1.18. This model 
prides itself on being based on solely on measurable quantities such as a and /3 for low 
LET x-ray radiation, however in reality the dose distribution in the nucleus produced 
by tracks from heavy charged particles is generally modelled using simulations. The 
LEM model has showed good agreement for carbon ions and has been used in clinical 
trials at GSI and is currently used clinically at the Heidelberg Ion Beam Therapy Center 
[55]. 
1.1.S Using Microdosimetry for Radiation Protection 
The dose equivalent is defined as the product of the absorbed dose and a quality factor 
and is used to estimate the dose received by a person upon radiation exposure. Using the 
lineal energy dependent quality factor Q(y ), defined in the ICRU-40 report for radiation 
protection [56], the dose is scaled to be proportional to the biological effects it causes 
with respect to effects produced by a reference radiation. This dimensionless quantity is 
defined in equation 1.30. 
where: 
a1 = 5510 keV/µm 
a2 = 5x 10- 5µm 2/keV2 
a3 = 2x 10- 7 µm 3/keV3 
(1.30) 
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To calculate the dose equivalent for a microdosimetric spectrum, the average quality factor 
Q is first determined by integrating the product of the dose-weighted microdosimetric 
distribution d(y) and quality factor across all lineal energies, seen in equation 1.31. 
Q = lo~ Q(y)d(y)dy (1.31) 
Previous studies using silicon microdosimeters have been performed previously, able to 
measure out-of-field dose-equivalents and quality factors in proton therapy [57]. In this 
case, the tissue-equivalent dose DT was calculated by first obtaining the dose deposited 
it in the silicon microdosimeter. To achieve this, the total energy deposited in the silicon 
sensitive volumes is found by integrating the MCA energy spectra counts over all chan-
nels. To convert this to dose, the total energy deposited is divided by the mass of the 
sensitive volumes which is simply the product of the density of silicon p and the volume 
of these sensitive volumes V. 
Previously, the dose in silicon was converted to that in tissue using a factor determined 
through comparison with TEPC results and Geant4 simulations, however more recent 
developments with improved Geant4 simulations have determined , = 0.57 is most ap-
propriate [58]. The dose equivalent is calculated using these quantities as seen in equation 
1.32 and is normalised to the dose received at isocentre in order to establish values with 
respect to dose delivered to a patient, with units mSv/Gy. 
where: 





E; = centre of the ith energy bin in the MCA spectrum 
(1.32) 
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1.2 Microdosimetric Technology 
The design and fabrication of microdosimeters at the Centre for Medical Radiation Physics 
(CMRP), University of Wollongong, Australia, has been ongoing for almost two decades. 
Its motivation for this effort is to replace the current gold standard microdosimetric detec-
tor, the tissue-equivalent proportional counter (TEPC). This chapter will explore micro-
dosimetric theory as well as previous, current and future microdosimetric technologies, 
and summarise their properties and roles in microdosimetry. 
1.2.1 The Tissue-Equivalent Proportional Counter 
1.2.1.1 Operation and Construction 
The TEPC is a radiation detection device that measures the charge liberated by radiation 
within its gaseous volume by individual energy deposition events from radiation. It was 
first developed by Harold Rossi in the 1950s and was and still is the gold standard micro-
dosimetric measurement instrument. Ranging from a physical size of the order of 10 mm 3 
[59][60] to tens of centimetres, the device deceivingly mimics a microscopic cell-sized 
volume with its detection volume consisting of very low pressure tissue-equivalent (TE) 
gas. The simulation of the cellular-sized tissue volume is achieved by adjusting the den-
sity of the gas such that [pd]038 = [pdJnssue• where p is the density and d is the diameter 
of each volume. Based on the desired simulated tissue volume, the pressure of the TE 
gas is adjusted to ensure the mass of TE gas is equal to the mass of the simulated tissue 
volume. Given these operating conditions are maintained, the interactions within each 
volume is for the most part equivalent. 
As illustrated in fignre 1.6, a TEPC stripped down to its core is comprised of a spherical 
or cylindrical cavity with a cathode coating its walls and an anode wire running through 
the centre of the cavity. In the case of a TEPC, its wall is made from a TE plastic (gener-
ally A-150 [61]) and the TE gas used is normally a propane-based mixture [62]. As with 
normal proportional counters, a voltage is applied between the anode and cathode (gen-
erally :C:: 500 V) such that electron-ion pairs generated from single ionisation events can 
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Figure 1.6: An example of the construction of a spherical tissue-equivalent proportional 
counter [8]. 
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be collected and measured through a multiplication process. This multiplication process 
occurs in close proximity to the centralised anode, ensuring that the magnitude of the total 
released charge is independent of the initial ionisation site location. 
Since the average chord length [ for any convex body with volume V and surface area A 
is equal to 4V / A [63], through this charge collection, the TEPC effectively measures the 
lineal energy, y, event-by-event. As with any other microdosimeter it is used to determine 
microdosimetric quantities discussed in section 1.1.3. 
The TEPC has been used in a wide range of applications including radiation protection, 
particle therapy, space, mixed field dosimetry, etc. While the idea of gamma-subtracted 
distributions have been able to be obtained for known fields, implementation of a separate 
gamma-sensitive proportional counter has the potential to be able to distinguish the whole 
neutron spectrum in mixed gamma-neutron field [64]. 
1.2.1.2 TEPC Shortcomings 
While the TECP is a robust, long-standing radiation detection device, it is not without 
its limitations. Accurate determination of microdosimetric quantities is essential for in-
terpretation and application of the TEPC data to fields such as radiation protection and 
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particle therapy. 
The fundamental TEPC technology departs from really what it is designed to simulate -
energy deposition within a cell in the body. One of the more obvious differences is that 
the TEPC uses a gas to simulate energy deposition within tissue and while TE gas does for 
the most part provide an equivalence, there many be differences in mass stopping powers 
of solids due to the polarisation effect [65]. Most of its issues however lie in its relatively 
large single physical volume and the relatively high density wall which encapsulates it. 
This departure results in discrepancies in the microdosimetric measurement, and while 
these effects can be compensated using correction factors (in known fields), they present 
inherent problems with the technology design [39]. 
The delta-ray effect describes the scenario whereby a primary charged particle and its 
delta-ray(s) may not traverse the same microscopic volume but both may traverse the 
large volume of the TEPC (figure 1.7a). This results in the TEPC measuring an increased 
YF value compared to that in the true microscopic site - Yn is relatively immune to this 
effect in low-medium energy cases [ 47]. The V-effect is the same as the delta-ray effect 
but the two ( or more) particles of interest are two heavy charged particles produced from 
an inelastic nuclear interaction (figure 1.7b), resulting in a large increase in both YF and 
Yn . The re-entry effect occurs where an unpredictable, winding track of an electron 
would cause it to interact with the microscopic volume just once, however in a TEPC, it 
may enter its volume, exit and then return through the TEPC again (figure 1.7c). This 
effect results in increased lineal energy measurement and is only relevant for delta-rays of 
energy less than 1 Me V. While these are inherent problems with the technology, correction 
factors can be calculated to compensate for these effects. Finally, the scattering effect 
occurs when an uncharged particle generates multiple charged particles along its track 
and these particles interact with the single TEPC volume, but would interact in separate 
sites on the microscopic level (figure 1.7d). 
As discussed, the TEPC volume physically takes up a relatively large volume compared 
to a cell, but also compared to many beam features in hadron therapy such as pencil 
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Figure 1.7: Illustrative examples of different wall effects in TEPCs: a) Delta-ray effect, 
b) V-effect, c) Re-entry Effect / Backscatter and d) Scattering effect. 
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beam spot size, penumbra width, Bragg peak width, etc. An example is the measure-
ment of the a scattered proton field (14 cm range, 10 cm modulation) width which has a 
penumbra width of approximately 2 mm (20-80%) [24], illustrated in figure 1.8. Within 
a lateral distance of less than 10 mm, the dose is both at its highest and is almost nil. The 
large volume of the TEPC means it cannot physically measure many beam characteris-
tics without volume-averaging. As such, its performance in charged particle therapy is 
put into question in many scenarios due to its poor spatial resolution. There are however 
small numbers of mini-TEPCs in development which may overcome this particular lim-
itation with volumes < 1 mm3, suitable for measurement in charged particle beams [66] 
[67]. 
Not only is the TEPC size often large, many earlier TEPC systems are even more cum-
bersome due to the gas flow systems that accompany them [62]. These gas flow systems 
serve many functions, namely a) providing the TEPC with a constant supply of pure TE 
gas, b) maintaining the required pressure to simulate the desired microscopic volume and 
c) clearing of contaminants from out-gassing within the TEPC which can have significant 
impact on the gas amplification. This cumbersome setup can be avoided by using sealed 
TEPCs, which can be filled with gas and then sealed for use where it would be impractica-
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Figure 1.8: An illustrative example showing a typical 12.7 mm spherical TEPC measur-
ing the 50% of the a proton lateral penumbra. Adapted from [24]. 
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ble for gas flow apparatus to be used. This however still requires regular refilling and care 
when handling to ensure out-gassing and physical damage to seals are avoided. The large 
of most TEPCs has been motivation for recent innovation of TEPC design. This effort 
to reduce their physical size has been driven by use in applications such as deep space 
missions [60] as well as measurements in Boron Neutron Capture Therapy where higher 
count rates and hence lower volumes are required [59]. Multi-element TEPCs have also 
been designed to tackle the TEPC size while also increasing sensitivity [68] [69]. 
While the size of the TEPC may decrease, its reliance on a carefully maintained gaseous 
detector volume creates the need for significant design and engineering effort to ensure 
robustness and practicality for many applications. This among its other limitations may 
make solid state microdosimeters a more desirable detector. 
1.2.2 Silicon Microdosimeters 
Solid state devices have been used in microdosimetry since 1980[70] due its compact 
and portable nature, low power requirements, high count rate capabilities, and of course 
the ubiquity of its underlying technology[71]. There exists a long-standing knowledge of 
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silicon's physical characteristics, and due to its ubiquity in the world of electronics, with 
it comes a widespread international net of fabrication capability and facilities. But like 
all microdosimeters, they have requirements that need to be satisfied in order to be used 
for microdosimetry: tissue equivalence, volume comparable to that of a cell ( ~ µm), low 
noise and a capability of recording single events[72]. 
1.2.2.1 Theory of Operation and Characteristics 
Silicon microdosimeters, like most silicon devices in most of the technology industry, rely 
heavily on the underlying physics of P-N junction. P-N junctions, as the name suggests 
requires P-type and N-type silicon. P-type silicon is created by the doping of silicon with 
group ill elements, creating an excess of holes, and n-type silicon is created by the doping 
of silicon using group IV elements, creating an excess of electrons. 
When these two are put into thermodynamic contact with each other, two processes occur 
simultaneously: 1) the excess electrons in then-type silicon diffuse into the p-type silicon 
and combine with its excess holes, and 2) the excess holes in the p-type silicon diffuse 
into the n-type silicon and combine with its excess electrons. As this process occurs, 
an electric field forms in the region between the two types from n-type to p-type which 
impedes the rate of diffusion between charge carriers. Eventually, equilibrium is reached 
whereby charge diffusion halts and a region free from mobile charge carriers is formed, 
known as the depleted region. The depleted region gives the P-N junction its rectifying 
properties i.e. each type of charge carrier can only flow in one direction. 
The existence of a depleted region enables silicon devices to be used as radiation detectors 
when operated in reverse bias. As illustrated in figure 1.9, The lack of any significant 
current flowing through the device when no radiation is present means that when charge is 
generated within the P-N junction, it can be detected and measured in an external circuit. 
With a small depletion region, the detector will lack the efficiency to detect mid to high 
energy gammas and neutrons, and charge particles will only deposition small amounts 
of energy. Naturally, larger depletion volumes result in the opposite effect, giving the 
detector greater sensitivity. 











Figure 1.9: P-N semiconductor device in reverse bias 
For a PN-junction with donor concentration Nn and acceptor concentration NA, the width 
of its depletion region due to its built-in potential VB1 is presented in equation 1.33. 
Wn= -VBJ -+-2e ( 1 1 ) 
q Nn NA 
(1.33) 
Often silicon microdosimeters are designed with a one-sided abrupt junction, in which the 
one side of the junction has a significantly lower relative doping concentration NB than 
the other. In this case, the depletion width is described in equation 1.34 [73]. Figure 1.10 
shows how this depletion region varies with applied reverse bias, as well as the effect of 
the relative dopant concentration. For a set doping concentration, the depletion width and 
hence the sensitive volume of a microdosimeter can be changed with the applied reverse 





Whilst it is assumed that there are no free charge carriers within the depleted reason, there 
are still minority carriers within each silicon substrate that are able to flow i.e. electrons 
in P-type and holes in N-type silicon. In addition, in normal operating temperatures, 
thermal generation of electron-hole pairs and their subsequent acceleration by the elec-
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Figure 1.10: An example of how the depletion width varies with reverse bias for 3 
differentdopantconcentrations: a)Nn= 1 x 1014, b)Nn= 1 x 1015 andc)Nn= 1 x 1016, 
with NA= 1 x 1018 and ni = 9.65 x 109 • 
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tric field also contributes to this current. The flow of these charge carriers brings about 
the unwanted phenomenon called leakage current which rises with applied reverse bias. 
Before breakdown, whilst normally of the order of n.As for silicon microdosimeters, the 
leakage current causes a detrimental increase in the minimum detectable lineal energy by 
essentially increasing the noise baseline on which real radiation events are detected. With 
a high noise baseline, small energy deposition events cannot be detected and therefore de-
tector leakage current should be as small as possible. If the applied reverse bias exceeds 
the devices breakdown voltage VBn, it will go into breakdown whereby significant current 
flows. While not permanently damaging if heat is removed from the device appropriately, 
the device simply cannot be used as a radiation detector in this state. 
As with any dielectric material, the capacitance of a silicon detector also changes with ap-
plied bias. For a one-sided abrupt PN-junction, its capacitance is only dependent upon its 
dielectric properties and its volume [73]. Using equation 1.34, the capacitance for a one-
sided abrupt junction is expressed in figure 1.35. Figure 1.11 shows how the capacitance 
varies with applied reverse bias, as well as the effect of the relative dopant concentration. 



















-N 0 = 1x10
14 
-·-·-N0 = 1x10 15 
N 16 --- □ =1X10 
--------- ------·-........ ...... ................... -...  __ .................. ___________________ ,.  .,.  ., __  
10
1 
.__ _______ ..._ ___ ....... ________ ...., 
0 W ~ ~ 00 100 
Reverse Bias (V) 
Figure 1.11: An example of how the junction capacitance varies with reverse bias for 3 
differentdopantconcentrations: a)Nn= 1 x 1014, b)Nn= 1 x 1015 andc)Nn= 1 x 1016, 
with NA= 1 x 1018 and ni = 9.65 x 109 • 
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Practically, as will be seen in later chapters, the shape of capacitance vs. voltage plot will 
indicate whether sufficient bias has been applied to deplete the bulk of the microdosime-




1.2.2.2 Tissue-Equivalent Chord Lengths 
2 (VB1-V) 
(1.35) 
When discussing silicon detectors in the context of microdosimetry, it goes without saying 
that there must be some consideration as to the lack of tissue equivalence of these devices. 
TEPCs use tissue-equivalent gas to ensure the signal generated within the detection vol-
ume represents energy deposited in a volume that is equivalent to to tissue. However, 
the signal measured in silicon is just that; without undergoing some sort of transform 
on the signal (or spectrum produced within), it fundamentally does not represent energy 
deposition within tissue. 
To compensate for this material difference, a study was first undertaken aiming to assess 
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the feasibility of conversion from silicon to that of ICRU muscle [74]. This was achieved 
using Geant4 simulations to effectively scale the average chord length of a silicon vol-
ume, to that of a muscle volume which provided the same lineal energy deposition i.e. 
y = e/lTissue = ,e/1s;. Further studies found that,= 0.56 was an appropriate conversion 
factor to water for proton energies [75] and for aviation radiation fields which primarily 
consisted of fast neutrons, , = 0.58 was found to be appropriate [76]. A further com-
prehensive study showed that for 12C therapy, conversion from silicon to muscle is best 
performed using , = 0.57[58]. Furthermore, this study also showed that due to the high 
directionality of ions in 12C therapy, relevant to the work of this thesis, using the SY thick-
ness as the mean chord length provided lineal energy responses more accurately than the 
mean chord length in equation 1.9. 
1.2.2.3 Planar SOI Microdosimeters 
The use of silicon-on-insulator (SOQ devices began in the 1970's with their creation and 
eventual industrialisation in the 1990's[77]. Their main difference with respect to con-
ventional silicon devices is that there is a silicon oxide layer below the junction(s) of the 
device. This insulating layer reduces parasitic capacitance by separating the sensitive re-
gion from the substrate, and hence reduces noise. Another important function of this layer 
is physically preventing charge carriers produced in the substrate layer from diffusing into 
the SY and being collected; this would produce enhanced energy depositions within the 
device[78]. After the first solid state detector was used for microdosimetry in the early 
1990's [79], the Centre for Medical and Radiation Physics (CMRP) at the University of 
Wollongong has designed and manufactured SOI and 3D detectors for microdosimetry. 
It has produced over 5 generations of SOI microdosimeters, with the last 3 generations 
being investigated in this thesis. 
First generation CMRP microdosimeters were developed in the earlier 2000's, fabricated 
by Fujitsu Research Laboratories based on technology used to study single event upsets 
(SEU). These SEUs are caused by secondary neutron cosmic radiation and can produce 
irreversible defects in digital electrons (e.g. pacemakers)[42]. Each device consists of 
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4800 diodes with a total area of 10 µm x 10 µm, depicted in figure 1.12. All SVs are 
connected in parallel, giving a single read-out channel. Four SOI devices were made 
having thickness 2 µm, 5 µm and 10 µm, as well as non-SOI bulk device[80]. A guard 
ring was not included in the design and as a result, shown in charge collection studies, 
lateral diffusion and funnelling from outside the SVs dominated the desired drift process. 
Funnelling occurs in the depletion layer and is due to high LET particles locally distorting 
the electric field, allowing charge collection from outside the depletion layer[81]. One of 
the necessities of a microdosimeter is a well-defined SV[72], hence this device needed 







Figure 1.12: Cell configuration of the CMRP first generation microdosimeter (adapted 
from [42]) 
The second generation microdosimeters were designed to overcome the problems seen in 
first generation, and to assess radiobiological effectiveness of mixed radiation fields. Two 
main designs were produced to isolate and prevent charge being collected from outside 
the SV s. The first design utilises mesa structures which are physically isolated to further 
define the SV, seen in figure 1.13. The sensitive region is 2 µm thick and is raised above 
the oxide and substrate layers, and isolated from adjacent SV s to prevent unwanted charge 
collection[82]. The device also included two electrically isolated arrays of diodes, called 
odd and even. One odd SV is surrounded by four even SV s and vice versa. This enables 
particles with the same LET but different delta electron properties to be differentiated 
from one another. Charge collection results, however showed that lateral diffusion still 








Figure 1.13: Schematic cross-section of the second generation mesa microdosimeter 
(adapted from [82]) 
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occurred in the mesa structures. But more importantly the fabrication of the devices had a 
prohibitively low yield. This was due to difficulties in evaporating the aluminium contacts 
over the raised structures[83]. 
The design was analysed and changed to a standard planar device with no mesa struc-
tures as the fabrication complications were unavoidable at the time. Two types of guard 
rings were incorporated to isolate and further define the SV to prevent lateral diffusion. 
The first guard ring being a standard annulus guard ring that surrounded each SV and the 
other design is known as guard ring everywhere, which exists in all regions outside the 
SVs. Differences can be seen in figure 1.14. Devices with thicknesses of 2 µm and 10 
µm were produced with 4 different versions, each having variation in guard ring design 
and doping method. The two doping methods used were dopant diffusion and ion implan-
tation, with the latter able to produce smaller doped regions. Charge collection studies 
showed revealed that incomplete charge collection occurred at the edge of each SV, and 
that fabrication yield was still not 100%. However it was seen that each SV was isolated 
from one another, meaning parallel whole-array readout was possible. 
The third generation microdosimeters were designed with a different use in mind; its pur-
pose was to predict single event upsets in electronics such as those in space as well as 
high energy, mixed radiation fields and real-time dosimetry[84]. Due to the very small 
sensitive area size of less than lmm 2 in the previous generation devices, the microdosime-
ters were made with a total area of 4.25mm x 3.60mm and thickness of lOµm, seen in 
figure 1.15. Each SV has a width between 6-lOµm, compared to 2µm previously, in-
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Figure 1.14: Guard ring configuration in second generation planar devices with a) simple 
guard ring and b) guard ring everywhere 






Figure 1.15: Schematic cross-section of the third generation microdosimeter (adapted 
from [84]) 
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creasing probability of interaction and hence its sensitivity. It also includes a guard ring 
everywhere configuration as seen in figure 1.14 to reduce charge sharing through coinci-
dences between the SV and guard ring channels. One main difference between previous 
generations is the use of high-resistivity n-type silicon and a p+ core surrounded by n+ 
electrodes. Other factors such as odd and even array readout and array configuration have 
remained the same. Charge collection studies showed that the devices had 100% yield 
which showed that some fabrication difficulties were eliminated. There was however 
larger than expected charge collection resulting from displacement current from charge 
carriers being produced in the lower layers of the substrate[85], below the oxide layer. 
This was thought to occur in this generation only due to the comparatively high-resistivity 
of the n-type silicon of the supporting silicon wafer[86]. 
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1.2.2.4 3D Silicon Microdosimeters 
The concept of 3D radiation detectors was first proposed in 1997 by Sherwood Parkerin 
[87]. The primary benefits of having small diameter electrodes running through the thick-
ness of a silicon wafer instead of along the transverse plane of the wafer come from the 
fact that the distance between electrodes is greatly reduced. This produces the favourable 
effects of lower bias voltage required for depletion, faster charge collection times, greater 
charge collection efficiency (CCE), better radiation hardness, and more perhaps most per-
tinent to microdosimetry, greater definition in the charge collection geometry. These ad-
vantages are particularly improve inherent problems in typical planar devices such as high 
count rates and radiation-induced depletion voltage increase[87]. 
The U3DTHIN detector is one such detector that was designed for high flux at the JET 
tokamak in 2009 [88]. It was designed to overcome the high count rate incapability, low 
sensitivity, poor energy resolution and low signal-to-noise characteristics of the scintillator-
PMT system that was previously employed. The most important cause for concern is the 
saturation of the detectors, preventing ions being detected that carry information about 
the plasma[88]. As illustrated in figure 1.16, vertical 5µm diameter p+ and n+ electrodes 
are placed in etched holes lOµm deep from the top of the substrate down to extremely 
thin oxide layer below. This is made possible due to high etch rate selectivity of 300: 1 
between the two materials, allowing the etching process to be stopped at the boundary 
in a relatively controller manner [89]. The n+ and p+ electrodes are etched and filled 
separately with their respective doped silicon, followed by a thin layer of thermal oxide. 
The distance between each electrode is much smaller than that of planer devices, enabling 
a much shorter charge collection time and hence reduced trapping potential[90]. In ad-
dition, a smaller inter-electrode distance means that reduced applied bias is required to 
reach full depletion. Vertical junctions mean that depletion occurs laterally, enabling a 
very thin detector that can operate under high fluence conditions. This is extremely de-
sirable for microdosimetric devices. This detector has previously been characterised and 
utilised for applications in Microdosimetry [91][92]. 
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Figure 1.16: Schematic cross-section of the U3DTHIN silicon detector (adapted from 
[88]) 
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A similar design has been built by Guardiola et. al. in 2012 [71] however applied in 
neutron detection and gamma rejection (figure 1.17). Normal detectors such as those 
with sensitive volumes composed Helium-3 or Li-6, whilst possessing much high neutron 
capture cross-sections for thermal neutrons, suffer from problems such as greater power 
requirements, bulkiness, as well as material transport restrictions (Li-6) and diminishing 
supplies (He-3). Whilst not intended for microdosimetry, the wafer sensitive volume 
thickness was selected to be on the microscopic scale of 10 µm, rendering the detector 
relatively insensitive to gamma rays. Due to robustness and versatility of silicon, a 10B 
converter layer was placed atop of the detector to capture thermal and cold neutrons and 
convert them to detectable charged particles. 
One of the advantages with the thin, lateral depletion is a decreased capacitance leading to 
increased SNR compared to planar devices. There are however considerations that must 
be taken into account in the design. Whilst reducing the space between the electrodes 
will decrease the depletion voltage and cause less charge trapping, the capacitance will 
increase giving a much noisier signal. Furthermore, the electrodes are sensitive to radi-
ation hence it is desirable to minimise their size which may cause material and etching 
issues[93]. 
These problems aside, using a thin detector means that heavier particles such as protons, 
neutrons and heavy ions won't be stopped by support layers before reaching the SV. Other, 
usually unwanted radiation, such as gamma radiation will have low probability of inter-
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Figure 1.17: Thin silicon device by Guardiola et al (adapted from [71]) 
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action due to relatively low-Z of silicon and the thinness of the detector. The use of a thin 
boron neutron conversion layer on the detector shows the feasibility of this detector as 
a thermal neutron detection with gamma rejection capabilities[71]. However, this detec-
tor was not designed for microdosirnetry as the bulk volume was monolithic, and hence 
did not possess individual SVs. This meant that oblique ion tracks could deposit large 
amounts of energy in the bulk silicon which has previously been shown with similar 3D 
detectors [94]. 
The same group developed this concept further and successfully fabricated a microdosirne-
ter with cylindrical SVs [95]. Based on a high resistivity n-type substrate, the p+ elec-
trodes of each SV were created using planar processes. After using deep reactive ion 
etching (DRIB) to remove an annulus region of silicon, n+ polysilicon was deposited 
along the depth of the wafer to create the n+ electrode. Charge collection studies [96] 
showed 100 % yield and successful charge collection, however well defined geometry 
was not observed. In addition, enhanced response was seen for 2 Me V protons, most 
likely due to contribution from the supporting silicon wafer. 
Meanwhile, the CMRP also ventured to produce its own truly 3D detector, called the 
Mushroom microdosirneter, with initial modelling and proof of concept performed in 
2014 [76]. The design consisted of arrays of 10 x 10 x µm cylindrical SVs on a 10 
µm thick SOI wafer. The more novel aspect of this design featured the etching of all 
silicon outside the SVs, and replacing it with PMMA to better mimic a tissue response 
and prevent external charge collection seen in previous generations. The PMMA would 
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also provide a suitable surface for the deposition of the aluminium buses. Modelling 
of this PMMA-embedded microdosimeter revealed very good agreement with a tissue-
equivalent spherical SY of the same size. More details of the first round of development 
of this patented technology [97] are discussed shortly. 
1.3 New Silicon Microdosimeters 
Three different types of microdosimeters are investigated in terms of their characteristics 
and use in microdosimetric applications in this thesis. All 3 designs are vastly different 
and all attempt to overcome the limitations and problems related to charge collection seen 
in previous generation devices . 
The Etched microdosimeter was created at SINTEF MiNaLab in Oslo using less sophisti-
cated planar technology, with the use of a guard ring to prevent external charge collection. 
While this technology has been shown to have flaws, the fabrication of this simpler de-
vice provided insight and direction at SINTEF for future fabrication of the Mushroom 
microdosimeter. Unfortunately, as will be shown in chapter 3, this device had poor charge 
collection characteristics due to silicon surrounding the SY s. 
The Bridge Yl Microdosimeter which was then fabricated at SPA-BIT in Ukraine, which 
had the surrounding silicon physically removed, making charge collection from outside 
the SYs impossible. Due to issues in fabrication, only ~5 µm of its 10 µm thickness was 
successfully etched, however its charge collection properties still outperformed previous 
generations [98]. This etching process was refined and the Bridge Y2 Microdosimeter 
was created. While charge collection characteristics were impressive (chapter 4), this 
microdosimeter still had relatively large, charge-collecting bridge regions in between the 
SYs which supported the aluminium bus; this deviated from the ideal microdosimetric 
concept of small, individual sensitive volumes. 
Meanwhile, processing parameters were refined and DRIB was utilised at SINTEF to fab-
ricate the first revision of CMRP-designed Mushroom microdosimeters at SINTEF. To 
assess and characterise this new technology, the first 3D mushroom microdosimeter de-
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vices were produced without PMMA-embedding or the removal of external silicon. 
This section provides more detailed descriptions of each of these microdosimeters used 
throughout this thesis. 
1.3.1 Etched Microdosimeter 
In 2013, CMRP started its collaboration with SINTEF to realise the patented 3D Mush-
room microdosimeter with well-defined, free-standing SYs. Located in Oslo, Norway, 
the SINTEF MiNaLab is one of only very few facilities in the world with expertise in 
3D technology for applications such as microdosimetry. The early prototype design came 
in the form of the planar Etched microdosimeter which, while based on planar processes 
only, helped gnide the various fabrication setup for future 3D devices. 
Its design is based on a high resistivity (10 kn.cm) p-type SOI substrate of 500 µm 
thickness and a total footprint of 10 x 10 mm2 • The back side of the wafer is etched 
down to 20 µm to produce the very thin sensitive volume required of a microdosimeter. 
Each SY is created using ion implantation to make an n+ core with 7 µm diameter on the 
front, with a continuous p+ implant on the back side, common to all SYs. In addition, a 
7 µm thick annular n+ implant is also created around each the SY which acts as a guard 
ring (GR) to help create a well-defined cylindrical SY. These GR electrodes are connected 
in parallel across the whole device. A p-spray layer also exists to compensate the positive 
charge trapping in the top oxide layer, preventing a surface inversion layer and a short 
between then+ electrodes [99]. A total of 9600 SYs are created on the 10 x 10 mm2 
footprint, yielding a total thinned area of 5. 7 x 5. 7 mm2 • A schematic of its structure is 
presented in fignre 1.18. 
As per its design, the microdosimeter contains well-defined SYs when the core and guard 
ring are biased such that the sensitive region is fully depleted. Under these conditions, 
based on the doping and concentric geometry of each implant, the boundary of the SY 
is approximately half way between the outer diameter (OD) of the n+ core implant and 
the inner diameter (ID) of the n+ GR implant, giving the SY a diameter of approximately 
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Figure 1.18: Schematic cross-section and top view of the planar Etched Microdosimeter 
(aluminium tracks not depicted for clarity) 
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12.5 µm. The distance from the centre of each of these 12.5 µm SVs is 50 µmin both X 
and Y directions. 
The SVs are divided into arrays of 600 which are electrically connected in parallel. Al-
ternating arrays are given the descriptor odd or even based on their position from the 
first array (top). As described previously, the production yield of these microelectronic 
devices can be poor and hence by separating the SV s into electrically separated arrays, 
potentially poorly performing SV s can be excluded from the data acquisition process by 
simply not connecting that array to readout electronics. In addition, separating the SV s 
into odd and even arrays reduces the input capacitance of the each preamplifying circuit, 
which increases signal-to-noise. This separation can also help reduce the probability of a 
charged particle depositing energy in multiple SV s, which would otherwise be recorded 
as a single event with enhanced energy deposition (cross-talk). 
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During fabrication, the implantation process is quite complicated and requires multiple 
thermal treatments to prevent thermal donors. Based on process simulations during the 
design and fabrication of the device, it was estimated that due to the design of the n+ and 
p+ implants, extreme recombination along the wafers depth would exist 1 - 2 µm on top 
of the backside implant and below the surface implants. In terms of charge collection, 
this essentially describes a dead layer in the detector, giving an average SY thickness of 
approximately 16 µm. 
1.3.2 Bridge V2 Microdosimeter 
The Bridge Y2 microdosimeter was collaboratively designed and fabricated at SPA-BIT, 
Ukraine. The Bridge Y2 design is technically an SOI device, fabricated with a 300 µm 
thick low resistivity 100 n.cm n-type supporting layer and a 10 µm thick, high resistivity 
3 kn.cm n-type layer on top of a silicon oxide layer. In order to isolate the detector 
from ambient effects and reduce surface leakage [100], a thin layer of phosphorus silicate 
glass and silicon oxide on top of device was deposited. The majority of interstitial silicon 
surrounding the SY s is removed via ion plasma etching, isolating the 30 x 30 µm SY s and 
20 x 15 µm bridge between them. This bridge is required to support the aluminium bus 
and is kept at a thickness of 10 µm to avoid fabrication complications seen in previous 
microdosimeters [82]. As shown in fignre 1.19, a 10 x 10 µmp+ electrode placed in 
the centre of the SY is used to bias and collect generated charge with a grounded 5 µm 
n+ strip that surrounds the SY and extends over the total area of the bridges. In contrast 
with Bridge Yl microdosimeter [98], angled ion implantation was used to extend this n+ 
electrode along the walls of the SY and bridge structures, in an attempt to improve the 
electric field shape and enhance charge collection. 
The 4.1 x 3.6 mm2 device die houses a total of 4,248 SYs, each 30 x 30 x 10 µmin size. 
In order to reduce capacitance and leakage, the die is divided into 3 larger segments, each 
consisting of two SY s arrays. Using the same convention as in chapter 3, these two arrays 
are called odd and even due to the alternating nature of their SY rows. Having alternating 
independently read out arrays allows for the possibility of using coincidence techniques 
CHAPTER 1. INTRODUCTION 
3001,1m 100 O.cm n-Si 
Substrate 
Figure 1.19: Schematic top view of the Bridge V2 Microdosimeter with cross-section 
view through the centre of an SV. A picture of each array row can be visualised by 
tiling the top-view schematic in the vertical direction. Matching colours represent like 
materials in both views. 
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to ignore events where a obliquely incident charged particles traverse multiple SV s (in 
low dose rates). 
1.3.3 Mushroom Microdosimeter 
The Mushroom microdosimeter was designed and fabricated in collaboration with SIN-
TEF MiNaLab in Oslo, Norway and was CMRP's first concrete implementation of truly 
3D silicon technology, as discussed in section 1.2.2.4. The Mushroom microdosimeter 
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consists of 2,500 free-standing cylindrical SY s, broken up into two arrays, odd and even, 
consisting of 1,250 SY s each. High resistivity (10 kQ.cm) p-type SOI substrate of 300 
µm thickness is used, with a 10 µm thick sensitive layer on top. 
The main variants investigated in this work are the air-trench device and the poly-trench 
device. For both of these devices, there are design variants which are listed below: 
• 18 µm diameter/ 30 µm diameter 
• Nop-spray layer/ p-spray layer/ p-stop layer on the device surface used as isolation 
betweenSYs 
• Device has 2400 SYs for low-medium dose rates/ device has just a single SY for 
high dose rates 
Further revisions of this device have included the deposition of PMMA [101], as discussed 
in the previous section, however are not apart in this thesis. 
1.3.3.1 Air-'Irenched Mushroom Microdosimeter 
A plan and cross-section view of a air-trenched Mushroom SY is show in figure 1.20. To 
describe the microdosimeter geometry, the main fabrication steps will be described. 
First, a p-spray layer was applied uniformly to the top. Ion implantation was then used 
to create two surface implants, an annular p+ implant on the periphery of the SY, and a 
circular n+ implant in the centre of the SY. DRIB was used to create two voids in the 
form of annular sectors on the outside of the SY (known as trenches), producing a near-
free-standing cylindrical silicon volume. The trench walls were then converted to p-type 
silicon using gas doping, establishing electrical conductivity to the p+ surface implant. An 
oxidation process was then performed. A circular channel in the centre of the device was 
then created along its depth using DRIB. Gas doping was again used to convert the inside 
walls of this central channel to n-type silicon, establishing electrically conductivity with 
the surface n+ implant. Another oxidation process was then performed. Small circular 
regions of the oxide layer were then etched away on the central n+ implant and one side 
of the of the p+ implant. Aluminium was deposited and patterned, making contact with 











Figure 1.20: Schematic top view of the air-trench Mushroom microdosimeter with cross-
section view through the centre of an SV (horizontally with respect to the plan view 
image). The diameter 52f is 18 or 30 µm, depending on the SV variant. Top oxide layer 
not shown in plan view. 
the exposed implants, as well as connecting to all other SV s. 
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This electrode configuration, as with all 3D devices, creates a strong electric field that 
propagates laterally from the core to the outside of the SV, creating a well-defined charge 
collection region. However, as can be seen from figure 1.20, the annular trench which 
defines the SV is not completely etched away, but has two small silicon bridges on either 
side of the SV remaining, which support the aluminium bus that runs centrally along the 
sv. 
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1.3.3.2 Poly-Trench Mushroom Microdosimeter 
A plan and cross-section view of a poly-trench Mushroom SY is show in figure 1.20. 
The fabrication steps are similar to the air-trenched device, however instead of leaving a 
small bridge of silicon in the outer trench, the trench is completely etched and filled with 
p-doped poly-silicon, which supports the aluminium bus that runs along the centre of the 
SY. In addition, in this early revision of the poly-trench device, the central n+ electrode 
is planar - not 3D as seen with the air-trench device. This design choice was made to 
improve fabrication yield with this developing technology and fabrication technique at 
SINTEF. This electrode confignration is similar to the Bridge Y2 rnicrodosimeter (section 
1.3.2) and, while not truly 3D, provides an isolated, well defined sensitive volume. 
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Figure 1.21: Schematic top view of the poly-trench Mushroom microdosimeter with 
cross-section view through the centre of an SV (horizontally with respect to the plan 
view image). The diameter !2f is 18 or 30 µm, depending on the SV variant. Top oxide 





Multiple microdosimeters have been characterised in order to understand their operating 
properties, performance and suitability for their use as a microdosimeter. While they are 
all designed to perform as microdosimeters on paper, the properties they exhibit after the 
fabrication process may render them unsuitable. These flaws may be revealed and as-
sessed through many different techniques, and only well performing devices are selected 
to assess their microdosimetric properties. Initial characterisation techniques allows sam-
ples that don't meet expected specifications to be excluded from further characterisation 
and application early on. 
The microdosimeters discussed in section 1.2 have undergone specification testing, in-
cluding visual or spectroscopic inspection via microscopy, electrical characterisation of 
current-voltage (1-V) and capacitance-voltage (C-V) relationships, and charge collec-
tion mapping; the latter of which describes the functionality fundamental to a dosime-
ter. This chapter contains descriptions of the methods used for characterisation of all 
sample types. As the actual tests performed were microdosimeter-dependent, specific 
characterisation techniques and steps undertaken may be omitted or different between 
microdosimeters. 
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2.1 Electrical Characterisation 
Electrical characterisation was performed at the ANSTO Ionising Radiation Lab in or-
der to determine operating properties of the microdosimeters such as depletion voltage, 
breakdown voltage, leakage current. With this information, it is possible to assess the 
suitability of each device as a microdosimeter. Multiple samples of each microdosimeter 
were characterised however only a limited subset of these will be reported on. 
1-V plots were obtained using a Keithley 237 high voltage source measurement unit, 
driven by ICS software (Metrics Technology). A range of bias voltages were applied 
and the corresponding current measured, starting from O V and increasing until a cur-
rent compliance limit of 500 nA was reached. 1-V measurements were conducted in a 
sealed vacuum chamber (unpressurised), preventing spurious pickup of electromagnetic 
radiation. C-V plots were performed over the same voltage range and under the same 
conditions using a Boonton 7200 capacitance meter. 
Typically, 1-V/C-V measurements are performed by biasing the core electrode (p+ for 
n-type silicon, n+ for p-type silicon) and grounding the backside or opposite electrode. 
Some designs require these characteristics to be measured by biasing the GR instead. In 
some cases, due to the close proximity of the GR and core, the punch-through effect is 
observed. When the GR region becomes depleted, it "latches" onto the built-in depletion 
region under the cores at a very low voltage which, in effect, biases all the cores on 
the device. As a result, this method overestimates the magnitude of leakage current and 
capacitance, however provides insight into the quality of each device. 
2.2 Design Verification using Microscopy and Spectro-
scopic Techniques 
Regional microdosimetry requires the geometry of detector SVs to be well defined in 
terms of charged charged collection. Using various characterisation methodologies al-
lows the microscopic structure of each SY, as well as the whole device to be better under-
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stood. 
Optical images were obtained through the use of an digital optical microscope at the Aus-
tralian Nuclear Science and Technology Organisation (ANSTO), Ionising Radiation lab. 
The macroscopic structure and construction of the device and packaging were visualised, 
as well as the arrays of SY s, allowing basic structural properties and superficial fabrica-
tion quality to be qualitatively estimated. 
A JEOL 7001F scanning electronic microscope (SEM) was used to measure the micron 
sized geometry and quality of the microdosimeters. Using voltages of 5 kV and 15 kV and 
working distances between 9-13 mm, imaging of plan and cross-sectional views was per-
formed. An XMax Oxford Instruments energy dispersive X-ray spectrometer (EDS) was 
used to map the elemental spatial distribution of some devices, providing both spatial and 
chemical/elemental information in both plan and cross-sectional views. Microdosimeter 
samples chosen for destructive imaging were heated and detached from the PCB. Some 
samples were selected for external imaging, allowing the surface geometry to be visu-
alised and others were fractured along the depth of the waver to reveal its cross-section. 
Due to the fragile nature of the latter samples and the potentially damaging effect that 
mechanical polishing posed, the cross-sectional surfaces were polished using ion milling, 
providing an unobstructed view of the internal structure of the microdosimeters. These 
observations where carried out at the Australian Institute for Innovative Materials (AIIM), 
University of Wollongong, with assistance from Dr. Mitchell Nancarrow and Prof. Elena 
Pereloma. 
2.3 Ion Beam Induced Charge Collection 
Charge collection of the microdosimeters was investigated using ion beam induced charge 
collection (IBICC) with the ANTARES heavy ion microprobe at ANSTO, Australia (fig-
ure 2.1). Detailed technical description of the microprobe components and function has 
been thoroughly described previously [102][103][104]. In the context of the acquisition 
process, a generalised description of the IBICC technique is provided below: 
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1. A beam of stripped ions is accelerated out of the ANTARES 10 MV tandem accel-
erator into the microprobe beamline 
2. The beam enters through multiple slits along the evacuated beamline with Faraday 
cups and beam profile monitors used to fine tune the beam 
3. A beam scanning system and quadrupole triplet is used to focus the beam down to 
a diameter of 1 µm and accurately scan the ion beam over a sample. This system 
also controls the field-of-view and magnification of the target sample. 
4. The beam enters a hexagonal evacuated chamber where a sample is placed, and 
where required electrical inputs/outputs are interfaced 
5. Within each sampling period, the (X ,Y) coordinate on the sampling plane is recorded 
6. Using spectroscopic equipment (described below), the charge deposited within the 
detector is measured and is binned into an MCA channel proportional to its magni-
tude 
7. For each acquisition, a list file is produced containing the X and Y coordinate for 
each detection event, along with the MCA channel number 
8. For each (X ,Y) pixel, the median energy of all energy deposited at this coordinate 
are used to generate a median energy map (MEM). 
These maps are the main product of the IBICC technique, allowing the localised visuali-
sation of the spatial charge collection distribution over different parts of the microdosime-
ter. 
Each microdosimeter sample was mounted within the evacuated sample chamber at nor-
mal incidence to the beam, connected to a low-noise Amptek A250 charge-sensitive 
preamplifier. A vacuum feed-through with breakout box provided the interface for biasing 
the detector and collecting the signal from the detector. The detector bias was provided by 
an Ortec 710 quad bias supply. A Canberra 2050 AFT research amplifier was connected 
directly to the preamplifer output and used to shape the raw detector tail pulse into an 
amplified Gaussian pulse. The Gaussian pulse was then injected into a Canberra 8076 
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Figure 2.1: Photograph of the ANSTO Heavy Ion Microprobe. The sample chamber is 
shown in the right-foreground and the accelerator and beamline in the background. 
ADC to produce an MCA spectrum. 
IBICC investigations were conducted for each microdosimeter sample between O V and 
their maximum operating bias (generally between ±6 V and ±10 V) in order to under-
stand how biasing affects the charge collection in and around its SV s. The effect of the 
GR was also investigated for some microdosimeters using both a floating configuration as 
well as being biased through a separate spectroscopic and biasing channel. This ensured 
that charge directly collected through the GR contact did not contribute to the core charge 
collection. Multiple magnification settings were used to capture the charge collection over 
multiple SV s, single SV s, and in some cases the bonding pads. 
To convert the MCA spectrum into an energy spectrum, a 300 µm thick Hamamatsu win-
dowless PIN diode was used. Using the same ion beam configuration and spectroscopic 
configuration that was used for irradiation of the microdosimeters, an MCA spectrum was 
obtained. Due to its large wafer thickness and windowless design, it is assumed that all 
5.5 MeV of the He2+ ion is collected, resulting in a full energy peak. The centroid chan-
nel of this peak was used to normalise the "pulse height" setting of a Ortec 419 pulse 
















Figure 2.2: Energy calibration spectrum using pulse generator, showing injected peaks 
which correspond to energy 1000, 2000, 3000, 4000 and 5000 keV. 
generator, where a dial value of 5.5 would inject a peak into this same channel. With the 
microdosimeter in place (which has similar capacitance to the PIN diode) and connected 
in the chamber, a spectrum acquisition was started (no beam). Using the pulse genera-
tor with the previously normalised settings, pulse heights of 1000, 2000, 3000, 4000 and 
5000 keV were injected into the spectrum, resulting in 6 well-defined peaks (figure 2.2). 
Using the known energy of these peaks, linear calibration factors were calculated and 
used to convert MCA channel to measured energy deposited. 
To provide a scale for the (X ,Y) coordinates of each charge collection map, a 1000 
lines/inch copper grid was mounted atop a surface barrier diode. For each magnification 
setting used to characterise the microdosimeter, a charge collection map was obtained 
using the diode. The grid lines collimate the beam and prevent most ions from reaching 
the detector. Since the spacing of these lines are known and the beam scanning system X 
and Y axes are calibrated equally, the pixels of the charge collection map can be binned 
spatially on a microscopic scale, seen in the median channel map in figure 2.4a. The pink 
structures are caused by attenuation of the beam through the grid lines which correspond 
to the smaller peak seen at around channel 600 in figure 2.4b. The higher energy peak cor-
responds to the yellow areas where the full energy of the He2+ ions have been deposited 
within the diode. 
Median energy maps are traditionally displayed using a colour map such as jet, which is 
quite visually pleasing. However it was found that for charge collection maps the transi-
tion of these colours provides an unintuitive visual display and can affect interpretation, 
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Figure 2.3: Spatial calibration data for IBICC results 
especially at lower energies. The slow transition from black to dark blue hides struc-
tures which have low charge collection. A custom map has been chosen for all median 
energy maps which thresholds very low energy events to black (near O keV), highlights 
low energy events in cyan and distinctly transitions through to higher energies with pink, 
red and yellow, followed by white which saturates energies greater than the displayed 
range. While this colour scheme is at odds with visual finesse, it provides a basis for clear 
visualisation of median energy maps. 
Software was written to convert and process the output binary files of the IBICC data 
acquisition system, called the CMRP IBICC Toolkit, shown in figure 2.4. This facilitated 
batch importation of files, energy and spatial calibration, adjustment of energy ranges and 
windows of the spectra and maps, and measurement of physical geometry and CCE - all 
with a user-friendly GUI. Previous processing methods involved performing a spatial and 
energy calibration manually, running four separate Matlab scripts on each file, and then 
formatting the figure for image output. This was an extremely time consuming task and 
small adjustments required repeating many of the steps. With the CMRP IBICC Toolkit, a 
batch of 30 files could be calibrated and displayed for output in approximately 5 minutes 
with minimal human input. 
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Figure 2.4: Screenshots of the CMRP IBICC Toolkit software, used for rapid and simple 
data processing and output for IBICC experiments 
2.4 Geant4 Simulation to Determine CCE 
Geant4 simulations were created to determine the expected energy deposition from 5.5 
Me V He 2+ ions at normal incidence, used to determine charge collection efficiency for 
specific microdosimeters. These simulations were carried out by colleague David Bolst 
(UOW). The Geant4 toolkit version 10.0 with the Quantum Molecular Dynamic and G4 
Standard EM option 3 (1 µm electron cuts) models were used to simulate hadronic and 
electromagnetic interactions, respectively. A single SV was constructed using geometri-
cal and material composition information from obtained from SEM and EDS data. For 
simplicity, the length of the aluminium tracks were not modelled. 
In the simulation, 5.5 MeV He2+ ions were normally incident on the microdosimeter top 
surface and the energy deposited within the SV recorded. An energy spectrum was con-
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structed and the centroid of the energy deposition peak Esim was determined. The average 
energy deposited within an SY Esv, was measured from IBICC results and equation 2.1 
was used to calculate an approximate CCE value. 




Characterisation of the Etched 
Microdosimeter 
A collaboration with the SINTEF MiNaLab, a microelectronics fabrication and research 
facility, was established in the early 2010's with a view to create a new generation of mi-
crodosimetric devices that overcome fabrication and design flaws seen with previous gen-
eration technology. The collaborations first microdosimeter was a planar microdosimeter 
designed to be used both in space and particle therapy. It features a large sensitive area for 
detection of ions in low dose rate fields and a GR in a vertical PIN diode configuration to 
better define the SY geometry. In contrast to previous SOI devices, a 20 µm thick sensi-
tive volume was produced using tetramethylammonium hydroxide (TMAH) etching with 
individual n+ core implants and common back-side p+ implant to achieve an improved 
uniform electric field. 
This chapter presents the characterisation of multiple device samples electrical and phys-
ical properties, as well as its charge collection characteristics. Refer to section 1.3.1 for a 
description of the Etched microdosimeter. The methods used for the characterisation have 
been described in chapter 2. 
The work described in this chapter has been published [105] with data collection per-
formed in collaboration with Dr. Linh Tran (CMRP, UOW), with simulations undertaken 
by Dr. David Bolst (UOW). 
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Figure 3.1: 1-V (black) and C-V (blue) characteristics of the Etched Microdosimeter 
(single SV), measured from the GR contact due to the punch-through effect (refer to 
section 2.1). 
3.1 Electrical Characterisation 
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The leakage current as a function of voltage for an Etched microdosimeter SV is shown 
in figure 3.1. The leakage current between 0.5 - 13 Vis approximately 1 pA with break-
down occurring at approximately 14 V. Based on manufacturer pre-packaged testing and 
simulation, breakdown was expected to occur at between 40 and 50 V. This discrepancy 
is thought to be due to a few defective SV s or from the wire-bonding / packing process 
carried out after device manufacture. Since 10 V is the typical operating voltage of thin 
SOI microdosimeters, this lower than expected breakdown voltage will have little impact 
on its microdosimetric capability. At its operating voltage, the leakage current was ~ 1 
pA per SV or ~0.6 nA per array. 
The C-V characteristics for the typical SV can also be seen in figure 3.1. As expected, 
capacitance decreases with voltage as the silicon diodes becomes depleted. A standard 
method for determining the depletion voltage using this data is by finding the intersection 
of two linear lines which approximately describe a 1/C2 vs. voltage plot. This is shown in 
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Figure 3.2: Graph showing approximate depletion voltage of the Etched Microdosime-
ter. 
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figure 3.2, yielding a depletion voltage of~ 1 V. The p-spray layer exists on the surface 
of the silicon which continues to deplete laterally past the bulk depletion voltage, hence 
why the C-V curve never truly plateaus. 
3.2 Design Verification using Microscopy and Spectro-
scopic Techniques 
Figure 3.3 shows optical images of the large area thinned microdosimeter obtained via 
optical digital microscope. However slightly blurry, these images clearly show the arrayed 
nature of the device and its extremely small circular SVs. No significant defects such as 
discontinuities in aluminium tracks or physical damage to the wafer were observed. 
Figure 3.4 shows a plan view of the microdosimeter top surface. Each SV is clearly 
defined by the the annular ring (GR) and central circular region (core). The aluminium 
tracks connecting each SV in an array can be seen to connect to the core and GR via 
small openings in the passivation of each SV. Whilst there are small edge defects in these 
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Figure 3.3: Optical microscope image showing device layout and arrays of Etched mi-
crodosimeter SV s. 
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aluminium tracks, no defects were observe that would inhibit conduction. Figure 3.5 
shows an isometric view of another set of SV s. 
Figure 3.6 shows a polished cross-sectional view of the device. The background (top) 
shows the top surface of the device and the foreground (bottom) shows the silver adhesive 
used to secure the device in the SEM. The fracture lines along the device surface that were 
created in the process of removing the device from its packaging can still be seen after 
polishing. The total thickness of the device was found to be less than the designed 20 µm, 
having an average measurable thickness of (19.1 ± 0.6) µm. 
Figure 3. 7 shows a plan view SEM image of the microdosimeter, with pitch measurements 
for each SV, yielding an equal pitch of rv48 µmin both X and Y directions. Figure 3.8 
displays measurements of a single SV core OD, and GR ID and OD, yielding 5.85 µm, 
19.42 µm and 32.85 µm, respectively. 
Figure 3.9 shows an EDS image of the microdosimeter cross-section. The cross section 
shows a layered structure of silicon nitride, silicon oxide, aluminium, a thin oxide layer 
and bulk silicon. There was no evidence of elemental doping in the silicon substrate. 
Concentrations of phosphorus or boron in doped regions is likely to be below the limit 
of detection of the instrument (limits of detection 0.1 atomic % per 500 nm3). The 
geometry and thickness of these layers were seen to be quite uneven, which is not unex-
pected due to modification of the oxide layer thickness during the various implantation 
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Figure 3.4: SEM image (plan view) showing the top surface of the etched microdosime-
ter. 
Figure 3.5: SEM image (isometric view) showing the top surface of the etched micro-
dosimeter. 
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Figure 3.6: SEM image of the cross-section of the etched microdosimeter, showing the 
measured thickness of the active area of the device. 
Figure 3.7: SEM image (plan view) of the top surface of the etched microdosimeter, 
showing the measured pitch and separation between adjacent SVs. 
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Figure 3.8: SEM image (plan view) of the top surface of the etched microdosimeter, 
showing the measured SV dimensions. 
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process. Furthermore, potential distortion may have occurred due to the SEM preparation 
processes. The thickness of material on top of microdosimeter surface reached ~ 2 µm 
over the aluminium contacts and ~ 1.4 µm over remainder of the device. These layers, 
which are often called over-layers, can cause large changes to particle LET ( depending 
on the particle energy) and can significantly affect charge deposited within the device 
SVs. 
3.3 Charge Collection Characterisation 
3.3.1 Ion Beam Induced Charge Collection 
The response of the Etched Microdosimeter to normally incident 5.5 MeV He2+ ions 
is shown in figures 3.10a and 3.10b. This response was measured from a single odd 
array and GR grounded, with the remaining 15 even and odd arrays left floating as in all 
subsequent measurements. The area irradiated with this scan was approximately 550 x 
550 µm 2, so most of the incident ions hit outside of the microdosimeter SV s, shown as 
pink circular regions in the median energy maps. A large low energy peak was observed 
at ~580 keV, which resulted in the median energy map being dominated by low energy 
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Figure 3.9: EDS image (cross-section) showing the detected spatial distribution of el-
ements existing inside the detector. The top EDS image is a combination of all the 
detected elemental distributions below it 
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events, originating from outside of the SVs. The events that occurred within the SVs were 
between ~ 1000 - 2000 ke V, which is much less than the expected energy that 5 .5 Me V 
He2+ ions would deposit in ~20 µm of silicon, showing the undepleted nature of the 
SVs. 
When biasing the odd array cores to 6 V and keeping the GR grounded, as seen in figure 
3.10d, charge collection was more defined, occurring primarily in the circular SVs. This 
is extremely important as the events occurring within an ideal microdosimeter should 
originate from charge generated along a particles passage through an SV, not outside of 
it. The corresponding peak created by He2+ ions crossing the thickness of the SV can 
be seen at ~2700 ke V in figure 3.1 0a. Biasing the cores produced a dramatic charge 
collection enhancement due to a larger depleted region in the SVs. However, this energy 
was still lower than expected, which will be discussed in section 3.3.1.1. 
With the scanning area reduced to approximately 30 x 30 µm2, a single SV was localised 
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(d) Median Energy Map (6 V core, grounded GR) 
Figure 3.10: IBICC data produced from 44 odd array SY s of the Etched Microdosimeter 
with GR grounded, showing the effect of biasing the cores. 
to understand its charge collection characteristics. As seen in figure 3.llb, with the core 
and GR biased at 6 V, the SV geometry was defined to a ~ 18 µm diameter circular 
region, with minimal external charge collection. The charge collection in the central 
region of the SV relatively uniform as it is directly under the 7 µm diameter n+ core, 
which produces a strong electric field which decreases radially towards the GR electrode. 
The charge collection geometry is similar to the design specifications shown in figure 
1.18, however the total charge collection area is significantly larger than the expected 
~ 12.5 µm diameter due to lateral diffused charge collection. 
Figure 3 .1 la shows the median energy map of the same single SV with core biased at 6 V, 
however with its guard ring grounded. As seen from these median energy maps, as well as 
the spectrum obtained in each configuration (figure 3.1 ld), the differences that biasing the 
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GR has on charge collection behaviour are significant. One notable difference is that with 
the GR grounded, there was a significantly larger charge contribution at greater distances 
from the centre of the SY. This degrades the geometrically definition of the SY and is 
a highly undesirable property of any microdosimeter, as previously discussed in section 
1.2.2.3. The energy deposited by He2+ ions within the SY was reduced by approximately 
300 ke Y when the GR was grounded, as seen in figure 3.lld. This can be explained by the 
absence of the punch-through effect when the GR is biased, which increases the electric 
field under and in close proximity to the n+ core. This enhances the vertical component 
of the electrical field due to lateral depletion under the biased GR. Finally, as seen by the 
shaded region of the spectrum in figure 3.lld and the median energy map showing only 
750- 1250 keY events in figure 3.llc, a wide peak at ~1000 keY was observed when the 
GR was grounded. The events causing this peak broadly occurred outside of the expected 
~ 12.5 µm diameter charge collection region. When the charge is produced around this 
region, the built-in electrical field of the GR causes a build up of charge which is able 
to be collected by the n+ core due to the parasitic capacitance between these structures 
(charge sharing phenomena). 
In order to investigate the low magnitude charge collection properties of the device, the 
lower level threshold (LLT) was reduced to a level which under normal operational condi-
tions would allow the injection of noise into the spectrum and reduce its integrity. Shown 
in figure 3.12a is the median energy map produced from irradiation with the cores and 
GRs biased at 6 V. It should be noted that every even row of SYs were left floating. With 
a decreased LLT, energy deposition was observed in the even array SY s, but the generated 
charge was being collected by the biased odd array SY s. These events correspond to very 
low energy events of the order of 30 keY. Seen in the median energy map showing only 
events < 30 ke Y in figure 3.12b, these events are confined to annular rings on the periph-
ery of the biased odd SYs (close to then+ GR electrode) and are widely and relatively 
evenly distributed across each of the floating even SY s. 
This effect can be explained by the capacitance-resistive charge sharing effect between the 
core and GR n+ electrodes, which is driven by a number of factors including: the applied 
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Figure 3.11: IBICC data produced from a single odd array SV of the Etched Micro-
dosimeter with core biased at 6 V, and comparing the effect of the GR biased at O V and 
6V. 
bias, geometry of the core and GR diodes, the parasitic capacitance between the core and 
GR n+ electrodes (and their PIN diodes), and the resistance parallel to the core and GR. 
The observed effect occurs when the distance between competitive electrodes is much 
smaller than the diffusion length. This effect causes the measured signal to be dependent 
not only on the actual energy deposited within the SV s, but rather by the physics of 
charge sharing between the core and GR. The observed charge collection phenomena 
has been observed in previous planar designs. The SV definition was improved using 
coincidence techniques between the SV and veto electrode (GR) [86]. Detailed analysis 
of the parameters of resistive-capacitive charge sharing can be investigated with TCAD, 
however are outside the scope of this thesis. 
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(b) Median Energy Map (0 - 30 ke V) 
Figure 3.12: IBICC data produced from 12 odd array SV s of the Etched Microdosimeter 
with cores and GR biased at 6 V with reduced LLT, showing charge contribution from 
floating even SVs. 












A Geant4 simulation was carried out on an Etched Microdosimeter SV using the geometry 
shown in figure 3.13. Figure 3.14 shows the simulated spectrum of energy deposited by 
5.5 MeV He2+ ions within a single Etched Microdosimeter SV, compared to that obtained 
from IBICC with the odd array cores and GRs biased at 6 V. The y-axis (counts) has been 
normalised to enable comparison between the spectra. 
Unlike packages like TCAD, Geant4 is only designed to simulate physical processes, 
hence the low energy charge collection seen in the experimental spectrum is not present 
in the simulated spectrum. In contrast, the simulation is unburdened by electronic noise 
or an acquisition LLT which has allowed very low energy events deposited by electrons, 
seen in the first few ke V of the spectrum. 
The feature of the spectrum most relevant to charge collection efficiency is the peak pro-
duced from He2+ ions crossing the SV thickness. In the simulation, two energy peaks 
were observed, both slightly higher energy than the experimentally observed peak. The 
lower energy peak at ~2700 keV was produced from the He2+ ions crossing the SV 
thickness where over-layers are thinner. The peak at ~2900 keV was produced by ions 
traversing the same volume, but with additional energy deposited within the aluminium 
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Figure 3.13: Schematic showing the Etched Microdosimeter SV geometry (a) top down 
and b) cross-sectional) and c) composition used for energy deposition simulations in 
Geant4. 
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Figure 3.14: Comparison of spectra obtained from experimental measurement of 5.5 
Me V He2+ ions incident on an Etched Microdosimeter SV and Geant4 simulation. 
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over-layers, resulting in LET enhancement. In contrast, the experimental measurements 
only showed a single high energy peak with energy 2630 keY, and with a significant low 
energy energy component. 
As discussed previously, the low energy events are caused by charge collection from the 
periphery of the SY s as well as the unbiased SY s due to charge sharing between the GRs 
and cores. The measured energy of the crosser peak was due to non-ideal CCE. Physical 
SEM and EDS measurements (used to determine simulation geometry) showed that this 
CCE shortcoming is not due to a lower than expected wafer thickness. Furthermore, ca-
pacitance measurements showed the device was sufficiently depleted at just 6 V. Reduced 
CCE was likely due to charge sharing effects between the biased cores and GR. Peak 
broadening may be due to slight device obliquity and/or ion range straggling, ultimately 
contributing to the observation of a lone crosser peak. 
The average energy deposited in the simulated SY was determined to be 2802 keY. Each 
5.5 MeY He2+ ion crossing an ideal etched microdosimeter SY with 100 % CCE would 
provide an average response of 2802 ke Y. As the Etched Microdosimeter clearly does not 
provide this ideal response, using the average expected deposited energy, a spatial CCE 
map was produced, shown in figure 3.15. A discrete colour scale was used to better visu-
alise the regions of varying CCE. As expected, this map mimics figure 3.1 lb with highest 
CCE of 92 % in the centre with rapidly decreasing CCE moving radially outward. 
The median CCE value was calculated for the entire image ( excluding pixels without reg-
istered events) and also within a circle of radius 6.25 µm, corresponding to the designed 
SY geometry. The median CCE value of the desigued SY area was determined to be (81.8 
± 3.0) %, and (64.1 ± 2.8) % for the entire 18 µm SY. A 1-pixel vertical slice through the 
CCE map is shown in figure 3.16, approximating a Gaussian charge distribution. 
3.4 Conclusion 
Electrical measurements showed the Etched Microdosimeter possessed at an extremely 
low leakage current of approximately 0.6 nA per array over its operating range of 0.5-

















Figure 3.15: CCE map produced from IBICC results and Geant4 simultation results for 
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Figure 3.16: A vertical 1-pixel slice from the CCE map produced from IBICC results 
and Geant4 simulation results for a single Etched Microdosimeter SY with core and GR 
biased at 6 V. 
73 
CHAPTER 3. ETCHED MICRODOSIMETER CHARACTERISATION 74 
13 Y. In addition, C-Y measurements showed full depletion of its SY at a low voltage 
of just 1 Y, relaxing requirements for powering this device. Overall, these results show 
favourable properties of a single etched microdosimeter SY, allowing the use of an array 
or many arrays connected in parallel to be used for radiation detection. 
Physical SEM measurements allowed the actual geometry of the device to be determined, 
which is often only assumed based on the design specifications. The measurements 
showed slight deviations between the design specifications and actual geometry, however 
the magnitude of these deviations are within processing parameter error margins during 
fabrication. The cross-sectional measurements were most important with respect to mi-
crodosimeter characteristics as they determine the average chord length of the device. The 
microdosimeter thickness was measured and determined to be (19.11 ± 0.61) µm. 
The charge collection characteristics of the Etched Microdosimeter were found using 
IBICC and unfortunately brought significant flaws of the device to light. The charge 
collection distribution in the SY s was circular in shape as expected, but was reminiscent 
of the previous generation microdosimeter with respect to charge collection: a lack of 
localisation compared to the designed SY geometry definition, due to inefficient charge 
collection on the periphery of the SY. In addition, due to common guard ring configu-
ration and the punch-through effect, unbiased arrays of SYs significantly contributed to 
charge collection, introducing a disproportionate weighting on the low energy component 
of each spectra. Using Geant4 simulation and IBICC results, the average CCE in the de-
fined SY region was determined to be (81.8 ± 3.0) %, and (64.1 ± 2.8) % for the entire 
SY volume. 
This results of the characterisation have shown that the design and/or fabrication of this 
planar device has not resolved the issues seen in previous generations of microdosimeters. 
While implementing a separate gnard ring structure per array would potentially improve 
part of the charge collection issues, the peripheral charge collection would still exist. 
The observed flaws further emphasises the need to move to entirely different fabrication 
techniques: 3D technology for silicon microdosimetry. 
Chapter 4 
Characterisation of the Bridge V2 
Microdosimeter 
The shortcomings of planar silicon microdosimeters that have been shown in chapter 3 
and in the literature [82, 83, 86] are mainly due to charge sharing effects between ad-
jacent SYs, which fundamentally result in poor SY definition. The first batch of 10 µm 
thick Bridge microdosimeters produced in 2014 brought design aspects from the 2nd gen-
eration Mesa device [82] in order both electrically and physically define the SYs. This 
was done through the removal of superfluous silicon outside the SY volume except for 
"bridges" of silicon between the SY s to support the aluminium bus, biasing the SY s and 
to collect the charge generated from within them. The first characterisation of the Bridge 
microdosimeter was carried out in 2015, revealing that only half the external silicon was 
removed in the etching process [98]. Despite incomplete etching of the silicon external 
to the SY boundary, charge collection characteristics and utilisation in a 290 MeY/u 12C 
beam showed promise for its application as a microdosimeter. 
The Bridge Y2 Microdosimeter was then produced to amend the poor etching processes 
during fabrication and optimise charge collection efficiency through slight changes to the 
electrode configuration as discussed in section 1.3.2. This chapter presents the character-
isation of the Bridge Y2 microdosimeter in terms of its physical and electrical properties, 
and its charge collection characteristics. 
Refer to section 1.3.2 for a description of the Bridge microdosimeter. The term "Bridge 
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microdosimeter" refers to the Bridge V2 microdosimeter and any mention of the Bridge 
Vl microdosimeter will explicitly use its complete name. Methods used for the charac-
terisation have been described in chapter 2. 
Part of the work described in this chapter has been published [98][106], with data collec-
tion performed in collaboration with Dr. Linh Tran (CMRP, UOW). 
4.1 Electrical Characterisation 
The leakage current of many devices were measured by applying a bias voltage from 
between O V and -10 V to the p+ core electrode while, grounding the n+ electrode on 
the core boundaries and bridges. Each array was biased individually and no significant 
punch-through effects were observed due to this unique electrode configuration. Shown 
in figure 4.1 are the 1-V characteristics of nine Bridge microdosimeter samples, showing 
the range ofl-V characteristics that occur a) within the same sample and b) within a batch 
of samples. Each measurement was performed with just one array connected (~700 SVs) 
with all other arrays left floating. Of all the arrays, ~53% reached a leakage current of 
less than 250 nA at 10 V, showing desirable characteristics which would minimise noise 
in obtained spectra. The proportion of arrays reaching a compliance current of 0.5 µA 
before reaching 10 V was 32%, with the remaining 15% reaching compliance without 
having a bias applied (0 V). The former arrays will have a high LLT and won't be able to 
record low lineal energy events. The latter cannot be used and these results are evidence 
of defective PN-junctions, most likely due to issues during implantation or defects in 
the n-SO1 active layer. Based on the 1-V characteristics of the batch tested in this work, 
the relatively low yield of well-performing arrays suggests there are fabrication issues to 
be investigated and overcome. Despite this, out of the 6 arrays in each microdosimeter, 
almost all devices contained on average 3-4 arrays which displayed desirable properties, 
allowing them to be used. 
The capacitance of the Bridge microdosimeters showed much less variation across de-
vices and as such, a less comprehensive measurement set was obtained. For an ideal 














0 2 4 6 
Reverse Bias (V) 
Good Samples 
i .. .. v 







..... -·• Samples 
8 10 
Figure 4.1: 1-V characteristics of multiple arrays of Bridge microdosimeter samples, 
measured from p+ core contact. 1-V curves from the same sample have been plotted 
in the same colour. Samples which reached compliance current at O V have not been 
plotted. 
PN-junction, the junction capacitance is inversely proportional to the depletion width. 
While the junction geometry of the microdosimeter is much more complex, the capac-
itance of the microdosimeter is expected to decrease as the depleted volume increases. 
Due to the depletion region being governed primarily by the microdosimeter SV's geom-
etry and applied bias, the variation in capacitance was expected to be less across different 
samples. 
Figure 4.2 shows the C-V characteristics obtained from the tested 12 Bridge V2 arrays, 
as well as 10 Bridge Vl arrays for comparison. The spread on both microdosimeter types 
is quite small, ranging from between 2 - 3 pF across all voltages. Due to the relatively 
complex nature of the junction(s) geometry, a unique capacitance profile is seen. The ca-
pacitance first decreases rapidly from O V and slowly decreases up until 3.5 -4V where the 
capacitance more sharply drops off and eventually plateaus. For some Bridge Vl samples 
the capacitance is seen to trough at 4 V and then increase slightly before plateauing. This 
feature is not seen in the Bridge V2 samples and is most likely due to the incomplete SV 
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Figure 4.2: Comparison of Bridge V 1 and V2 Microdosimeters C-V characteristics 
While ideal PN junction capacitance decreases smoothly with increasing bias ( equation 
1.35), the microdosimeters of course do not possess junction characteristics even close 
to an ideal 2D PN junction. The lack of straightness in the 1 / C2 curves shown in figure 
4.3 emphasise this expected departure from the model and show that depletion is reached 
between 4-5 V across all samples. 
4.2 Design Verification Using Microscopy Techniques 
Figure 4.4 shows optical images of the Bridge microdosimeter device including bonding 
pads, as well as a magnified view. These show the segmented nature of the silicon die, the 
arrayed nature of the device and its rectangular SV s, and bridges connecting them. For 
most samples, no significant defects were observed. 
Figure 4.5 shows an isometric view of the top surface of two of the Bridge microdosimeter 
samples. These images show the impressive definition of the SVs, and the bridges that 
connect them, resulting from the successful removal of all silicon surrounding them. The 
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Figure 4.3: Graph showing 1 / C2 vs. reverse bias, indicating depletion between 4-5 V. 
(a) (b) 
Figure 4.4: Optical microscope images of the Bridge V2 microdosimeter a) device and 
b) SV arrays. 
lack of silicon is confirmed by being able to view the large dark regions that the SVs sit 
upon; this is the oxide layer (hence, SOI), dark in colour due to the relatively low electrical 
conductivity of silicon oxide. The aluminium tracks can be seen to penetrate through 
the passivation into the n+ strip and p+ core in the SV s, with the bridges successfully 
supporting them between each SV, as per the design in figure 1.19. 
An interesting difference between these two Bridge V2 microdosimeter samples is the 
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difference in etching quality. While the bulk of the silicon in both samples was removed 
to expose the buried oxide layer, the uniformity and definition of the SV walls differs in 
each sample. Sample 1 shows very uniform etching profile with minimal etching artefacts 
seen. In contrast, sample 2 has very prominent lines on the SV walls, where it seems that 
sections of silicon were not etched as precisely. This effect is known as notching and is 
due to the deflection of the plasma due to locally varying electric fields [ 107]. The reason 
for the presence of this effect in one sample and not others is unknown, however it is 
unlikely to impact on their charge collection properties. 
(a) Sample 1 (b) Sample 2 
Figure 4.5: SEM image (isometric view) showing the top surface of two Bridge micro-
dosimeter samples. 
The physical dimensions of the Bridge microdosimeters were verified using these images 
by comparing the actual device geometry with the design specification. Figure 4.6b shows 
SEM images of a polished cross-section through an SV core. The average total thickness 
of the device across a range of samples on different wafers was (9.62 ± 0.18) µm, devi-
ating slightly from the design by 3.8 %. Figure 4.6b shows the a cross-section through a 
section of a bridge, with an adjacent SV core seen in the background. In both cases, the 
aluminium contacts can be seen on top of the silicon layer and below the passivation. The 
dark layer at the base of the SV /bridge is the buried oxide layer, completely revealed by 
the successful etching of silicon above it. Figure 4.6c shows a plan few of the top surface 
with measurements of the pitch and SV dimensions, deviating by 1-2 µm from the design, 
mainly due to the passivation layer on all sides of the silicon. 
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(a) Cross-section of SY core (b) Cross-section of SY bridge 
(c) Top surface 
Figure 4.6: SEM images of the Bridge Microdosimeter with physical measurements. 
Figure 4.7 shows an EDS image of an SV cross-section. Using the EDS spectra, signa-
tures of aluminium, oxygen, phosphorus and silicon were detected at high levels. Unlike 
EDS images obtained of the Etched Microdosimeter in section chapter 3, the geometry of 
the microdosimeter is much more structured, with high fidelity to the design. This is partly 
due to the fact that the Bridge microdosimeter has a solid 300 µm substrate for support 
through the entire fabrication process, including handling, wire-bonding, etc. The EDS 
image shows that the aluminium deposition is confined to the core and bridge regions, 
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and oxygen confined to the buried oxide layer and passivation, as expected. The existence 
of silicon and phosphorus is seen throughout the entire device, except where aluminium 
exists. It was known from the design specification that silicon was present in the SY bulk 
volume, the Si02 buried oxide layer and surface passivation, as well as phosphorous ex-
isting in the n-type bulk volume. Interestingly, it appears as if the phosphorous has either 
diffused into the buried Si0 2 layer or present due to the implantation process, creating a 
form of silicon glass [ 108], albeit with less a lower phosphorous concentration than the 
bulk n-type silicon. 
Figure 4.8 shows the different results of the etching process. Fignre 4.8a shows the 
"Bridge" microdosimeter without any etching at all, effectively a purely planar device. 
Figure 4.8b shows the Bridge Yl microdosimeter with only 5 µm of the silicon removed. 
Figure 4.8c shows the complete etching of the Bridge Y2 microdosimeter. Finally, fignre 
4.8d shows an example of an etching defect, resulting in sections of the bridge micro-
dosimeter without its silicon completely removed. Not only will this create charge diffu-
sion in these SY s (albeit small in comparison to the size of the microdosimeter), but it will 
also effect capacitance and charge collection due to the n+ electrode not being implanted 
properly in these surrounding SY s. However, due to the extremely low number of defects 
observed, microdosimetric function is unlikely to be affected. 
4.3 Charge Collection Characterisation 
The Bridge Y2 microdosimeter was irradiated using 5.5 MeY He2+ ions generated and 
raster scanned across the microdosimeter surface using the ANTARES heavy ion micro-
probe at ANSTO. By logging the known position of the beam when an event is detected, 
the charge collection geometry was mapped at biases between O - 10 Y. Figure 4.9 shows 
the median energy maps and corresponding spectra of a sampling of Bridge Y2 micro-
dosimeter SYs biased at 10 Y (nominal operating voltage). The Bridge Yl spectra and 
map taken previously with identical parameters is included for comparison. 
Figure 4.9a shows the Bridge Y2 median energy map, where the SY s are well-defined, and 
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Figure 4.7: EDS image (cross-section) showing the detected spatial distribution of ele-
ments existing inside the Bridge microdosimeter. The top EDS image is a combination 
of all the detected elemental distributions below it. 
have crisp geometries with no charge collection in between adjacent SVs, greatly surpass-
ing those of previous generations. The resulting charge collection regions has high fidelity 
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(a) No etching (b) Incomplete etching (Bridge V 1) 
(c) Full etching (Bridge V2) (d) Etching Defect (Bridge V2) 
Figure 4.8: SEM images (isometric view) showing the different types of etching states. 
to both the design geometry (figure 1.19) and physical characteristics found using SEM 
techniques (section 4.2). The well-defined, relatively uniform distribution is reflected in 
the corresponding spectrum in figure 4.9c, showing a very flat low energy response and a 
wide peak centred at approximately 1250 ke V, known as a crosser peak. 
In comparison, the Bridge Vl map in figure 4.9b only vaguely resembles the Bridge V2 
charge collection geometry, despite having the same design. The SV s are indeed defined 
with connecting bridges, however the high charge collection regions are rounded in shape, 
and a dynamic spectrum of events exists throughout the entire detecting volume. The 
range of these events can be seen in the spectrum in 4.9d, which is more disconnected to 
that of the Bridge V2 device. The high energy peak originated from events in the middle 
of the SV s, the continuum to its left from the SV edges, the peak at l"V500 ke V from the SV 
edges and bridges, and the events between 0 - 250 ke V from the interstitial silicon [98]. 
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The biggest difference between the charge collection of these two devices is the existence 
of very low energy events in the interstitial silicon between Bridge Vl SVs, which was 
not removed completely during the etching process. Finally, the difference in geometry 
sharpness between these geometries is in part attributed to the n+ electrode implanted in 
the Bridge V2 SV and bridge edges. 
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(c) Bridge V2 spectrum (d) Bridge Vl spectrum 
Figure 4.9: Median energy maps and spectra of the Bridge Vl and Bridge V2 micro-
dosimeters, both biased at 10 V. 
The effect of silicon removal is emphasised near the bonding pads as seen in figure 4.10, 
showing a resolved geometry in the Bridge V2 while the Bridge Vl geometry is drowned 
by a sea of low energy events. These results emphasise the importance of removing the 
silicon external to the SV s; even a small amount of residual silicon can result in significant 
charge sharing between electrically connected SV s, which is impossible to completely 
remove with guard ring configurations. 
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(b) Bridge Vl map 
Figure 4.10: Charge collection maps produced using the Bridge Vl and Bridge V2 






The spectra shown in figure 4.11 was obtained by increasing the bias voltage from 0 - 10 
V, in 2 V increments. Each spectrum was normalised to the total counts over all channels, 
allowing for easy comparison. Two features can be seen among the spectra: a) one lower 
energy peak that increases with bias ("lower energy peak") and b) a higher energy peak 
that changes only very slightly with bias. At 0 V, the majority of the events are located 
within the lower energy peak, spanning a wide energy range of around 600 ke V, with the 
remaining events small proportion of events occurring within a region at approximately 
1200 keV. When a 2 V bias was applied to the SV cores, the lower energy peak shifts 
to approximately 200 keV and the higher energy peak was well-defined at approximately 
1311 ke V. As the bias was increased further, the lower energy peak shifted towards the 
higher energy peak until at 10 V, where they combined. The higher energy peak did not 
change position with bias after 2 V, but upon amalgamation with the lower energy peak, 
became wider with a lower centroid energy. 
Figure 4.12 displays the origins of these peaks through the corresponding median energy 
maps. Relevant energy windows were chosen to include only events corresponding to the 
changing peaks, while excluding all other events in each map. As a result, events from 
the lower energy peak are shown on the left side of the figure, and events from the higher 
energy peak are shown on the right. While the broad characteristics of energy maps were 
similar, subtle variations in the maps acquired at different bias voltages were seen. 
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Figure 4.11: 5.5 MeV He2+ ion MCA spectra of the Bridge Microdosimeter spectra at 
various biases. 
The low energy windows maps show that the lower energy peak events were produced 
within the bridges that connect each SV, and the edges of the SV. Before depletion (10 
V), the lowest energy events occurred within the bridge region due to the greater distance 
between the biasing electrode and then+ electrode as seen by the distinct colour difference 
in the maps for O V and 2 V. Once the bias was increased, the difference between event 
energies in the bridge and SV edges decreased, with the lowest energy events occurring 
on the edges of the detecting geometry, at 10 V. This is likely a recombination effect due 
to defects on the SV edges, which is pronounced in this microdosimeter due to its very 
large surface area to volume ratio in comparison to normal diodes such as the Hamamatsu 
PIN diode. 
The maps on the right of figure 4.12 show that the higher energy peak events were pro-
duced within the SVs themselves. Before depletion, these events were of distinctly lower 
energy and were contained within the center of the SVs. After depletion, the collected 
charge from He2+ ions was greater and remained constant, however the area in which 
these events occurred increased laterally toward the SV edges with increasing bias. At 10 
V, an increased number of events originated from the bridge regions, with the charge col-
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Figure 4.12: 5.5 MeV He2+ ion median energy maps of the Bridge Microdosimeter 
spectra at various biases, windowing over the lower energy peak (left) and higher energy 
peak (right). 
lection region resembling the designed microdosimeter geometry. These findings show 
that as the bias increases, the bridge regions become increasingly depleted, which was ex-
pected due to the larger distance from the p+ core electrodes. Higher energy events were 
detected in these regions due to the horizontal component of the electric field increasing 
with bias. 
Despite these excellence performance characteristics, the issue of radiation damage is ever 
present with silicon devices, especially those made from n-type silicon [109] [110]. The 
effects of damage has previously been studied with previous thin detectors using the same 
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IBICC setup [94 ], albeit with higher beam currents. During the course of these Bridge V2 
irradiations radiation damage was obserbed, due to the continuous high LET flux incident 
on the detector. This is visible in the median energy map in figure 4.13. A significant 
loss of charge collection in the irradiated area can be seen when the device was not bi-
ased, occurring primarily in the bridges. At 10 V, the effects of this damage were still be 
observed, but to a lesser extent. During these irradiations, a total of 868,613 events were 
detected from high LET 5.5 MeV He2+ ions. These were detected within the ~29 SVs 
(including bridges), which resulted in a surface density of~ 2.5 x 109 particles per cm2, 
occurring over a short few hours. Due to the very high LET of the He2+ ions, the corre-
sponding dose is of the order of ~ 100,000 cGy which corresponds to ~400-500 particle 
therapy fractions, justifying its application both practically and economically. While fur-
ther dedicated radiation damage studies are required to deduce any meaningful outcome, 
these observations show that the bridge regions are the most susceptible to damage, re-
sulting in a widening and decrease in energy of the lower energy peak. This damage 
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Figure 4.13: Charge collection maps showing the effects of radiation damage that oc-
curred during radiation 
4.4 Conclusion 
1500 
Through the use of standard electrical characterisation methods, leakage currents of be-
tween 50 - 200 nA per array were observed for high performing samples ( ~200 pA/SV), 
but many samples were seen to breakdown well before the nominal 10 V operating volt-
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age. This indicates that the reproducibility of the fabrication methods used require im-
proving. C-V measurements of high performing samples revealed SY junction depletion 
occurring between 4 - 5 V, which displayed good uniformity between samples. These re-
sults were favourable, allowing the device to be depleted at relatively low voltages, while 
having flexibility for biasing at higher voltages and/or low noise multi-array usage. 
Physical SEM measurements showed the remarkable improvements from the Bridge Vl 
microdosimeter, with the complete removal of interstitial silicon between the SVs and 
bridges, exposing the buried oxide layer below. The etching quality of the walls of the 
sensitive geometry varied between samples with some having extremely uniform walls 
and others having undulating characteristics. Some small, localised defects were discov-
ered in some samples, however these were rare. Physical measurements of the device 
geometry showed slight deviations between the design and fabricated product, with the 
physical thickness measured across multiple samples to be (9.62 ± 0.18) µm. EDS mea-
surements also confirmed the expected composition of all components through a section 
of the microdosimeter. 
The charge collection characteristics of the device were revealed using the IBICC tech-
nique using the ANTARES heavy ion microprobe at ANSTO. Clean, isolated SVs and 
bridges were observed for the first time at all biases with the absence of low energy 
events, truly confirming the complete removal of interstitial silicon over the observed 
regions of the device. It was revealed that higher biases were required to increase the 
charge collection efficiency of the bridge regions, due to their greater distance from the 
biasing p+ electrode and weaker electric field. The complete etching of silicon and the 
additional n+ implantation in the walls of the entire device on its surface produced crisp 
and square geometry, in comparison to the rounded, less defined structures seen in the 
Bridge Vl device. In addition to the silicon removal, the n-stop layer significantly con-
tributed to decreased charge collection in regions external to the sensitive geometry ( e.g. 
pads). 
The results of this characterisation have shown remarkable improvements over the Bridge 
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Vl microdosimeter, and especially over previous planar designs. This work has confirmed 
that isolation of the sensitive geometry is of paramount importance for the removal of 
invasive low energy contamination. This will both allow for true microdosimetric appli-
cation in lower LET radiation fields, where low energy events are produced. These char-
acterisation results also provide confidence that the Bridge V2 microdosimeter is suitable 
for measurements in clinical heavy ion beams, presented in chapter 7. 
Chapter 5 
Characterisation of the Mushroom 
Microdosimeter 
The Mushroom microdosimeter was produced as a first step toward truly 3D micro-
dosimeters. The fabrication of such delicate structures using micro-machining processes 
had to be developed and tested before fully free-standing SY s could be reliably produced, 
as discussed in section 1.2.2.4. The Mushroom microdosimeter takes the technology used 
to develop the Bridge Y2 microdosimeter on step further, using DRIB etching to create an 
annular trench outside of the SY and incorporates two 3D electrodes in the air-trench de-
vice, and the use of doped polysilicon to create a 3D outer electrode that defines the SY s 
in the poly-trench device. However, the first revision of the Mushroom microdosimeter 
investigated here does take one step back in the sense that it still retains silicon in between 
its SY s, despite a trenched geometry. 
This chapter presents the characterisation of multiple Mushroom microdosimeter vari-
ants, in terms of their electrical and physical properties, as well as their charge collection 
characteristics. Refer to section 1.3.3 for a description of the Mushroom microdosimeter. 
Methods used for the characterisation have been described in chapter 2. 
Part of the work described in this chapter has been published [111], with data collection 
performed in collaboration with Dr. Linh Tran (CMRP, UOW) and simulations performed 
by Dr. David Bolst (CMRP, UOW). 
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5.1 Electrical Characterisation 
The leakage current of many devices (and device variants) where measured by applying a 
bias between O V and + 10 V to the n+ core electrode while grounding the p+ electrode on 
the SV periphery. Each array was biased individually and no significant punch-through 
effects were observed. Figure 5.1 shows the 1-V characteristics of a variety of devices 
including the 18 µm diameter air/poly-trench devices, 30 µm diameter air-trench/poly-
trench devices, as well as p-spray and p-stop variants. The colour of the curve indicates 
the device variant. 
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15 - • -18 µm air-trench p-stop 
- .,. -30 µm air-trench p-spray 
10 
--+·-18 µm poly-planar .... 
····•··· 18 µm poly-planar p-stop .,,...,,,,.. 
0.2 
________ ..,. .. 
---if- 30 µm poly-planar .,.----·--· .-----·-- 30 µm poly-planar p-spray ___ ........ -·-
,., . ..,,,,•"' ...... ..... 
~~:::.-_ ~ ... ............  
2 4 6 
Reverse Bias (V) 
-----......................... 
8 10 
Figure 5.1: 1-V characteristics of multiple arrays of Mushroom microdosimeter samples 
and variants, measured from the n+ core electrode. 1-V curves from the device variant 
have been plotted in the same style. Some values at 0, 1 and 2 V have not been plotted 
due to being negative. 
At a first glance, it can be seen that the curves are generally grouped together within 
bands of the same device variant, perhaps indicating fabrication uniformity across the 
relatively small amount of samples. At 10 V, all poly-trench devices are grouped together 
within 0.01-0.10 nA, which is between 10-100 times less than the air-trench devices, all 
of which are above 1 nA. However, out of all 26 poly-trench devices measured, 5 of the 
arrays reached compliance at O V and were not plotted. Out of the 16 air-trench devices 
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measured, all devices operated without reaching compliance up to 6 Y. The seemingly 
lower yield of the poly-trench devices may be a result of complications arising from the 
more complex fabrication processes involved in filling the trench with doped polysilicon, 
as well as deposition of aluminium over the polysilicon. 
Given that 79% of all samples (33 / 42) had smooth 1-Y characteristics and reached a 
leakage current of less than 10 nA at lOY, the majority of devices showed desirable char-
acteristics which would enable low noise spectral measurements, and to be candidates for 
further testing. 
The single sensitive volume (SSV) variants were also measured, however due to the ex-
tremely small nature of these devices, the leakage current magnitude approached the lower 
measurement limit of the Keithley current meter, indicating that instrument noise domi-
nated these measurements. Between O and + 10 Y, values of less than 100 pA were seen. 
This is higher than 111250th of the leakage current measured with the 1250 SY devices. 
However, given that many of these SSY samples are built upon a large common die, it 
is likely that contributions from the surrounding silicon contributed to these higher than 
expected values. 
Figure 5.2 shows the C-Y characteristics obtained the same 42 arrays, measured between 
0 Y and +10 Y (or their respective compliance voltage). The variation in these curves 
is large ( ~ 10 pF to ~60 pF) across devices types, which is not too surprising given all 
devices have different geometry and/or materials. Given the small number of samples, 
it is somewhat unexpected that within many of the device groups, there is large variation 
between samples. All device types except the 18 µm air-trench/poly-trench p-stop and the 
30 µm air-trench p-spray devices have significant variation between at least one of their 
samples. This again the influence of the non-uniformity resulting from the fabrication 
process. On average, the truly 3D devices (air-trench) possessed slightly lower capaci-
tance for each device size which is expected for the 3D column electrode configuration. 
However, the higher capacitance of the poly-trench devices may also be due to poor SY 
yield as a result of potential fabrication complications discussed previously. 
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Figure 5.2: C-V characteristics of multiple arrays of Mushroom microdosimeter samples 
and variants, measured from the n+ core electrode. 
Like ideal PN junctions, the capacitance of the Mushroom microdosimeters increases 
relatively smoothly without the trough-like features previously seen in the Bridge Vl 
and V2 Microdosimeters in section 4.1. The 1/c2 curves shown in figure 5.3 give some 
insight into the approximate depletion voltage of these devices. It would appear that some 
devices, namely the 30 µm air-trench p-spray devices (cyan) and 18 µm air-trench/poly-
trench p-stop devices (red/orange) are still depleting at 10 V, as seen by their curve's 
positive gradient. However, this changing capacitance profile could be related to lateral 
depletion of the surrounding silicon due to it not being removed in the etching process. 
All other devices indicate depletion at between 2 and 5 V. 
5.2 Design Verification Using Microscopy Techniques 
SEM was used to verify design geometry, however due to the material cost involved in 
sacrificing many devices, just a single 30 µm air-trench device was imaged to produce 
plan view and cross-section view images of the device. In addition a SSV devices were 
also imaged. 
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Figure 5.3: Graph showing 1 / C2 vs. reverse bias, showing indications of varied deple-
tion voltages across multiple Mushroom microdosimeter device types. 
Figure 5 .4 shows optical images of the Mushroom microdosimeter device including bond-
ing pads, as well as a magnified view. These show the arrayed nature of the device, with 
its circular SVs and aluminium bus visualised clearly. No significant defects were ob-
served. 
(a) (b) 
Figure 5.4: Optical microscope images of the mushroom microdosimeter a) device and 
b) SV arrays. 
Figure 5.5 shows an SEM isometric view of the top surface of the 30 µm air-trench 
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microdosimeter sample. This image shows successful etching of the annular trenches, 
leaving behind a small silicon bridge and well-defined cylindrical SV, as per the design 
(figure 1.20). The void in the centre of the SV can also be observed. The aluminium 
tracks are seen to successfully propagate between each SV, making contact with the p+ 
electrode through the centre of the SV and with the n+ on the outer-right edge of each 
trench. The aluminium, while making continuous contact in the image, appears to be less 
uniform then observed in both the Etched and Bridge microdosimeter. Aluminium is also 
seen on the inside edge of each trench, left over from the sputtering process. 
Figure 5.5: SEM image (isometric view) showing the top surface of a Mushroom Mi-
crodosimeter (air-trench) 
Measurements of these images were taken to verify the physical device geometry com-
pared to design specifications. Figure 5.6 shows SEM images of a polished cross-section 
through an SV core. Unfortunately aligning the plane through which the microdosimeter 
was sectioned and the true geometrical SV centre was not possible due to time constraints, 
hence why the central SV void cannot be seen. The average thickness of the device was 
(9.1 ± 0.1) µm, deviating from the design by 8.5 %. The dark layer at the base of the 
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SY/bridge is the buried oxide layer, completely revealed by the successful full etching 
of the silicon above it. Figures 5.6a and 5.6b shows SEM plan view images of the top 
surface with measurements of the SV and pitch which deviated by just 2 - 4 µm from the 
design, which was mainly due to the passivation layer on all sides of the silicon. 
(a) SV Measurement (b) Pitch Measurement 
(c) Cross-section 
Figure 5.6: SEM images of the Mushroom Microdosimeter with physical measurements. 
A 30 µm SSV sample was also imaged using SEM, shown in figure 5.7. This displays 
a greater degree of detail, clearly showing n+ implant location as well as DRIB etching 
features of the trench and central void. The horizontal lines seen on the walls of these 
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structures are the result of the repetitive nature of the DRIB technique, known as the 
Bosch Process [112), used to create 3D silicon structures. The process involves using 
short pulses of isotropic plasma etching which removes the silicon primarily in the ver-
tical direction, followed by a protective passivation deposition on the substrate surface. 
Broadly, these two steps are repeated up to hundreds of times with the number of repeti-
tions and etching time determining the quality of the resulting structure. As the etching 
cannot be isolated entirely in the vertical direction, it is common for structures to be left 
with an undulating pattern where the plasma has laterally removed the passivation of the 
previous layer [ 113] [ 114]. Less prominent undulation would be seen with shorter etching 
times and a greater number of etching steps. Based on the SEM images here, approxi-
mately 10 etching steps were carried out, with each removing~ 0.9 µm per step. 
Figure 5.7: SEM image (isometric view) showing the top surface of a SSV Mushroom 
Microdosimeter (30 µm air-trench) 
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5.3 Charge Collection Characterisation 
The Mushroom microdosimeter was irradiated using 5.5 MeY He2+ ions generated and 
raster scanned across the microdosimeter surface using the ANTARES heavy ion micro-
probe at ANSTO. By logging the known position of the beam when an event is detected, 
the charge collection geometry was mapped at biases between O - 10 V. Charge collection 
studies were performed on a variety of variant types including 30 µm air-trench p-stop, 
30 µm poly-trench p-stop, 18 µm poly-trench p-stop and 18 µm poly-trench. All mea-
surements were performed by biasing and reading out from an odd array, with the even 
array left floating. 
Due to the time consuming nature of the IBICC process, only 1 sample per device type 
could be tested. While a single sample is certainly not sufficient to characterise a popu-
lation, it provides indications as to the performance qualities of each variant. For most 
measurements, there was unfortunately slight drift of the sample stage at a rate of ap-
proximately 0.5 µm per minute, resulting in a slight decrease in clarity, effectively due to 
motion blur. This however does not significantly impact the qualitative analysis of these 
results. 
5.3.1 30 µm air-trench with p-stop 
Acquisitions were performed at various voltages between O and 10 V, however all maps 
obtained with biases between 1 and 10 Y showed no visible differences in observed fea-
tures. Maps for O Y and 10 Y are shown in figures 5.8. 
The map obtained at O Y was expected, showing circular high energy charge collection 
regions within the SYs, low energy collection in a strip between each SY, and a few low 
energy events in the interstitial silicon between the SY s. Furthermore, minimal charge 
collection was not seen in the even array, which was grounded. At 10 Y, the only sig-
nificant difference is a reduction in the low energy events in between the SY s due to the 
presence of the p-stop layer over the entire wafer, with no change in collection under 
the aluminium bus between adjacent SYs. In both cases the SY is as desigued: a cylin-
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Figure 5.8: 5.5 MeV He2+ ion median energy maps of the 30 µm Mushroom Air-trench 
Microdosimeter. The microdosimeter shifted by approximately 100 µmin the downward 







drical SV with relatively uniform collection with dead regions is the centre and trench 
regions. 
When comparing the normalised spectrum of the device obtained at each voltage, shown 
in figure 5.9, the similarities between the maps acquired at O V and 10 V were not sur-
prising. Due to the 3D electrode configuration, thin silicon wafer and the short electrode 
spacing, the Mushroom microdosimeters appears to be almost depleted due to its built-in 
voltage. The spectra changed very little between 1 and 10 V, with the only discernible 
difference being a slight increase in low energy events at 10 V, which resulted in a crosser 
peak with slightly less net area due to normalisation. At O V, the low energy component is 
slightly larger, with the high energy crosser peak having less energy and area, compared 
to when biased. 
The peak generated by ions fully crossing the active volume of the device was 1258 ke V. 
Using the geometry measured from SEM images (section 5.2), a Geant4 simulation was 
carried out by David Bolst (UOW) to determine the expected energy deposition, taking 
into account the measured aluminium and oxide over-layers. The simulated energy within 
the SV was determined to be 1367 keV [111] which is slightly more than measured ex-
perimentally. Using this value and equation 2.1, the charge collection efficiency was 
determined to be 92 % for this device. 
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Figure S.9: 5 .5 MeV He2+ ion energy spectra of the 30 µm Mushroom Air-trench Mi-
crodosimeter spectra at various biases. 
By only plotting events within specific energy windows over each region of the spectra 
and excluding all other events in each map, the origins of charge collection region can be 
identified. Figure 5.10 shows maps obtained with only events between 0 - 23 keV, 25 -
309 keV, 312 - 1118 keV and 1121 - 1573 keV. Very low energy events below 25 keV, 
corresponding to the left side of the low energy peak, occurred in the interstitial silicon 
between non-adjacent SVs. These events appeared to make a greater contribution to the 
spectrum when the microdosimeter was not biased (0 V). Events corresponding to the 
right side of the lower energy peak, up to around 309 ke V, were produced from a lateral 
strip of silicon between adjacent SVs. This strips appear to be somewhat non-uniform 
across the SV rows (see the bottom most row), possibly due to non-uniform etching of 
the annular sector trenches in this Mushroom sample. Events within the main part of the 
spectral plateau occurred predominantly from the edges of the SV s, and events within the 
crosser peak originated from throughout the entire SV. 
No charge collection was observed around the die edges or bonding pads when biased at 
lOV. 
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Figure 5.10: 5.5 MeV He2+ ion median energy maps of the Mushroom Air-trench Mi-
crodosimeter spectra at 10 V, windowing over 4 spectral regions. 
5.3.2 30 µm poly-trench with p-stop 
Acquisitions were performed at various voltages between O and 10 V, however as with 
the air-trench devices, maps obtained with biases between 1 and 10 V showed no visible 
differences in observed features. Maps for O V and 10 V are shown in figure 5 .11. 
At O V, a very high density of low energy events was observed in the interstitial silicon, 
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with well defined cylindrical SV s in which high energy events occurred. At 10 V, the map 
completely changed, with the removal of almost all low energy events in the interstitial 
silicon, except for a small annular area around the SV s. All charge collection occurred 
only from biased odd SV s, despite He2+ ions depositing energy within the floating even 
SV s. A dead region outside of the SV was observed as expected, with degraded collection 
at the SV centre. In contrast with the air-trench device (figure 5.8), this central electrode 
was fabricated using ion implantation, leaving functional silicon underneath, as per its 
design. Due to the strong recombination within the planar n+ electrode, there is effectively 
a dead region of thickness ,...., 1 µm. The effects of this dead region come in the form of 
slightly lower charge collection in the SV center, seen as the red spot in the centre of each 
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To create a better comparison between the spatial charge distribution and the device ge-
ometry, the SEM image of the air-trench device is overlaid atop the poly-trench map. This 
comparison could not be done with the air-trench map as higher magnification maps were 
not collected with this device. The comparison is shown in figure 5.12, clearly showing 
the charge collection volumes with respect to the physical geometry. 
The dramatic change in charge collection with increasing bias can be seen when plotting 
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Figure 5.12: 5.5 MeV He2+ ion median energy maps of the 30 µm Mushroom Poly-
trench Microdosimeter with overlaid SEM image, registering charge distribution with 
physical SV geometry. 
the spectra together, as shown in figure 5.13. At O V there exists a dominating wide low 
energy peak, with a similar plateau and crosser peak as seen with the air-trench device. 
When the bias is increased to 1 V and above, this low energy peak decreases both in energy 
and width. From this figure and figure 5.8, it is obvious that the poly-trench device and 
the air-trench device are worlds apart in regards to their charge collection characteristics. 
A spectral comparison between the poly-trench and air-trench device is shown in figure 
5.14, showing greater charge collection efficiency and significantly reduced low energy 
contribution in the poly-trench device. Once diminishing difference is that the width of 
the poly-trench crosser peak is wider than the air-trench device, as can be seen by the 
similar height of the normalised crosser peak in figure 5 .14, despite significantly less low 
energy events. 
The peak generated by ions fully crossing the active volume of the device is 1304 ke V 
across all biases, slightly higher than the air-trench device, indicating that the poly-trench 
configuration provides greater charge collection efficiency within the SV. Using results 
from the Geant4 simulations and equation 2.1, the charge collection efficiency was deter-
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Figure 5.13: 5.5 MeV He2+ ion energy spectra of the 30 µm Mushroom Poly-trench 
Microdosimeter spectra at various biases. 
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Figure 5.14: 5.5 MeV He2+ ion energy spectra of the 30 µm Mushroom Poly-trench 
and Air-trench Microdosimeters at l0V. 
By only plotting events within specific energy windows over each region of the spectra 
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and excluding all other events in each map, the origins of charge collection region can be 
identified. Figure 5.15 shows maps obtained with only events between 0 - 49 keV, 52 -
905 keV, 908 - 1205 keY and 1208 - 1661 keY. 
It can be seen that very low energy events below 50 ke Y originate from within the annular 
ring outside the poly-silicon filled trench. These events are thought to be produced from 
diffusion of charge generated outside the SY, through the poly-silicon and into the drift 
region. The rather crisp and well-defined annulus shape may simply be an artefact brought 
about due to the LLT cutting off lower energy events. Regardless, a similar (low) LLT will 
exist when utilising the device as a microdosimeter, so the charge distribution seen in the 
map is representative of the collected events during a microdosimetric acquisition. Events 
between 52 keY and 905 keY, corresponding to the plateau region in the spectrum, come 
from the edges of the SY and may be due to dead regions within the p+ electrode or the 
lower lateral electrical field strength at this distance. The region on the right side of the 
plateau and the left side the crosser peak originated from the SY edges, but primarily 
from centre of the SY s due to an effective decrease in the active silicon volume where the 
n+ implant exists. Finally, the majority of the crosser peak comes from the SY volume, 
excluding the centre and edges as previously discussed. 
While the results obtained using this device are somewhat favourable, the quality of this 
device was put into question after finding an area which possessed low yield, as shown in 
the median energy map in figure 5.16. An entire row and the remainder of another are not 
collecting. This is most likely due to a discontinuity of the aluminium bus, hence why a 
number of adjacent devices in a row were functional and the remainder of the row were 
non-functional. 
No charge collection was observed around the die edges or bonding pads when biased at 
lOY. 
CHAPTER 5. MUSHROOM MICRODOSIMETER CHARACTERISATION 108 
1500 1500 
200 200 
150 1000 150 1000 
> > 
E l!-~ E ! 
:;_ >, :;_ >, 






50 100 150 200 50 100 150 200 
x(µm) x(µm) 
(a) 0 - 49 keV (b) 52 - 905 keV 
1500 1500 
200 200 
150 1000 150 1000 
> ~ 
E ! E ~ 
:;_ >, :;_ >, 






50 100 150 200 50 100 150 200 
x(µm) x(µm) 
(c) 908 - 1205 keV (d) 1208 - 1661 keV 
10" K: :r:~ 77 .:.as::,::...:..;s:J rn -C: ::J 0 (.) 
0 200 400 600 800 1000 1200 1400 1600 
Energy (keV) 
( e) Spectrum showing the 4 window locations as shaded areas 
Figure 5.15: 5.5 MeV He2+ ion median energy maps of the Mushroom Air-trench Mi-
crodosimeter spectra at 10 V, windowing over 4 spectral regions. 
5.3.3 18 µm poly-trench with p-stop 
The 18 µm poly-trench p-stop device was also investigated, however the sample investi-
gated exhibited signs of fabrication errors in the form of low yield, shown in the median 
energy map in figure 5 .17. Despite the low yield, the charge collection characteristics of 
the SV s were actually more favourable than the same 30 µm variant, as the low energy 























Figure 5.16: 5.5 MeV He2+ ion median energy maps of the 30 µm Mushroom Poly-
trench Microdosimeter at 10 V, showing non-functional SVs in array rows. 
annulus around the SV was not observed. This can be seen in the median energy map 
in figure 5.18. This like likely due to smaller 18 µm diameter SV, resulting in a stronger 
electric field on its periphery. All other characteristics were identical to the 30 µm device, 
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Figure 5.17: 5.5 MeV He2+ ion median energy spectrum and map obtained with the 
18 µm Mushroom Poly-trench Microdosimeter (p-stop) at 10 V, showing non-functional 
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Figure 5.18: 5.5 MeV He2+ ion median energy map of the 18 µm Mushroom Poly-








Through the use of standard electrical characterisation methods, 1-V and C-V characteris-
tics for 42 Mushroom microdosimeter samples of various device variants were measured. 
For air-trench samples, leakage currents between 5 - 20 nA per array were observed in 
most samples with only 4/16 samples exhibiting defective characteristics. For poly-trench 
devices, leakage currents of between 0.1 - 0.2 nA were observed for most devices with 
5/26 showing defective characteristics. Within each device type, a relatively high degree 
of uniformity was observed based on 1-V characteristics. However, C-V measurements 
revealed relatively large variations in capacitance between 0-10 V. This could have sig-
nificant implications when connecting both arrays on single device together with a single 
readout, resulting in varied gain. For most samples, depletion was observed between 2 - 5 
V. The lack of uniformity is somewhat concerning, however most of the observed charac-
teristics suggest that operation at relatively low bias voltages is possible with low leakage 
currents, allowing biasing at higher voltages and/or low noise multi-array usage. 
Physical SEM measurements showed complete etching of the two annular trenches, pro-
ducing a well-defined nearly free-standing cylindrical SV with a small bridge to allow for 
n+ electrode connection. Complete vertical and horizontal etching showed great promise 
to produce the surface area for 3D p+ and n+ regions. Physical measurements of the 
CHAPTER 5. MUSHROOM MICRODOSIMETER CHARACTERISATION 111 
device geometry showed slight deviations between the design and fabricated product, 
with the physical thickness measured across a single air-trench samples to be (9.1 ± 0.1) 
µm. 
The charge collection characteristics of multiple device variants were discovered using 
the IBICC technique using the ANTARES heavy ion microprobe at ANSTO. In almost all 
variants, expected charge collection geometry was seen through well-defined cylindrical 
SYs. 
The 30 µm air-trench p-stop device showed well defined cylindrical SY s with high charge 
collection efficiency of 92 % at 10 V. However, a low energy component was observed, 
generated in between adjacent SY s, due to the residual silicon bridges left after etching 
which support the aluminium bus. Dead regions in the central core and outer trenches 
were seen, confirming the complete removal of silicon during the etching process; this is 
an important process on which present and future 3D technology heavily relies. 
The 30 µm poly-trench p-stop device showed quite different however more favourable 
characteristics. When biased at 10 Y well defined cylindrical SYs were observed with 
charge collection efficiency of95%. The only low energy component observed originated 
from a thin annulus around each SY, which contributes significantly less to its overall 
response compared to the 30 µm air-trench p-stop device. There was evidence of some 
fabrication issues in the form of a small proportion of non-functional SYs. 
The 18 µm poly-trench p-stop device also showed signs of poor yield, however the SY 
characteristics were the most favourable of any device, possessing well defined cylindrical 
SYs with minimal low energy components. The desirable charge collection properties 
and small SY s of this device provide great potential for its application in high dose rate 
radiation environments. 
The IBICC technique is an extremely useful tool which provides detailed charge collec-
tion characteristics of the microdosimeter structures, and verifies the expected function 
of their design. Although only a small number of samples were investigated, results ob-
tained for all microdosimeter variants assisted in explaining the unique features seen in 
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MCA spectra acquired during alpha spectroscopy measurements. 
With the information learned from this characterisation, a new variant is planned to be 
developed, whereby complete trenches will be formed around the SY, filled with polysil-
icon and the surrounding silicon etched away and replaced with PMMA, creating a more 




As microdosimetric acquisitions are generally performed in charge particle therapy facili-
ties that are almost exclusively overseas, beam time is considered extremely valuable and 
sought after. As a result, experimental efficiency was optimised in order to make the most 
of the allocated beam time. Previously, experimentation with microdosimetric devices 
have involved the use of a PMMA phantom with rigid housing, which required some-
times lengthy in-person adjustment of the apparatus to change experimental variables. 
This chapter briefly describes implemented design improvements to the microdosimetric 
experimental setup in order to increase productivity, allowing for more comprehensive 
research outcomes. 
6.1 Software Development 
A software package, called the "CMRP Microdosimetry Suite", was developed in-house 
with an aim to quickly and efficiently acquire and process MCA energy spectra into the 
various microdosimetric quantities and representations, as outlined in subsection 1.1.3. 
The suite was used to acquire spectra with the direct control of an Amptek 8000A MCA, 
and in real-time, generate microdosimetric data for analysis and inform real-time deci-
sions regarding the irradiation e.g. beam current, detector location, etc. As an MCA spec-
trum was being obtained, using known microdosimeter parameters such as chord length, 
113 
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CCE correction and energy calibration, microdosimetric quantities were calculated (with 
uncertainty) and displayed during the acquisition. These quantities included f(y), Yn, YF 
, y*, RBE10 and the microdosimetric spectra. Batch processing on a whole data set after 
the experiment provided complete depth dose profiles and spectra comparison. Screen 
shots showing the various operating modes are shown in figure 6.1. 
•- l 
·- ·- l 
►-- - l-
(a) MCA Acquisition (b) Microdosimetric calculations (c) Motion control 
Figure 6.1: Screenshots of the CMRP Microdosimetry Suite. 
While this software was extremely useful, there was still a need to have to physically 
change the experimental setup in between device irradiations, in order to vary the detector 
position with the phantom. Every time the detector had to be moved inside the phantom, 
a user had to wait for the dose rate in the beam room to drop below an acceptable level, 
wait for a heavily shielded door to open slowly and then proceed to change the setup. This 
process at HIMAC for example took between 3 and 5 minutes each time, and sometimes 
up to 10 minutes depending on the beam current used. In addition, while the dose rate 
was below acceptable limits at room dose meter, the localised dose rate at the collimator 
or phantom could sometimes be greater than 100 mSv per hour, increasing the risk of 
exposure to the person adjusting the setup. The solution to this problem relied on creating 
a new phantom that was portable and could be controlled remotely. The decision was 
made to move away from a solid PMMA phantom to a water phantom, which would 
ultimately improve efficiency and capability. However, with this decision came challenges 
including the physical design of the movement stage, water proofing of the electronics and 
writing control software - all on a very tight timeline and budget. 
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6.2 Electronics Development 
A new electronics probe was developed by CMRP to replace the Amptek A250 front-end 
electronics with a application-specific, compact and low noise alternative for use in water 
phantom experiments. The MicroPlus Probe, shown in figure 6.2, provided a means to 
place any microdosimeter housed on a DIL-20 package on its PCB, with jumpers used to 
enable or disable the use of any of the microdosimeter arrays. Only a very small number 
of passive components are placed within a 5 cm distance of the microdosimeter in order 
to prevent active and more radiosensitive integrated circuits (amplifiers, etc) from being 
irradiated in a 10 cm x 10 cm ion beam, and to minimise radiation-induced activation. 
The probes I/0 connector is a single D-subminiature 9-pin (D9) connector, providing a 
means to read out the pre-amplified microdosimeter signal, and facilitate the necessary 
power rails for the electronics. An in-house shaping amplifier was also created, which 
connected to this D9 connector to convert the microdosimeter tail pulse to a Gaussian. 
Coaxial breakout connectors from the shaper box passed this shaped signal to an Amptek 
8000A MCA for processing and analysis. 
Figure 6.2: Image of the MicroPlus Microdosimeter Probe showing the location of the 
microdosimeter. 
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6.3 Mechanical Development 
A waterproof PMMA sheath was designed by former CMRP research fellow Dr. Michael 
Weaver and fabricated at the UOW workshop, shown in figure 6.3. The sheath model 
was split along its length to enable the cutouts for electrical components and the micro-
dosimeter to be machined, and then screwed together and sealed with silicon. The volume 
of PMMA on the front of the sheath was machined out to create a 0.5 mm thick PMMA 
window on top of the microdosimeter, ensuring that the majority of the media in front of 
the detector was water. A mounting zone with four M3 holes was created at the top of 
the sheath to allow it to be mounted to a motion stage, as well as secure the shaper box 
on top of the probe. The sheath is covered in aluminium foil (expect the 0.5 mm PMMA 
window) and is grounded to form a Faraday cage to reduce EM pickup. 
1/0 D-Sub 
Figure 6.3: Render of the MicroPlus Microdosimeter Probe PMMA sheath with Mi-
croPlus probe inside. 
A low-cost motion stage was then created from a Makerbot Replicator 3D printer and 
PMMA water tank, controlled remotely using Arduino-driven stepper motors with limit 
switches for X-Z homing of the stage. The MicroPlus sheath geometry was designed to 
be mounted on the motion carriage with it's Y-axis fixed, positioning the microdosimeter 
in the center of the water tank. The CMRP Microdosimetry Suite was used to control 
the microdosimeter depth and lateral position within the tank, as well as perform homing, 
automated calibration of the steps/mm, as well as execute custom motion profiles. An 
Ethernet interface allowed remote operation over long distances, often useful at beam 
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lines and clinical treatment rooms where mazes exist. Due to the open-loop nature of 
the movements (no encoders), a camera was mounted on top of the stage in order to 
verify that movement commands were actually undertaken. In addition, over-layer offsets 
could be added to the motion control system to ensure the microdosimeter was positioned 
at an water-equivalent depth for particular beams. This meant that the water-equivalent 
thickness of upstream media such as the PMMA tank wall, sheath window, light-tight 
film on microdosimeter surface, air gap, etc were all accounted for when positioning the 
microdosimeter. The motion stage is shown in figure 6.4, as well as a custom rebuild of 
the stage using 3D-printed parts to increase motion reproducibility and ruggedness during 
transport. 
(a) Initial Build 
(b) Rebuild 
Figure 6.4: Images of the initial motion stage design and the rebuild version. 
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6.4 Associated Simulations 
With these mechanical upgrades came the introduction of materials that are not water-
equivalent, such as the tank walls, PMMA sheath, foil, etc. In order to put the micro-
dosimeter at a particular depth in water, the water equivalent thickness of the materials 
must be known for the beam type under investigation. This was determined by simulations 
performed by Dr. David Bolst (CMRP, UOW) with pristine proton and carbon beams of 
various energies. For each material simulated, the pinnacle of the Bragg peak was used as 
a measure of ion range and use to calculate the water equivalent ratios (W ER) as defined 
as WERx = Rx/ RH2o. Tables 6.1 and 6.2 show the WER values for a variety of different 
materials and beam energies for proton and carbon ion beams. Given the relatively low 
energy dependence of this value, the values over all energies were averaged for each ion 
species and used to offset the microdosimeter position system, to take these materials into 
account. Comparisons with the ratios of NIST projected ranges are all within 1 %. 
Table 6.1: Simulated ranges and water-equivalent ratios calculated for carbon ions of 
various energies in various materials 
50MeV/u 150MeV/u 290MeV/u 
Material Range(mm) WER Range(mm) WER Range(mm) WER 
Water 7.5 1.00 53.0 1.00 162.8 1.00 
Aluminium 3.6 0.48 25.0 0.47 76.0 0.47 
PMMA 6.4 0.85 45.3 0.85 139 0.85 
Latex 7.9 1.05 55.8 1.05 171.5 1.05 
HDPE 7.4 0.99 52.6 0.99 161.8 0.99 
Graphite (1.7 g/cm 3) 3.9 0.52 27.0 0.51 82.9 0.51 
Graphite (0.82 g/cm 3) 10.5 1.40 76.4 1.44 235.7 1.45 
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Table 6.2: Simulated ranges and water-equivalent ratios calculated for protons of various 
energies in various materials 
30MeV lO0MeV 200MeV 
Material Range(mm) WER Range(mm) WER Range(mm) WER 
Water 8.9 1.00 76.8 1.00 285.7 1.00 
Aluminium 4.4 0.49 36.9 0.48 121.8 0.47 
PMMA 7.6 0.85 66.3 0.86 221.2 0.86 
Latex 9.1 1.02 80.2 1.04 269.4 1.04 
HDPE 8.7 0.98 76.2 0.99 256.6 0.99 
Graphite (1.7 g/cm3) 4.5 0.51 38.8 0.51 130.2 0.50 
Graphite (0.82 g/cm3) 12 1.37 105.1 1.44 356.8 1.38 
Chapter 7 
Microdosimetric Applications in Heavy 
Ion Therapy 
While the He2+ ions generated by the ANTARES accelerator have been shown to be 
useful for characterising the charge collection in the silicon microdosimeters, tandem ac-
celerators are not capable of generating high energy heavy ions used for the treatment of 
cancer in heavy ion therapy (and the mixed secondary spectrum), for which these micro-
dosimeters were designed. 
This chapter presents experimental work from the utilisation of multiple microdosime-
ters including the Etched microdosimeter, Bridge V2 microdosimeter and Mushroom 
microdosimeter, as well as a thin 3D detector, using a 290 MeV/u SOBP 12C beam at 
the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan. Microdosimetric spec-
tra were obtained in PMMA and water phantoms at many locations along the central 
axis of the beam, where 12C ion LET changes with depth, especially at the end of the 
SOBP, generating a spectrum of secondary particles along their passage. In addition, lat-
eral profile measurements in-field and out-of-field were performed, as well as a selection 
of distal locations. Using the obtained spectra, microdosimetric quantities such as Yn 
were calculated, as well as the derivation of RBE10 for HSG cells, using the modified 
microdosimetric-kinetic model. Using these values and measured physical dose, the bi-
ological dose profile was approximated as a function of depth in water phantom. The 
results obtained from each microdosimeter were compared with each other, and with pre-
120 
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Figure 7.1: Image of the HIMAC Bio-Cave beam room 
viously obtained TEPC measurements, which provided insights into the impacts of the 
various microdosimeter designs on their potential for use in hadron therapy QA. 
Parts of the work described in this chapter have been published in multiple journal articles 
[98, 105, 106, 115], with data collection performed in collaboration with Dr. Linh Tran 
(CMRP, UOW). 
7.1 The HIMAC Bio-Cave Facility 
The Heavy Ion Medical Accelerator in Chiba (HIMAC) is located at the National Institute 
of Radiological Sciences (NIRS) in Japan. It was built in 1994 and was dedicated to 
research and treatment of cancer using particle therapy, and also served to replace the 
existing fast neutron therapy facilities at NIRS [116]. As of 2015, it has treated more 
than 10,000 patients using 12C ions [117]. Whilst this is its primary focus, HIMAC is 
also capable of accelerating a vast array of conventional and exotic ion species to the 
Bio-Cave, where radiobiological experiments are carried out, shown in figure 7 .1. 
The HIMAC accelerator consists of a linear accelerator for low Me V /u ions and an Al-
varez type linac for medium Me V /u ions, which also acts as an injector to the two main 
synchrotrons. The maximum energy deliverable is 400 Me V /u. In order to generate a 
typical clinical 12C ion field ( e.g. 10 cm x 10 cm, 290 Me V /u SOBP with 6 cm modula-
tion) from the HIMAC Bio-Cave beam port, the following processes are undertaken, and 
is illustrated in figure 7 .2 [ 118]: 
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Figure 7.2: Schematic of the IIlMAC Bio-Cave beam line components, adapted from 
[118] (not-to scale). 
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1. An approximately monochromatic 290 Me V /u beam with spot size 3.4 mm a enters 
the evacuated beam line 
2. X and Y wobblers are used to spread out the pencil beam into a larger field 
3. The beam then passes through a tantalum scatter to improve lateral dose uniformity 
4. The beam is then collimated by a thick brass collimator with diameter 100 mm 
5. A neutron shutter then reduces neutron flux generated within this brass collimator 
and then the beam is collimated again by a thick brass collimator 
6. An aluminium ridge filter then selectively degrades the beam, producing a weighted 
spectrum of ions necessary to produce the required modulation (SOBP) 
7. A PMMA range shifter then shifts the range of the SOBP (if required) 
8. A final 5 cm thick brass collimator shapes the beam into the desired field size close 
to the sample being irradiated 
7 .2 Microdosimetric Application in a 290 Me V /u 12C Ion 
Beam at HIMAC (PMMA Phantom) 
7.2.1 Materials and Methods 
Etched Microdosimeter and Bridge V2 Microdosimeter samples were selected for irradi-
ation based on properties revealed in chapter 3 and chapter 4, respectively. The micro-
dosimeters were housed in aluminium cases of dimensions ~ 20 cm x 4 cm x 3 cm with 
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a wall thickness of 1.5 mm. A small 2 cm x 2 cm window was cut out just above the mi-
crodosimeter location and covered with thin aluminium foil. This formed a Faraday cage, 
whilst also minimising beam perturbation through the foil. Housed within the same case 
was an Amptek A250 preamplifying circuit, with its output connected to the case break-
out ports. A battery-powered Cremat-150 shaping amplifier circuit was used to convert 
the amplified tail pulse into a Gaussian, with a pulse-height energy spectrum created us-
ing an Amptek 8000A Pocket MCA. The calibration process was performed as outlined in 
chapter 2, however through the use of a portable battery-powered pulser, calibration peaks 
were created at the beginning of the experiment. The microdosimeters were all operated 
at 10 V, requiring only one calibration to be carried out per microdosimeter. 
The phantom used was a modular PMMA slab phantom consisting of 13 slabs ranging 
from 2 mm to 48 mm. A 48 mm PMMA slab was first placed on the back of the sam-
ple stage to provide appropriate scatter material. A 30 mm PMMA slab with a cut-out 
allowed for two detector cases to be inserted from the top. The effective depth of the 
microdosimeter was changed by varying the amount of PMMA slabs that were upstream 
of the microdosimeters. The depth was able to be discretely varied between 2 mm to 178 
mm using unique combinations of the PMMA slabs. Of course, with the use of a solid 
phantom and encapsulated detector sheath, a small air gap between the front of the de-
tector window and phantom and a larger air gap behind the detector the the 48 mm slab 
existed. The phantom can be seen in figure 7.3. 
A 290 MeV/u 12C beam with 6 cm SOBP width was used with the final brass collimator, 
producing a field size of 10 x 10 cm2 • Lineal energy spectra were obtained at various 
depths from O - 150 mm depth in PMMA with each microdosimeter surface perpendic-
ular to the beam (face-on). Acquisitions were carried out until sufficient statistics were 
obtained, which varied with depth. A fixed LLT for each microdosimeter was used for 
acquisitions. Using the obtained energy spectra, lineal energy spectra were generated us-
ing the mean chord length, as per equation 1.8. Using these lineal energy spectra, the 
dose-mean lineal energy Yn was calculated at each position along and downstream of the 
SOBP. A conversion factor of 0.63 [74] was used to convert the lineal energy deposited 
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Figure 7.3: Image of Microdosimeters placed within the PMMA phantom in the HIMAC 
Bio-Cave 
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within the silicon to that in tissue, with additional CCE corrections applied for each mi-
crodosimeter. Uncertainties in Yn and RBE10 were calculated using equations A.13 and 
A.20, respectively. Uncertainty in the PMMA thickness was estimated to be 0.1 mm per 
sheet, ranging from 0.2 mm to 1.0 mm over all depths. 
7 .2.2 Results and Discussion 
7 .2.2.1 Etched Microdosimeter 
Displayed in figure 7.4 are the microdosimetric spectra obtained at various depths between 
0 mm and 141.0 mm in PMMA, produced from energy deposited in the detector when 
exposed to a 290 Me V /u 12C beam. As seen in figure 7.4a, the first 5 depths show quite 
similar characteristics with two similar features: a low energy component and a higher 
energy component. While both components change significantly with depth, the high 
energy component has more significance as it is produced from primary 12C ions entering 
the detector, depositing energy and then exiting the detector - these 12C ions are known as 
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Figure 7.4: Microdosimetric spectra obtained using the Etched Microdosimeter at vari-
ous depths in PMMA with a 290 MeV/u 12C beam. 
crossers. The measured crosser lineal energies deposited ranged from ~20 keV/µm up to 
~ 1000 keV/µm. As the microdosimeter was moved deeper within the PMMA, the lineal 
energy deposited increased as a result of increasing stopping power (LET), which can be 
seen by the increasing peak position in the microdosimetric spectra. Therefore, the lineal 
energy deposited in the detector increased, as seen by the increasing peak position. This 
peak continued to shift towards higher lineal energies until a depth of 129.0 mm (figure 
7 .4b) where all the carbon ions stopped - these 12C ions are known as stoppers. 
This can also be seen in figure 7 .5, through the dose mean lineal energy depth distribution, 
showing entrance Yn at ~13 keV/µm and increasing to a maximum of 68 keV/µm. A 
ridge can also be seen at approximately 75 mm where the SOBP plateau starts and high 
dose area begins. The 12C ions undergo nuclear interactions with the PMMA phantom, 
the probability of which increases with depth, resulting in the generation of neutrons 
and fragments. This produces a charged particle spectrum primarily consisting of ions 
between hydrogen and boron, with the fragment fluence increasing up until just before 
the carbon stops within the microdosimeter [119]. This fragmentation process, while 
only consisting of light ions contributes ~20% of the dose close to end of the SOBP [ 120]. 
These light fragment ions are able to travel beyond the point at which the primary beam 
stops, depositing energy distal to the SOBP. Fast neutrons that are produced from within 
the beam line components and PMMA phantom create secondary ions [121], contributing 
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Figure 7.5: Dose-mean lineal energy at various depths in PMMA obtained using the 
Etched Microdosimeter in a 290 MeV/u 12C beam. 
to these distal spectra in figure 7 .4b, and subsequent non-zero YD values. 
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Previous experiments performed using similar thinned silicon detectors [103] and TEPC 
[122] in a 290 MeY/u 12C ion beam tell a different story, recording spectra with a clearly 
defined and dominating crosser peak throughout most depths, and very wide ranging frag-
mentation spectral features. However, the spectra obtained with the Etched Microdosime-
ter is for the most part dominated by the low energy peak. From previous IBICC results 
in section 2.3, it is undoubtedly a result of the low charge collection component due to 
unbiased SYs, and to a lesser extent the low CCE of the SY periphery. Due to the small 
size of each SY and the proportion of events generated from the SY periphery and unbi-
ased arrays being large compared to the high CCE events within the SY, reduced average 
lineal energy deposition can be seen. 
The result of this has been observed in the microdosimetric spectra but can also be seen 
the YD distribution, as well as the RBE10 depth distribution shown in figure 7.6. While the 
shape of both distributions is expected, the YD values are significantly lower, and naturally 
so too are the RBE10 values. RBE10 values derived using microdosimetric spectra with 
a TEPC have previously been acquired with this beam, yielding ~ 1.2 at entrance and 
peaking at ~2.5 near the distal edge of the SOBP [122]. 
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Figure 7 .6: Derived RBE 10 at various depths in PMMA obtained using the Etched Mi-
crodosimeter in a 290 MeV 12C beam. 
7 .2.2.2 Bridge Microdosimeter 
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Shown in figure 7.7 is the microdosimetric spectra obtained using the Bridge micro-
dosimeter at various depths between O mm to 141 mm in PMMA. In contrast with the 
Etched microdosimeter results, the microdosimetric spectra contains only a single peak 
in each spectrum, produced from 12C ion crossers. This is expected due to the extremely 
well-defined, high CCE SVs of the Bridge microdosimeter (see section 4.3). The single 
peak can be seen to increase in lineal energy with depth, due to increasing particle LET. 
Contributions from fragments and neutrons can also be seen at greater depths in the form 
of a lower energy shoulder between ~3-20 keV/µm. The decrease in peak height is due 
to the increase in high LET events, which have a greater influence on the normalisation 
of the microdosimetric spectra (yd(y) oc /). After a depth of 130 mm in PMMA, the 
primary beam had stopped and the spectra comprised of energy deposition events from 
fragments and secondary particles from neutron interactions. 
Shown in figure 7 .8 is the YD distribution obtained with the Bridge Microdosimeter. The 
measured YD value at entrance was ~12 keV/µm, increasing to ~22 keV/µm at the start 
of the SOBP at ~75 mm, and reaching a maximum value of 157 keV/µm at a depth of 
130 mm. In comparison with the Etched microdosimeter, the YD values are quite similar 
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Figure 7.7: Microdosimetric spectra obtained using the Bridge Microdosimeter at var-
ious depths in PMMA with a 290 MeV/u 12C beam. The yd(y) axis scale was changed 
between graphs to improve visualisation, at the cost of easy comparison. 
up until a depth of ~90 mm. After this, the Yn values obtained from the Bridge micro-
dosimeter start to increase at a much greater rate, with the maximum Yn value being ~2.3 
times greater than that of the Etched microdosimeter. The similarities at lower depths 
could indicate that the Etched microdosimeter may have had an inherent under-response 
for higher LET particles, which was not investigated using IBICC. 
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Figure 7.8: Dose-mean lineal energy at various depths in PMMA obtained using the 
Bridge Microdosimeter in a 290 Me V 12C beam. 
Using the lineal energy spectra obtained with the Bridge microdosimeter, the RBE10 dis-
tribution for HSG cells was derived using the MKM model, shown in figure 7.9. Entrance 
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values of RBE 10 were ~1.1, similar to the average value used in proton therapy, and 
reached a maximum of 2.53 at 130 mm. As Yn values for the Bridge microdosimeter 
were higher, it is not surprising that the RBE10 values are also much greater than those 
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Figure 7.9: Derived RBE10 at various depths in PMMA obtained using the Bridge Mi-
crodosimeter in a 290 MeV 12C beam. 
RBE values using the same method, beamline and conditions were previously obtained 
by Kase using a TEPC [122]. A comparison between these TEPC values and those de-
rived with microdosimetric spectra from the Bridge microdosimeter is shown in figure 
7 .10. The Etched microdosimeter values are also shown, emphasising its underwhelming 
microdosimetric performance. In contrast, the derived RBE10 values using the Bridge mi-
crodosimeter results compare reasonably well with with that of the TEPC, in both shape 
and magnitude. 
Due to the phantom used and the physically thin sensitive volume of the microdosimeter, 
more detailed acquisitions were able to be performed very close to the edge of the SOBP, 
where LET is highest. As opposed to the 12. 7 mm diameter TEPC, the volume-averaging 
effect when using the physically thin microdosimeter is presumed to be negligible, which 
may explain the slightly greater RBE10 value at the edge of the SOBP. However, with 
using the PMMA phantom, as opposed to the water phantom that the TEPC measurements 
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were performed in, there is undoubtedly differences in the fragment and neutron spectra 
within the phantom. This may have contributed to the greater RBE10 values downstream 
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Figure 7 .10: Comparison of derived RBE 10 values for HSG cells using the Bridge Mi-
crodosimeter, Etched Microdosimeter and a TEPC for a 290 Me V 12C beam. 
These results show that the Bridge microdosimeter is a device that has the potential to 
estimate Yn and RBE10 values relatively quickly, which could open pathways for micro-
dosimetric quality assurance techniques. 
7 .3 Microdosimetric Application in a 290 Me V /u 12C Ion 
Beam at HIMAC (Water Phantom) 
The development of both the MicroPlus probe and the movable phantom described in 
chapter 6 opened avenues for fast experiments with different microdosimeters/detectors 
using the 290 MeV/u SOBP 12C beam at HIMAC. Measurements were performed at vari-
ous positions in a water phantom along its depth, laterally and at out-of-field locations, as 
well as the estimation of biological dose using measurements from an ionisation chamber 
and RBE10 values derived from microdosimetric spectra. 
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(a) Motion stage and phantom (b) Beam's eye view of MicroPlus probe 
Figure 7.11: Image of Microdosimeter attached to the motion stage, inside the water 
phantom before being irradiated with a 290 Me V /u SOBP field at HIMAC. 
7.3.1 Materials and Methods 
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The following experiments involved the use of the Bridge V2 microdosimeter, U3DThin 
detector (discussed in section 1.2.2.4), a 30 µm Mushroom air-trench microdosimeter and 
an 18 µm poly-trench Mushroom microdosimeter. The samples used were selected based 
on their properties, characterised in previous chapters. In addition, a PTW 31006 pinpoint 
ionisation chamber was used for measuring the physical depth-dose profile of the beam 
in a water phantom. 
Two PMMA holders were made for the Bridge and Mushroom microdosimeters The 
Bridge/Mushroom microdosimeters were mounted to the MicroPlus Probe PCB and in-
serted into the water proof sheath. 
For the Bridge and Mushroom microdosimeters, each sample was mounted to the Mi-
croPlus probe PCB and inserted into the waterproof sheath (see figure 6.3). Each sheath 
was wrapped in aluminium foil which was grounded to eliminate RF pickup, placed inside 
a latex condom to prevent possible leaks in the sheath water proofing, and then attached 
to the motion stage. A custom PMMA holder was designed to house the U3DThin detec-
tor in an aluminium case, with associated spectroscopic and power equipment attached, 
as described in section 7 .2.1. For all detector types, the calibration method described in 
section 7 .2.1 was used. An image of the setup can be seen in figure 7 .11. 
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A 290 MeV/u 12C beam with 6 cm SOBP width was used, with the final brass collimator 
producing a field size of 10 cm x 10 cm. The spectroscopic equipment described in 
chapter 6 was used to obtain lineal energy spectra from each microdosimeter, generated 
using the thickness of each microdosimeter as the mean chord length (see section 1.2.2.2). 
Simulation studies carried out by Dr. David Bolst (CMRP, UOW) revealed that a silicon-
to-tissue conversion factor of 0.57 was a more appropriate factor to use for 12C ion therapy 
[58] than 0.63 used in previous experiments. Using the lineal energy spectra, the dose-
mean lineal energy YD was calculated at various positions in-field and out-of-field, as well 
as derived RBE10 values for HSG cells, using the MKM. 
Uncertainties in YD and RBE10 were calculated using equations A.13 and A.20, respec-
tively. Uncertainty in the motion stage movements alone was estimated to be less than 
~0.5 mm. The basis of this estimation involved tracking the physical position of the top 
of the waterproof sheath, which extended out of the water phantom. The exact micro-
dosimeter location inside the phantom was unable to be measured directly, but by mea-
suring the thickness of all layers in front of each microdosimeter, the effective point of 
measurement relative to the top of the sheath was determined. Using conversion factors 
from table 6.1, and providing water-equivalent thicknesses of all over-layers to the con-
trol software, the microdosimeters were able to be moved to a specified water-equivalent 
depth inside the phantom. The uncertainty was determined to be at most ~ 1 - 2 mm. 
Acquisitions were performed in a sequential manner, ensuring mechanical issues such as 
backlash were minimised. As such, it is estimated that most uncertainty is related to the 
absolute position of the microdosimeter within the phantom, not the relative distances 
between each acquisition location. 
7.3.1.1 Central Axis Microdosimetric Measurements 
Using each of the microdosimeters and the U3DThin detector, acquisitions were obtained 
at various depths along the central axis of the field, starting from entrance to downstream 
of the SOBP distal edge. A stepwise approach was used, however exact acquisition loca-
tions varied between microdosimeters due to physical constraints of each detector sheath. 
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Regardless, the entire profile along the beams central axis was measured using each de-
vice. Acquisitions were carried out until sufficient statistics were obtained, which varied 
with depth and microdosimeter type. 
7.3.1.2 Biological Dose Determination 
The biological dose, known as RBED is the product of the RBE and physical dose. The 
RBE was calculated using equation 1.24 and physical dose was measured using the PTW 
31006 pinpoint ionisation chamber. By measuring the physical dose at the same effective 
point of measurements as that of a microdosimetric acquisition, the RBED was calculated 
at various depths using the Bridge microdosimeter and U3DThin detector. 
7.3.1.3 Lateral Measurements and Dose Equivalent Determination 
The lateral profile of the field was measured using the 30 µm air-trench Mushroom mi-
crodosimeter, with measurements obtained between O mm and 75 mm from the center 
of the field. These measurements were performed at two depths, entrance depth (19.41 
mm) and near the distal edge of the SOBP (146 mm). Out-of-field acquisition locations 
are shown in figure 7 .12. Measurements at distances further out-of-field could not be 
obtained due limitations of the physical size of the water phantom and motion stage lim-
its. Microdosimetric spectra were obtained at these locations and lateral Yn and derived 
RBE10 distributions were generated. In addition, the dose-equivalent at out-of-field loca-
tions were calculated, using the method outlined in section 1.1.5. 
7.3.2 Results and Discussion 
7.3.2.1 Central Axis Microdosimetric Measurements 
Bridge V2 Microdosimeter 
Figure 7.13 shows the microdosimetric spectra obtained with the Bridge microdosimeter 
in a 290 MeV/u 12C ion SOBP field. The spectra acquired in water was found to be quite 
similar to those previously measured in PMMA, however the range of the ions in the water 
was ~ 1.17 greater. This can be seen with the relatively large increase of high LET events 
at ~87 mm as the detector enters the SOBP, which previously occurred at ~75 mm in 
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Figure 7.12: Schematic showing the out-of-field (OOF) acquisitions locations for a 290 
MeV/u 12C SOBP field at HIMAC. 
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PMMA. The spectra recorded in-field showed the primary 12C ion crosser peak shifting 
towards higher lineal energies as ion LET increased with depth. The relative contribution 
from neutrons between 1-20 ke V / µm also increased with depth, due to the greater volume 
of water upstream in which interactions with beam took place. The spectra past the distal 
edge of the SOBP consisted of much lower lineal energy events, with a peak occurring 
at ~25 keV/µm, generated from heavier fragments, as well as some lineal energy events 
between 1 - 10 ke V / µm generated from neutrons and lighter fragments. 
Figure 7.14a shows the corresponding YD distribution, which is extremely similar to the 
previous results obtained using the PMMA phantom (figure 7 .8). The YD at the shallowest 
depth was ~ 18 ke V / µm, followed by an increase to ~40 ke V /µmat the start of the SOBP, 
where the lowest energy ions stopped. Within the first 40 mm of the SOBP plateau, the YD 
rises gradually until within ~ 10 mm of the end of the SOBP, where it reaches a maximum 
of ~ 160 ke V / µm. Of course, this maximum occurred at a greater depth of 145 mm, 
compared to when using the PMMA phantom. 
The corresponding RBE10 distribution is shown in figure 7 .14b. RBE10 values at the 
entrance were ~ 1.2, reaching a value of ~ 1.6 at the start of the SOBP peak. RBE10 
increased in the SOBP plateau, reaching a maximum value of 2.58 at the edge of the 
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Figure 7.13: Microdosimetric spectra obtained using the Bridge Microdosimeter at var• 
ious depths in water with a 290 MeV/u 12C beam. The yd(y) axis scale was changed 
between graphs to improve visualisation, at the cost of easy comparison. 
SOBP. Distally, the RBE 10 values were ~1.4, naturally much lower due to the absence 
of high LET 12C ions, however still greater than for photons, highlighting one of the 
disadvantages of heavy ion therapy. 
Both the RBE10 and YD distributions obtained within the water phantom decreased past 
the distal edge, confirming that the increase in YD and RBE10 past the distal edge in the 
PMMA phantom was likely due a different secondary spectra produced from within the 
PMMA material itself (e.g. high LET carbon recoils). 
U3DThin Detector 
Figure 7.15 shows the microdosimetric spectra obtained using the U3DThin detector in 
a 290 MeV/u 12C ion SOBP field. The spectra are quite similar compared to the Bridge 
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Figure 7.14: Yn and derived RBE10 distributions obtained using the Bridge Micro-
dosimeter at various depths in water with a 290 Me V/u 12C SOBP beam. 
Microdosimeter for all depths, including those obtained past the distal edge. For these 
out-of-field measurements, the spectra contain more counts due to the much larger area 
of the U3DThin device compared to the Bridge microdosimeter. Fluctuations seen at 
lower lineal energies are a binning artefact due to relatively large linear bins of the MCA 
spectrum. 
One observable difference between the U3DThin spectra and those from the Bridge mi-
crodosimeter is the presence of a peak close to ~700 keY/µm in the U3DThin spectra, 
at the SOBP edge. This is likely the carbon edge peak, caused by the highest energy 12C 
ions stopping within the U3DThin sensitive volume. The absence of this peak in other 
microdosimeters could simply be due to slight deviations in acquisition locations but also 
could be related to the U3DThin geometry. Due to its elongated parallelepiped detection 
volume, particles incident at oblique angles are more likely to stop within the detector, 
resulting in a significant energy deposition. In contrast, the Bridge microdosimeter has 
the majority of its silicon outside of its well-defined SY s removed, resulting in decreased 
probability of obliquely incident particles stopping within the device. 
This enhanced response is evident in the YD and derived RBE10 distributions seen in figure 
7 .16. An effect of the U3DThin elongated parallelepiped SY geometry can be seen when 
comparing the YD values with the Bridge Y2 Microdosimeter. The YD of both devices 
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Figure 7.15: Microdosimetric spectra obtained using the U3DThin Detector at various 
depths in water with a 290 Me V/u 12C beam. The yd (y) axis scale was changed between 
graphs to improve visualisation, at the cost of easy comparison. 
was found to be equal at depths before the start of the SOBP, where the 12C ion LET 
is relatively low and energy is deposited primarily by crossers. However, the U3DThin 
detector measured greater Yn values within the SOBP, where 12C ions began to stop, 
likely due to the increased energy deposition of oblique particles, as well as straggling. 
However, the average chord length was assumed to be equal to the thickness of the thin 
detector. Within the first ~40 mm of the SOBP, U3DThin Yn values were on average 
larger than the Bridge values by ~10% due to the reasons outlined above. A maximum 
value of 224 keV/µm was measured, ~40% greater than the value obtained with the 
Bridge microdosimeter. Despite this much larger difference, due to the overkilling effect 
incorporated into the MKM, the maximum derived RBE10 value with this detector was 
2.69, only slightly greater than that obtained with the Bridge Microdosimeter. 
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Figure 7.16: Yn and derived RBE10 distributions obtained using the U3DThin Detector 
at various depths in water with a 290 MeV/u 12C SOBP beam. 
Mushroom Microdosimeters 
138 
Figures 7.17 and 7.18 show the rnicrodosirnetric spectra obtained with the 30 µm air-
trench Mushroom rnicrodosirneter and 18 µm poly-trench Mushroom rnicrodosirneter in 
a 290 MeV/u 12C ion SOBP field, respectively. This was the first 12C ion irradiation per-
formed with this detector technology. Both sets of spectra were extremely similar to that 
obtained with the Bridge rnicrodosirneter, showing clear tracking of the main crosser peak 
with increasing depth, as well as the detection of fragments and neutrons, both in-field and 
distal to the SOBP edge. Extra measurements downstream were obtained through utili-
sation of the beamline PMMA range shifter for the 30 µm air-trench device, enabling 
the measurement of lineal energy spectra much deeper than previously achievable. For 
both rnicrodosirneters, the measurements at 150 mm and 160 mm are similar to that ob-
tained by the Bridge rnicrodosirneter, showing a gradual decrease in high LET events as 
fragments stop within the phantom. This is further emphasised at 249 .42 mm, where low 
lineal energy events from neutrons dominated the spectrum. 
Using the lineal energy spectra obtained, YD and derived RBE10 distributions were ob-
tained for both Mushroom rnicrodosirneters, shown in figure 7.19. At entrance and shal-
lower depths, as seen with other rnicrodosirneters, YD values were seen to remain fairly 
constant at between ~15 - 20 keV/µm, before reaching the start of the SOBP where YD 
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Figure 7.17: Microdosimetric spectra from the 30 µm Air-trench Mushroom micro-
dosimeter in a 290 Me V/u 12C beam. The yd (y) axis scale was changed between graphs 
to improve visualisation, at the cost of easy comparison. 
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increased to ~44 keV/µm. From this point, the Yn values obtained using the poly-trench 
Mushroom microdosimeter were slightly higher for most of the SOBP. At the end of the 
SOBP, the air-trench device reached ~178 keV/µm and the poly-trench device reached 
~ 171 ke V / µm at a slightly earlier depth. As both microdosimeters were utilised sepa-
rately, each had a different hardware and tank setup, resulting in a slight positional offset 
( <0.5 mm), which is emphasised here at the end of the SOBP where dramatic changes in 
field quality exists. 
The RBE 10 values display a very similar trend before the SOBP, starting at~ 1. 15 and in-
creasing to ~ 1.45 at the proximal edge of the SOBP. The RBE10 values of the poly-trench 
device are again slightly higher than the air-trench device, and reaching a maximum value 
of ~2.69. The air-trench device, however peaked at just ~2.50, which is lower than other 
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Figure 7.18: Microdosimetric spectra from the 18 µm Poly-trench Mushroom micro-
dosimeter in a 290 Me V/u 12C beam. The yd (y) axis scale was changed between graphs 
to improve visualisation, at the cost of easy comparison. 
microdosimeters utilised in this study. As reiterated throughout this work, overkilling oc-
curring above 150 keV/µm does play a role in the reduction of RBE10 calculated using 
the MKM. In addition, the contribution oflow energy events in the air-trench device, seen 
from IBICC results (section 5.3.1), produces a lower YF value (equation 1.10) which is 
seen especially in the air-trench spectra within the SOBP. This resulted in an air-trench 
y* value that was ~33% lower than the poly-trench device, which ultimately reduced the 
RBE10 value. An example showing the exaggerated low energy response in the air-trench 
device at depths of 130 mm and 140 mm is shown in figure 7.20. 
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Figure 7.19: Yn and derived RBE10 distributions obtained using the 30 µm Air-trench 
and 18 µm Poly-trench Mushroom Microdosimeters at various depths within water for a 
290 MeV/u 12C SOBP beam. 
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Figure 7.20: Microdosimetric spectra from the 30 µm Air-trench and 18 µm Poly-trench 
Mushroom microdosimeters in a 290 MeV/u 12C SOBP beam. 
Comparison with TEPC 
The derived RBE10 distributions obtained with all detectors is compared with that ob-
tained using the TEPC in figure 7 .21. Error bars have been omitted for clarity, however 
uncertainties of these values are between 5 - 15 %. These uncertainties are a combination 
of relatively large errors in LQM parameters for HSG cells [123], as well as y* , which 
is governed by statistics of the lineal energy spectra and also the size of tissue-equivalent 
size and shape or the SV. The TEPC size is equivalent to a ~2 µm diameter tissue sphere, 
while the SOI microdosimeters are equivalent to a ~ 17 µm tissue cylinder, leading to 
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differences in stochasticity of the deposited energy and variance in the SV chord length 
distribution. 
The RBE10 distribution obtained using the microdosimeters are generally in good agree-
ment with the TEPC results, showing a similar shape and features with respect to the 
SOBP profile, as well as magnitude. However, all silicon detectors showed an enhanced 
response in the SOBP and at the distal edge, with the U3DThin detector and poly-trench 
Mushroom microdosimeter producing maximum RBE10 values of ~2.69. Maximum val-
ues with the microdosimeter were different to the TEPC in part due to the low granular-
ity of TEPC measurements at the edge of the SOBP. However, even if a greater density 
of measurements were performed, volume averaging would most likely produce lower 
RBE10 values due to the relatively large diameter of the TEPC. In addition, differences in 
values over the entire distribution will differ slightly due to differences in the SV geome-
try [124]. Investigations into how the average chord changes as a function of depth have 
shown that at distal locations, the field is more isotropic. As a result, the average cord 
length decreases at depths beyond the distal edge of the SOBP, which would decrease 
lineal energy and provide lower RBE10 values [58]. 
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Figure 7.21: Comparison of derived RBE10 distributions from thin silicon detectors with 
values obtained with the TEPC for a 290 MeV/u 12C ion SOBP beam. 
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7.3.2.2 Biological Dose Determination 
The measured physical dose measured with a PTW 36001 pinpoint ionisation chamber is 
shown in figure 8.1. Due to a miscalculation in the effective point of measurement of the 
chamber, the measured dose at specific depths did not match those of the microdosimeters. 
While not ideal, a fit was applied to the obtained dose profile and dose was interpolated 
at the required positions. This increases uncertainty in RBED, especially at shallower 
depths due to less granular measurements compared to those in the SOBP. 
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Figure 7.22: Normalised depth-dose profile for the 290 MeV/u SOBP beam at HIMAC. 
Using the measured dose and the derived RBE 10 distributions of the Bridge Microdosirne-
ter and U3DThin detector, the RBED distribution was calculated, shown in figure 7 .23. 
Uncertainty in the obtained values were based on RBE10 uncertainty and have been omit-
ted for clarity (values ranged between 5 - 15 %). For the purposes of comparison, both 
RBED distributions have been normalised to the RBED value measured by the Bridge mi-
crodosirneter in the centre of the SOBP. The distributions measured by each detector are 
similar, however an enhanced dose response is seen with U3DThin device due to greater 
derived RBE10 values. This is a known limitation of this technology as oblique ion tracks 
can a deposit greater energy in through the bulk silicon [91], emphasising the importance 
of 3D cell-sized SV s that these SOI microdosirneters possess. 
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These dose profiles resemble the SOBP shape, showing an rapid increase at approximately 
80 mm up to the start of the SOBP plateau. Between the depths of ~85 - 120 mm, the 
RBED is roughly constant as expected but decreases slightly with depth, followed by a 
sharp increase at the SOBP edge. The RBED values decrease rapidly after this increase, as 
expected. As seen in figure 7 .24, data from TEPC and HSG cell measurements performed 
in the same beam [122] also deviated from the flat TFS-calculated RBED distribution in 
a similar fashion to that obtained with the Bridge microdosimeter and U3DThin detector. 
This may be associated with difficulties in determining accurate fluence weights for each 
pristine Bragg peak, especially for higher energy Bragg peaks which provide the major 
contribution to physical dose proximal to the SOBP distal edge. The sharp increase in 
RBED obtained with the thin silicon detectors at the distal SOBP edge may also be at-
tributed to the ability of this technology to measure field characteristics in much greater 
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Figure 7.23: Normalised biological dose distributions for the 290 MeV/u SOBP beam 
at IDMAC, measured using the Bridge microdosimeter and U3DThin detector. 
7.3.2.3 Lateral Measurements and Dose Equivalent Determination 
Shown in figure 7 .25 is the microdosimetric spectra obtained using the Mushroom micro-
dosimeter at a depth of 19 .41 mm and 146 mm, moving laterally across the 290 Me V /u 
12C SOBP field. 
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Figure 7.24: Measured RBED distribution for HSG cells, measured with a 1EPC. The 
solid and dashed lines are TPS-calculated biological dose distributions. Taken from [122] 
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At a depth of 19.41 mm, the in-field (0-50 mm) spectra are extremely similar, comprised 
of a large peak at ~ 14 ke V / µm with a low energy tail caused by fragments and neutrons. 
Low energy events also likely contribute to the signal acquired using this device, as seen 
in section 5.3.1. At a distance of 5 mm from the field edge (55 mm off-axis), some 
12C ions were still detected, however with slightly higher LET due to scattering. At 10 
and 15 mm out-of-field, no evidence of the primary carbon beam was seen, with a low 
lineal energy spectrum comprised of events from fragments and secondary particles from 
neutron interactions. Due to the relatively low LET of the primary beam at this shallow 
depth, the particles that make up the secondary spectra out-of-field are actually higher 
LET, as can be seen from the higher lineal energy tail in spectra from 5 mm out-of-field 
onwards. This can also be seen in figure 7.2£,a as YD is ~14 keV/µm inside the field, and 
then increases to ~31 keV/µm at 10 mm out-of-field, then finally decreasing as the higher 
LET particles reach their range. The corresponding RBE10 values in figure 7.26b inside 
the field are~ 1.15 with a slight increase to 1.26 at 10 mm out-of-field. 
At a depth of 146 mm, which is very close to the SOBP edge, the spectra is comprised 
of a very wide carbon peak above 100 keV/µm that consists of both ions that cross the 
microdosimeter volume and a few that stop within it At this depth, the YD actually de-
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creases slightly when moving towards the field edge and then drops dramatically from 
~170 keV/µm at the field edge down to ~53 keV/µm at 5 mm out-of-field and then to 
~26 keV/µm at 10 mm out-of-field. The RBE10 , however increased towards the edge of 
the field up to 2.4 and then decreases down to a minimum of 1.26 at 10 mm out-of-field. 
The increase in RBE10 with a decreasing YD is due to the overkilling effect which occurs 
at lineal energies above 150 keV/µm. The spectra at 10 and 15 mm out-of-field for both 
depths are very similar, resulting in extremely similar YD values and RBE10 values. 
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Figure 7.25: Microdosimetric spectra from the Mushroom microdosimeter in a 290 
MeV/u 12C beam at IIlMAC, obtained at different depths as a function of lateral po-
sition. The yd(y) axis scale was changed between graphs to improve visualisation, at the 
cost of easy comparison. 
The YD and derived RBE10 distributions at both depths is shown in figure 7 .26. 
Using the lateral out-of-field spectra, the dose-equivalent was calculated at locations 5 
mm, 10 mm and 25 mm from the field edge, shown in figure 7 .27a. The calculated values 
were normalised per Gy at the center of the SOBP, measured using an ionisation chamber. 
At a depth of 19.41 mm, the dose-equivalent was determined to be 16.8 mSv/Gy (Q = 
4.4) at 5 mm out-of-field and decreased to 3.6 mSv/Gy (Q = 4.0) 25 mm out-of-field. At 
a depth of 146 mm, the dose-equivalent was determined to be 137 mSv/Gy (Q = 7.1) at 5 
mm out-of-field and decreased to 2.3 mSv/Gy (Q = 5.4) 25 mm out-of-field. As seen by 
the similar spectra andyD values obtained at 10 mm out-of-field (figure 7.26a), so too are 
the calculated dose-equivalents, yielding very similar values of ~5.5 mSv/Gy (Q = 5.0). 
Due to the contribution of lower energy, higher LET 12C ions scattered at greater depth, it 
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Figure 7.26: Lateral Yn and derived RBE10 distributions obtained using the Mushroom 
microdosimeter in a 290 MeV/u 12C beam at different depths. 
100 
is not surprising that the both the dose-equivalent and quality factor are greater at a depth 
of 146 mm. However, at 25 mm out-of-field, the quality factor is larger at deeper depths, 
while the dose-equivalent is larger at shallower depth. This can be explained due to the 
greater contribution of heavier fragments and particles from fast neutron interactions, seen 
as higher lineal energy events in the spectra. As Q is dependent on both the lineal energy 
and dose-weighted lineal energy distribution, these higher energy events naturally cause 
Q to increase. 
In addition, using the spectra distal to the SOBP edge (depths 150 mm, 160 mm, 180.24 
mm and 249.42 mm in figure 7.17c), the dose-equivalent was calculated, normalised per 
Gy at the centre of the SOBP, shown in figure 7 .27b. The physical dose is shown for 
reference. Values at 150 mm were 137 mSv/Gy and decreased to a value of 13 mSv/Gy 
at a distance of 250 mm. Close to the SOBP edge, dose is highest in part due to Carbon 
ions reaching the microdosimeter due to range straggling, but mainly due to contributions 
from fragments such as boron and beryllium. Lighter fragments and particles from fast 
neutron reactions contribute to the dose-equivalent further downstream after all 12C ions 
stopped. 
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Figure 7.27: Dose-equivalents calculated using the Mushroom microdosimeter down-
stream of the 290 Me V/u 12C ion SOBP distal edge at IIlMAC. 
7 .3.3 Conclusion 
This work presented various applications of a range of microdosimeters in the measure-
ment of microdosimetric characteristics of a 290 MeV/u 12C ion SOBP field at HIMAC, 
Japan. 
Microdosimetric measurements were performed inside a modular PMMA phantom, using 
the Etched microdosimeter and Bridge V2 microdosimeter to characterise the beam along 
its central axis. Microdosimetric spectra obtained with the Etched microdosimeter con-
firmed its flaws, revealing a dominating low energy component as seen in IBICC results 
in chapter 3. While characteristic features of the SOBP 12C ion beam such as the carbon 
peak and fragment tail could be recognised through the microdosimetric spectra, the low 
energy component dominated causing YD and RBE10 values to be vastly underestimated, 
recording a maximum YD and RBE 10 values of just 68 ke V / µm 1. 7 5, respectively. In con-
trast, results of the Bridge V2 microdosimeter were much more impressive, measuring a 
maximum YD value of 157 keV/µm at the SOBP edge which corresponds to an RBE10 
of 2.53. Both the shape and magnitude of the RBE10 distribution agreed well with gold-
standard TEPC measurements performed previously. These results validated the design 
and fabrication of the Bridge V2 microdosimeter, especially its 3D-like electrode config-
uration and the removal of surrounding silicon, providing high CCE and a reduction of 
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low energy artefacts. 
With the development of improved spectroscopic electronics, a remote and automated 
motion control stage and waterproof hardware, measurements with the same beam were 
performed with various microdosimeters in a water phantom. The Bridge microdosime-
ter performed well as expected, yielding similar results to those obtained in the PMMA 
phantom. The maximum YD values obtained were 159 keV/µm. Through the use of the 
water phantom, downstream YD and RBE10 values decreased as expected, as opposed to 
when the PMMA phantom was used. The U3DThin device response showed an enhanced 
YD response, likely due to its slab-like geometry, allowing for obliquely incident 12C ions 
to deposit energy over a much greater distance than its nominal 10 µm cord length. The 
effect of this resulted in the detection of the carbon edge at multiple depths at the end 
of the SOBP, not seen by other microdosimeters. The maximum YD and derived RBE10 
value measured was 224 keV/µm and 2.69, respectively. The first deployment of two 
Mushroom microdosimeter variants resulted in extremely similar results with maximum 
YD values between ~170 - 180 keV/µm. However, maximumRBE10 values differed with 
the 18 µm poly-trench device producing a value of ~2.69 and the 30 µm air-trench device 
a value of ~2.50. It was concluded that this difference is due to difference in YF values 
obtained as a result of enhanced low energy charge collection in the air-trench device, as 
well as positional uncertainty of the microdosimeter in this rapidly changing part of the 
beam. All RBE10 values agreed well with results obtained using a TEPC. 
By measuring the physical dose along the central axis of the field, estimated radiobio-
logical depth profiles were calculated with the RBE10 values derived from the microdosi-
metric spectra obtained using the Bridge microdosimeter and U3DThin detector. These 
distributions resembled the familiar SOBP profile, however with a decline in dose near the 
end of the SOBP, followed by a sharp rise. Generally, the obtained distributions agreed 
well with those obtained with the TEPC, as well as those obtained in HSG cell experi-
ments. The increase of biological dose at the end of the SOBP was not seen in TEPC or 
cell measurements, likely due to very high resolution measurements possible through the 
use of the movable phantom and thin silicon detectors. 
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Lateral measurements across the field to out-of-field locations at entrance depths and at 
the end of the SOBP revealed large differences in obtained microdosimetric spectra. Dose 
equivalents between at 2 mm past the distal edge were measured to be 137 mSv/Gy which 
decreased to 13 mSv/Gy at a depth of 250 mm. At these depths, the spectra measured was 
created from straggling 12C ions and heavier fragments, with contributions from frag-
ments and neutron interactions dominating at deeper locations. 
The diverse range of measurements performed show the versatility of these silicon mi-
crodosimeters, and their potential for use in quality assurance in heavy particle therapy. 
Measurements of Yn and derived RBE10 provide much more information relevant to cell 
damage as opposed to physical dose measured with an ionisation chamber which is the 
clinical standard. High resolution acquisitions at the SOBP edge showed the true po-
tential and advantage of SOI microdosimeters over the larger, commercial TEPCs which 
have volume-averaging, considered to be the gold standard microdosimeter. 
Chapter 8 
Microdosimetric Effects of Motion in 
12C Ion Beams 
While the stationary measurements previously acquired showed some great potential for 
using silicon microdosimeters for characterising heavy ion beams, the static conditions 
under which they were performed are not representative of what actually occurs during 
treatment. This chapter describes investigations performed using the Bridge and Mush-
room Microdosimeters in passive and active scanning 290 MeV/u 12C ion fields, where 
the microdosimeter position is varied during the measurement. The aim of these measure-
ments was to replicate the motion that a hypothetical organ would make during a heavy 
ion therapy treatment and observe its effect on microdosimetric spectra and derived quan-
tities. 
Parts of the work described in this chapter have been published [125], with data collection 
performed in collaboration with Dr. Linh Tran (CMRP, UOW). 
8.1 Introduction 
A factor that can affect the dose delivered to the treatment volumes and out-of-field 
organs-at-risk is organ motion. This is true for all radiotherapy modalities, however it 
is especially important in particle therapy in which increased RBE occurs in the Bragg 
peak due to bulk energy deposition of high LET particles. Furthermore, due to the PBS 
151 
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delivery systems having to swap energy layers, there is time in between the delivery of en-
ergies of different ranges, making this delivery method is more sensitive to motion effects 
[126]. 
One method of motion management, typical to particle therapy, is to use the superposition 
of the clinical volumes in all motion phases to construct an internal target volume (ITV). 
The ITV is then used to help generate a treatment plan delivering dose to the target, 
irrespective of its motion phase. This ensures that tumour volume is covered, however it 
does not take into account the difference in range and LET of the particles incident on the 
volume. Methods have been proposed to incorporate these changes including the use of 
phase-divided clinical treatment volumes, which provided more conformal plans which 
are suitable for intensity modulated proton therapy [127, 128]. Organ tracking using 
fiducial markers combined with phase gating, as is seen in conventional radiotherapy, can 
also be used to on deliver the beam during specific motion phases [129]. Motion during 
a single fraction is also an issue due to the interplay effect, which is often remedied in 
active delivery systems using rescanning. This involves delivering fractions of the dose 
at different phases and under different conditions, leading to an averaging effect on the 
overall dose delivered. The respiratory trace can be used to monitor the phase at which 
multiple fractions are delivered and ensure that they are delivered in a pseudo-random 
manner [130]. 
While there a number of motion management strategies, the effect that organ motion has 
on particle spectra and the RBE needs further investigation. Theoretical calculations and 
cell studies have been undertaken to investigate motion in particle therapy [131, 132]. 
These methods involve obtaining 4D CTs to record and bin the organ motion into discrete 
respiratory phases using deformable image registration algorithms. For each phase, plan-
ning is performed and dose algorithms applied with respect to a reference phase, normally 
at exhale (50%). In treatment, motion is measured and the phase determined, such that 
the appropriate treatment plan was delivered. Simulations with motion unsurprisingly re-
vealed sub-volumes in the target volume were both underdosed by as much as 18% and 
overdosed by 9%, which is prohibitive in treatment. Conventional consequences of un-
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derdosing the target include a lack of local disease control and treatment efficacy, where 
an increase in dose can lead to an increase of normal tissue complication probability and 
worsening severity of any toxicity. However, cell experiments concluded that the overall 
effect was an underdose of just 1.7%, which is comparable to maximum allowable limits 
in routine QA. 
Respiratory motion is prevalent in radiotherapy delivery and can cause decreased treat-
ment efficacy as it not only affects the ability to accurately deliver the treatment beam to a 
target volume in the lung, but also causes the movement and deformation of surrounding 
organs [129]. Motion amplitudes of up to 20 mm have been observed for the pancreas 
[133] and up to 17 mm for liver [134], with this motion being determined by patient spe-
cific anatomy and physiology. Studies have shown that for the majority of lung tumours, 
the maximum amplitude was less than 13.4 mm and was characterised as sinusoidal [135]. 
The results of which could cause large errors in delivered dose to the tumor and critical 
organs, especially if close to the Bragg peak. 
Motion effects are most detrimental when there is a large density difference between the 
tissue that is planned to receive dose and the tissue that actually receives the dose. The 
result of this tissue interchange is that the path length of the ion is changed and hence the 
location of its Bragg peak is not the planned location. The overall result is a dose distri-
bution that no longer conforms to the planned target volume and hence, can negatively 
impact tumour control and induce effects in healthy tissue. Naturally, this makes lung 
treatments very susceptible to motion effects due to their heterogeneous surroundings and 
the large magnitude of movement. 
Organ motion has not previously been investigated in terms of the effects of the lineal 
energy spectrum and other quantities derived from microdosimetry. This section presents 
work undertaken at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan and 
Gunma University Heavy Ion Medical Center (GHMC), Japan to investigate the effect that 
motion has on microdosimetric spectra and RBE 10 using passive beam and PBS delivery, 
respectively. 
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8.2 Motion Effects in Passive Delivery at IDMAC 
8.2.1 Materials and Methods 
Experiments were performed at the Heavy Ion Medical Accelerator in Chiba, NIRS, 
Japan, utilising a passively scattered 12C ion beam to irradiate a Bridge microdosime-
ter. The microdosimeter was mounted on the Microplus probe PCB, which in preliminary 
testing prior to the experiment, proved to have excellent microphonic properties, allowing 
high measurement quality independent of motion. A 10 x 10 cm2 field with a 6 cm SOBP 
and maximum energy of 290 Me V /u was created with a ridge filter. The absorbed dose 
was measured using a PTW pinpoint ionisation chamber and is shown in figure 8.1. 
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Figure 8.1: Normalised depth-dose profile for the 290 MeV/u SOBP beam at IDMAC. 
The effect of lung motion on a hypothetical critical organ, which was considered to be 
positioned just distal of the SOBP, was investigated. Using the movable water phantom 
described in section 6.3, the microdosimeter was placed at the distal edge of the SOBP 
along the central axis of the beam (148 mm depth), and a lineal energy spectrum was 
acquired while the microdosimeter was stationary. A continuous lung motion movement 
trace was then applied to the microdosimeter and a spectrum was acquired. The breathing 
trace consisted of motion in a single plane, 7 mm upstream and 1 mm downstream from 
the SOBP distal edge, obtained from a clinical 4D-CT data set (as described in [136]). 
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The aim of measuring both scenarios was to determine what microdosimetric changes 
happen in reality when an organ moves, changing the particle spectra that is incident 
upon it. 
Further testing evaluated motion with the dosimeter centred about a depth of 134 mm, 
with a 30 mm linear motion profile applied, moving the microdosimeter between depths of 
119 mm and 149 mm. This set of measurements emulated the microdosimetric changes to 
the target volume itself undergoing motion. Acquisitions were performed when stationary 
at 134 mm depth and while performing the described motion, as done previously. 
Changes to microdosimetric quantities within a spherical treatment volume when intro-
ducing motion were also investigated. A laterally changing particle field was produced 
using a spherical polyethylene bolus, placed in front of the water phantom, centred along 
the central axis of the beam. The microdosimeter was positioned at various off-axis lo-
cations in the water tank, labelled A and B in figure 8.2b, corresponding to depths of 92 
mm and 122 mm, respectively. A linear motion profile was applied at each depth, moving 
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(b) Lateral motion schematic with bolus 
Figure 8.2: Schematics describing the microdosimeter motion during irradiation with a 
290 Me V /u SOBP beam at HIMAC 
For all motion configurations, microdosimetric spectra were obtained while stationary and 
while undergoing motion. The motion profiles used for all motion types can be seen in 
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figure 8.2a. Using the spectra, the dose-mean lineal energy Yn was determined, as well as 
the RBE10, derived using the MKM model (see section 1.1.4). 
8.2.2 Results and Findings 
Figure 8.3 shows a comparison of the microdosimetric spectra when undergoing lung 
motion and when stationary. A significant difference was observed between the stationary 
spectra at 148 mm (1 mm downstream of the distal edge) and when undergoing lung 
motion between 141 mm and 149 mm. When the microdosimeter moves upstream, it 
enters the highest LET region of the field, with large amounts of energy deposited by 12C 
ions near the end of their range. Due to the 8 mm motion, 12C ions of lower energies that 
reach their range are also incident on the microdosimeter, resulting in a dominating wide 
peak in the microdosimetric spectra, centred at ~70 keV/µm. 
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Figure 8.3: Microdosimetric spectra obtained at the distal edge with the Bridge Micro-
dosimeter stationary and when undertaking lung motion along the central axis of a 290 
MeV/u SOBPbeam atlilMAC. 
In the stationary case, the microdosimetric spectra is comprised of lower lineal energy 
events from neutron interactions and fragments, as the 12C ions have primarily stopped 
1-2 mm upstream. From this observable change in field quality, for a hypothetical organ-
at-risk just downstream of the treatment volume (SOBP), there would be significantly 
more dose delivered to the non-target volume in a clinical scenario. Not only would dose 
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Table 8.1: Yn and RBE10 values for all stationary and motion configurations using a 290 
MeV/u SOBP beam at HIMAC. 
Configuration Yn (keV/µm) RBE10 
Lung Motion (depth) 96.98 ± 9.57 2.24 ± 0.30 
Stationary 31.98 ± 5.11 1.41 ± 0.12 
Linear Motion ( depth) 61.41 ± 3.30 1.90 ± 0.22 
Stationary 68.89 ± 4.79 1.94 ± 0.23 
Linear Motion A (lateral) 48.30 ± 2.46 1.70 ± 0.18 
Stationary 44.22 ± 2.32 1.64 ± 0.16 
Linear Motion B (lateral) 84.34 ± 6.90 2.03 ± 0.25 
Stationary 74.23 ± 4.60 2.00 ± 0.25 
be considerably higher in this case, but the biological effect would be enhanced due to the 
high LET of particles incident on it when entering the field. The Yn and RBE10 values 
were calculated using each of the spectra, seen in table 8 .1. The motion is seen to increase 
the Yn value by a factor of ~3 and RBE10 value by a factor of ~1.6. The less dramatic 
increase in RBE is due to the overkilling effect of events above 150 keV/µm, which the 
MKM model takes into account. These results show the significant and potentially dam-
aging effects of motion if not taking into account in the CTV or by using other methods 
discussed previously. 
Figure 8.4 shows the rnicrodosimetric spectra obtained at 134 mm depth and when under-
going longitudinal motion with a total magnitude of 30 mm. Due to this location being at 
a depth approximately 2/3 into the SOBP, the effect of motion is less dramatic. In con-
trast with the lung motion, the spectra obtained when undergoing motion actually contains 
more lower lineal energy events. As the physical dose is weighted higher at the shallower 
depths (figure 8.1) as dictated by the ridge filter design, there is a greater number oflower 
LET 12C ions. This can be seen in the decrease in Yn from 68.9 keV/µm when in motion 
to 61.4 keV/µm when stationary, corresponding to a very slight RBE decrease from 1.94 
to 1.90 (table 8.1). Despite this exaggerated, high amplitude motion, an organ moving in 
this manner would have experienced a slightly degraded biological effect, which suggests 
that sensitivity to motion along the central axis of the beam is low for sub-volumes well 
within the target volume. 
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Figure 8.4: Microdosimetric spectra obtained within the SOBP with the Bridge Micro-
dosimeter stationary and when undertaking linear motion along the central axis of a 290 
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Figure 8.S: Microdosimetric spectra obtained with Bridge Microdosimeter at stationary 
positions A (92 mm depth, 20 mm off-axis) B (122 mm depth, 20 mm off-axis) and when 
undertaking lateral motion toward edge of a a 290 Me V /u SOBP field at IIlMAC 
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Figure 8.5 shows the microdosimetric spectra when the microdosimeter is stationary and 
when undergoing lateral motion at points A and B. Corresponding YD and RBE10 values 
are shown in table 8.1. At both points, the YD values acquired during motion were greater 
than the corresponding stationary measurements, showing a relative increase of 9 .2 % at 
point A and 13.6% at point B. When undergoing motion, the spectra in both cases shifts 
towards higher lineal energies due to the contribution of high LET 12C ions stopping at the 
end of their range, towards the edge of the treatment volume, created due to the spherical 
bolus. An increase in low lineal energy events was also observed when in motion from 
point B, due to a higher contribution of fragments and neutrons produced from particle 
interactions further upstream. 
8.3 Motion Effects in Active Delivery at GHMC 
8.3.1 The Gunma University Heavy Ion Medical Center Facility 
The Gunma University Heavy Ion Medical Center (GHMC) was built in 2010 and is 
located Gunma, Japan, oferring treatment from 2016. It was designed initially for prostate 
patients and has treated a total of ~4000 [137]. The centre has 3 treatment rooms, each 
containing a passive delivery system which, in essence is the same technology used in the 
HIMAC bio-cave, although many parameters differ slightly e.g. distances between beam 
forming components such as ridge filter, range shifter, etc. 
The only ion species GHMC uses for treatment and research is 12C . It generates the ions 
using a compact electron-cyclotron resonance ion source which is injected into a radio-
frequency quadrupole linac to boost to 600 keV/u, then to a compact alternating phase 
focussing linac accelerates the ions to 4 Me V /u. These ions are injected into the main 
63.3 m diameter synchrotron, and are able to be accelerated up to a maximum energy of 
400 MeV/u, with a maximum dose rate of 5 GyE/min [138]. There also exists a vertical 
beam port which is used for the research and development of active delivery pencil-beam 
scanning (PBS) carbon therapy. This beam port with research water phantom is shown in 
figure 8.6. 
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Figure 8.6: Photograph of the vertical beam port room with adjustable water phantom 
used for research and active delivery development at GHMC. 
8.3.2 Materials and Methods 
Further investigation into the effect of motion was also performed at GHMC. however 
with a actively delivered scanning 12C beam. This marked the first use of solid state 
microdosimeters in an active delivery carbon therapy facility. A single 290 MeV/u layer 
was used with a ripple filter. used to smear energy layers together. The depth-dose profile 
obtained with a PTW thin-window. Advanced Markus chamber can be seen in figure 8.7. 
showing a relatively wide Bragg peak due to the ripple filter. A 10 x 10 cm2 field was 
delivered at a dose rate of~ 1 Gy/s. 
In order to avoid pileup. a single sensitive volume variant of the mushroom microdosime-
ter was used to record the lineal energy spectra. See section section 1.3.3 for a description 
of this technology and figure 5.7 for an SEM image of the single SV. Microdosimetric 
spectra were obtained at depths of 110.9 mm. 120.9 mm and 130.9 mm when undertaking 
motion and when stationary. Unfortunately locations at the distal edge were not obtained 
due to experimental time limitations. 
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Figure 8.7: Normalised depth-dose profile for the 290 MeV/u SOBP PBS field at 
GHMC. 
While previous experiments used the phantom described in section 6.3, the scanning beam 
port at GHMC is vertical in nature, preventing the use of this phantom and other more con-
ventional phantoms used in radiotherapy. As such, varying the microdosimeters effective 
depth was achieved by remotely adjusting the water level of a phantom which was located 
above the microdosimeter and below the vertical beam port, seen in figure 8.8a. 
The microdosimeter was housed in a small PMMA casing and attached to a Thor Labs 
motion stage, allowing the microdosimeter to be moved laterally, shown in figure 8.8b. 
The beam delivery system's research-mode was required to use the vertical water phan-
tom and to adjust other settings necessary for the experiment. As a result, a patient plan 
(which is delivered using multiple energy layers) could not be expressly delivered, and 
only a 290 Me V /u 12C ion energy was used. A modulated, clinical field was simulated 
using a patient specific polyethylene bolus (figure 8.9a), such that the field changed as 
the microdosimeter was moved laterally. Due to limitations on the speed and number 
of motion profiles that could be used with the Thor Labs motion stage, the lung motion 
profile seen in figure 8.2a was approximated in the lateral direction with two linear mo-
tions, shown in figure 8 .9b. The stationary location of the microdosimeter with respect 
to the motion profile was at O mm displacement, corresponding to a bolus thickness of 
16.6 mm, shown in figure 8.9b. As such, the effective depth both increased and decreased 
when in motion, dictated by the bolus thickness (13 - 21 mm) along the microdosimeters 
trajectory. 
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(a) Adjustable water column (b) Microdosimeter attached to lateral motion stage 
Figure 8.8: Images of the phantom/beam port and microdosimeter used at GHMC. 
(a) Render of bolus used 
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(b) Motion profile used with bolus thickness 
Figure 8.9: Render of the patient-specific bolus used to vary the ion range and motion 
profile used at GHMC 
8.3.3 Results and Findings 
It was realised that as the phase of the motion and the scanning were not synchronised, the 
effect of motion in a scanning delivery could not necessarily be quantified as reliably as 
in section 8.2.2. However, examples of motion effects were investigated using a scanning 
field which has a scanning speed much greater than the speed of target motion. Figure 
8.10 shows the microdosimetric spectra obtained when stationary and when undergoing 
lateral motion at a depth of 110.9 mm. The spectra is characterised by a narrow peak 
produced from carbon ions crossing the microdosimeter thickness and a lower energy tail 
from neutrons and fragments. As seen from table 8.1, both the Yn and RBE10 values 
varied only slightly between the stationary and moving acquisitions. The main difference 
between the two measurements is that when undergoing motion, there were a greater 
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number of high LET events and primary crossers as seen by the taller primary peak and 
small higher energy shoulder at ~40 ke V / µm. This may be due to the microdosimeters 
movement into a location where the bolus thickness was greater, and where incident ions 
have can deposit greater energy deposition within the microdosimeter due to increased 
stopping power. As a result, there was a greater proportion of lower lineal energy events 
when stationary. 
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Figure 8.10: Microdosimetric spectra obtained at a depth of 110.9 mm with the Single 
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 Me V /u 
PBS beam at GHMC. 
Table 8.2: YD and RBE10 values for all stationary and motion configurations using a 290 
MeV/u PBS beam at GHMC. 
Configuration Yn (keV/µm) RBE10 
Motion (110.9 mm) 21.13 ± 0.43 1.30 ± 0.09 
Stationary 19.96 ± 1.15 1.26 ± 0.08 
Motion (121 mm) 28.35 ± 3.37 1.30 ± 0.09 
Stationary 40.16 ± 6.63 1.34 ± 0.10 
Motion (131 mm) 31.48 ± 3.47 1.39 ± 0.11 
Stationary 34.13 ± 3.54 1.37 ± 0.10 
Figure 8.11 shows the microdosimetric spectra obtained when stationary and when un-
dergoing motion at a depth of 120.9 mm. The shape of the spectra is similar to that 
at 110.9 mm, however with an enhanced lower energy component from neutrons and 
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fragments which increases with depth. The YD value when stationary was ~40 keV/µm 
and decreased to ~28 keV/µm when undergoing motion, showing extremely different 
results. This difference is a combination of the effects of motion, but mostly due to in-
creased random high LET events above 1000 ke V/ µm were detected when stationary, 
which dramatically changes the amplitude of lower lineal energy features in the micro-
dosimetric spectra. The effect on RBE 10 is less dramatic due to the MKM taking into 
account overkilling above 150 ke V / µm. Despite this large difference, effects of motion is 
normally managed with fast rescans and is in effect averaged over the many energy layers 
used for the plan. 
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Figure 8.11: Microdosimetric spectra obtained at a depth of 120.9 mm with the Single 
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 Me V /u 
PBS beam at GHMC. 
Figure 8.12 shows the microdosimetric spectra obtained when stationary and when un-
dergoing motion at a depth of 130.9 mm. The difference between the two spectra is small 
and mainly differs due to variation in higher lineal energy events. Both YD and RBE10 
values agreed within error. 
The low energy component in all of the spectra presented is greater than expected for 
an actively delivered beam when compared to results in previous chapters in which the 
beam was passively delivered. Due to the scanning nature of ion delivery, the small 
microdosimeter is not being irradiated by the beam for most of the acquisition; only for 
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Figure 8.12: Microdosimetric spectra obtained at a depth of 130.9 mm with the Single 
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 Me V /u 
PBS beam at GHMC. 
fractions of a second is the pencil beam incident on the microdosimeter. As a result, 
the field incident on the microdosimeter for most of the acquisition is effectively out-of-
field. Hence, the measured spectra contain relatively higher contributions from low lineal 
energy events produced from neutron interactions and fragments within the phantom, 
resulting in lower Yn and RBE10 values compared to passively delivered beams. 
8.4 Conclusion 
This work presented the first investigation into the microdosimetric effects of motion in 
12C ion therapy, in both passive and active delivery modalities. These results show the 
importance of accounting for motion when planning for and delivery treatments, and pro-
vides insight into the microdosimetric impact of these effects through the microdosimetric 
spectra obtained. 
Using a passively delivered 290 MeV/u 12C SOBP beam at HIMAC, significant increases 
in Yn and RBE10 values were observed when the microdosimeter mimicked a lung motion 
trace, moving into the field. This showed how unaccounted motion could vastly affect the 
beam quality in a real cancer treatment for an OAR. Acquisitions at shallower depths with 
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linear motion along the central axis actually showed a decrease in YD and RBE10 values 
due to the time spent at shallower locations where particle flux is greater but 12C ion en-
ergy is higher. Lateral linear motion profiles were also applied to the microdosimeter at 
various depths with a bolus used create a laterally changing field. In both of the configu-
rations, motion toward the field edge increased YD by ~9-13% and RBE10 values by just 
~1.5-4%. 
Using a high dose rate PBS-delivered 290 MeV/u 12C beam at GHMC, the effects of mo-
tion were much less obvious. However, differences in YD and RBE10 were less varied 
between stationary and moving acquisitions due to the fast scanning speed. Furthermore, 
in all acquisitions, an enhanced low energy response was observed due to the micro-
dosimeter effectively being out-of-field for most of the acquisition. Due to the scanning 
nature of PBS delivery, more development is required to synchronise motion and beam 
scanning to produce more meaningful and reproducible results. 
Obtained results show that this device is suitable for investigating interplay effects by 
mimicking organ motion due to its lightweight construction and the stable microphonic 
properties of the MicroPlus probe front-end. The high spatial resolution of the SOI mi-
crodosimeters has also been shown to be important for understanding the interplay effect, 
especially close to treatment volume borders. These results show that the effects of mo-
tion in a measurement can be detected using a solid state microdosimeter, and can result 
in both increases and decreases to microdosimetric quantities depending on the nature of 
the movement with respect to the beam. 
Chapter 9 
Microdosimetric Applications in 
Mono-Energetic 12C Ion Beams 
This chapter presents the results of experiments performed using mono-energetic 12C 
ions of different energies, delivered using a variety of delivery techniques. These include 
microdosimetric measurements at HIMAC using a passively-delivered mono-energetic 
290 MeV/u 12C beam, and at GHMC using an actively-delivered mono-energetic 290 
MeV/u 12C beam. In addition, microdosimetric measurements were performed at the 
Australian National University Heavy Ion Accelerator Facility (Canberra, Australia) using 
low energy 70 MeV 12C ions, which have a much shorter range and significantly less 
straggling compared to 290 MeV/u 12C beams. 
Parts of the work described in this chapter have been published in multiple journal articles 
[98, 115], with data collection performed in collaboration with Dr. Linh Tran (CMRP, 
UOW). 
9.1 Microdosimetric Measurements in a 70 MeV 12C Ion 
Beam 
9.1.1 The ANU Heavy Ion Accelerator Facility 
The Heavy Ion Accelerator Facility (HlAF) has been operating since 1973 and is main-
tained on the Australian National University campus in Canberra, Australia. It houses a 
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superconducting booster linac and a 14UD pelletron accelerator [139]. The research un-
dertaken at this facility generally falls under nuclear and particle physics, as well as mass 
spectrometry and accelerator research. Thie 14 UD pelletron accelerator is vertically ori-
ented and nonnally operates above 15.5 MV, able to deliver many ion species to over 9 
beam lines. For studies related to carbon therapy, it can produce 12C ions with energy 
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Figure 9.1: Schematic of the ANU Heavy Ion Accelerator Facility (taken from [140]) 
9.1.2 Materials and Methods 
Microdosimetric acquisitions were performed using 70 MeV/u 12C ions, generated using 
the HIAF at ANU. Due to the extremely low ion energy, the whole beam line and sample 
chamber was under vacuum. As a result, every time the experiment setup needed to be 
modified (e.g. detector change, physical verification of setup), the chamber had to be de-
pressurised and then the air pumped out to resume the experiment. The sample chamber 
is shown in figure 9 .2. 
The Bridge V2 microdosimeter was selected to detect the low energy 12C ions. In or-
der to shift the microdosimeter along the 12C ion Bragg peak, different thicknesses of 
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Figure 9.2: Image of the sample chamber and beam line at the ANU Heavy Ion Accel-
erator Facility 
low-density polyethylene (LDPE) were used. Given that the range of these carbon ions 
is rv 180 µm, using phantoms that are common in particle therapy treatment and research 
was not plausible. However, the chamber featured a remotely controlled vertical stage, 
upon which a "ladder" type fixture was be attached. Different thicknesses of LDPE film 
were placed between the rungs of the ladder, enabling the effective depth of the micro-
dosimeter to be varied, simply by varying the vertical position of ladder. High precision 
thickness LDPE film was used, with thickness measured using a micrometer with an un-
certainty of ±2 µm. 
As microdosimetry is spectroscopic in nature, the microdosimeter could not be irradiated 
directly due to the prohibitively high flux of the accelerator. This would have resulted 
in significant pileup effects, and most likely device damage, inhibiting meaningful data 
acquisition. Calculations were performed by HIAF physicists and it was determined that 
by passing the beam through a 1 mg/cm2 gold foil, an acceptable reduced flux would exist 
at the microdosimeter if it were placed at an angle of 20 degrees, due to elastic scattering. 
Given the very small size of the microdosimeter die, the spread in both incidence angle 
and energy was determined to be acceptable. This setup can be seen in figure 9 .3a. 
A detector bracket was designed and fabricated to hold the microdosimeter at the same 
height as the beam line port. A Cremat preamplifing and shaping circuit was placed the 
backside of the detector bracket, minimising the chance of damage from the harsh radi-
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ation environment within the chamber. Based on CAD drawings provided, a mechanical 
stage was designed to be able to position and orientate the detector at the specified 20 
degree angle, normally incident to the beam, with an acceptable flux. The mounted mi-
crodosimeter and LOPE ladder is shown in figure 9.3b. 
(a) (b) 
Figure 9.3: Experimental setup showing sample chamber, LOPE ladder and micro-
dosimeter setup at the ANU HIAF. 
Lineal energy spectra were obtained for a period of 300 sat each depth, and microdosi-
metric spectra and associated quantities were calculated from these spectra. Calibration 
was performed exactly as in chapter 2. 
9.1.3 Results and Discussion 
The microdosimetric spectra obtained using the Bridge microdosimeter is shown in figure 
9 .4. Each spectrum in figure 9 .4a contains a low energy peak and a high energy peak. The 
high energy peak is due to high LET 12C ions crossing the microdosimeter volume. As 
seen by the high energy shoulder, there are a small proportion of carbon ions that have 
higher LET, most likely due to interactions with the experiment setup in the beams path 
(e.g. traversing the edges of the aluminium LOPE ladder), as well as range straggling. 
This peak shifts towards higher lineal energies and widens as the LOPE film thickness 
increases. This is due to an increase in 12C ion LET after losing increasingly more energy 
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in preceding LDPE film thickness. At a depth of 180 µm, this 12C ion peak decreased 
in energy and widened, eventually disappearing after 200 µm as the 12C ions stop. At 
greater depths, the spectra are dominated by low energy electron events. While previous 
IBICC results showed minimal erroneous low energy events occurring within the micro-
dosimeter SV s, the low energy peak recorded in these spectra is likely due to electron 
spray generated during the scattering process with the gold foil (as well as the chamber 
and surrounding media). As can be seen from the microdosimetric spectra at 400 µm, 
the main peak actually decreases in energy, indicating that higher LET particles were 
stopped by an increase in LDPE, confirming the primary source of these particles was the 
scattering foil. 
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Figure 9A: Microdosimetric spectra obtained with the Bridge microdosimeter in a 70 
Me V 12C beam through various thicknesses of LDPE at the ANU IIlAF. The yd (y) axis 
scale was changed between graphs to improve visualisation. 
The trends observed in the microdosimetric spectra can be seen in the Yn distribution, 
shown in figure 9.5a. The Yn of the beam without any interaction with LDPE was 190 
keV/µm and reached a maximum of 473 keV/µm at a depth of 165 µmin LDPE. At this 
depth, the 12C ions traversing the microdosimetric volume come to a stop very close to 
the end of the 10 µm SV thickness, or very close to it. With an increase in LDPE thick-
ness, the carbon peak in the spectra shifts towards lower lineal energies due to the 12C 
ions coming to rest within a smaller fraction of the microdosimetric volume (stoppers), 
resulting in less energy deposition. It can be seen that due to factors including a small 
degree of obliquity and energy spread from the scattering process, as well as range strag-
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gling, the 12C ions come to a stop over a distance of just ~20 µmin LDPE. After the 12C 
ions completely stop within the LDPE, the YD values decrease to~ 6 keV/µm. This is 
naturally much less than values seen in high energy 12C experiments in chapter 7 due to 
the very low ion energy, effectively resulting in a neutron and fragment-free beam. 
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Figure 9.5: Yn and RBE10 distributions obtained with the Bridge microdosimeterin a 70 
MeV 12C beam through various thicknesses ofLDPE at the ANU HIAF 
The RBE10 distribution derived using the microdosimetric-kinetic model is shown in fig-
ure 9.5b. A maximum derived RBE10 value of 2.57 was observed without the presence of 
any LDPE (entrance). This is approximately the same values obtained at the distal edge 
of the 290 MeV/u SOBP field, seen in section 7.3.2.1. As the microdosimeter depth was 
increased, the RBE10 decreased down to 1.77 at 150 µmin LDPE. While the very high 
LET particles produced an increase in YD with depth, due to the overkilling effect in the 
MKM of events above 150 keV/µm, they* value decreases which results in a decreased 
RBE10 . At a depth of 185 µm, which is 20 µm past the depth where the greatest YD value 
was recorded, the RBE10 reaches a local maximum of 2.32. The derived RBE10 value at 
greater depths decreased to ~ 1.00 (i.e. same biological effect as 200 kV x-rays), which 
is not surprising given that the 12C ions have stopped and these spectra are comprised of 
events due to electron interactions, not heavy charged particles. 
These results show that the 70 Me V particles are present in any therapeutic 12C ion beam 
can deposit significant energy within critical structures over a distance of ~ 10-20 µm. 
For the purposes of characterising or investigated phenomena in high LET fields, it is 
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clear that the measurement device must have a physical sensitive volume comparable the 
distance over which this energy is deposited, and thin over-layers compared to the ion 
range. As a result, thin microdosimeters have a large advantage over larger detectors and 
conventional TEPCs, due to wall perturbation (including other wall effects discussed in 
section section 1.2.1.2) and volume-averaging. 
While investigation at these depths is not necessary to validate current methods of ac-
counting for patient setup, motion and the other sources of positional uncertainty, it high-
lights the potential of these very low energy, high LET particles to damage healthy tis-
sue. A comparison between the microdosimetric spectra obtained with the Bridge micro-
dosimeter in the middle of a 290 MeV/u 12C ion SOBP beam and at 170 µmis shown 
in figure 9.6. This figure shows the vast difference between the particles which deposit 
energy within the middle of a treatment volume and only those at the end. 
Microdosimetric spectra produced by 290 MeV/u 12C ions are comprised of not only 
events from primary 12C ions, but also by fragments, neutrons and electrons. This makes 
it impossible to measure the RBE associated with 12C ions alone, especially at the end of 
their range where secondary contributions are highest (e.g. at the edge of a 290 MeV/u 
SOBP). This emphasises the uniqueness of these results, showing successful application 
of SOI microdosimeters for studying radiobiological effects of low energy 12C ion beams 
with minimal straggling. 
9.2 Microdosimetric Measurements in Mono-energetic 290 
Me V /u 12C ion beams 
Microdosimetric measurements were performed using a mono-energetic 290 MeV/u 12C 
beam in two facilities using different beam delivery technologies; passive scattering and 
pencil beam scanning. The aim of this study was to investigate the difference in beam 
characteristics through the lens of microdosimetry. 
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Figure 9.6: Microdosimetric spectra obtained with the Bridge microdosimeter at a depth 
of 170 µmin LOPE using a 70 MeV 12C beam and in the middle of a 290 Me V/u SOBP 
field. 
9.2.1 Materials and Methods 
At HIMAC, a 30 µm poly-trench Mushroom microdosimeter was used to investigate a 
passively scattered 10 x 10 cm2 mono-energetic 290 MeV/u 12C ion field. This field 
was generated exactly the same way that 290 MeV/u 12C SOBP fields are generated, 
however with the aluminium ridge filter removed. Measurements were performed using 
the experimental setup described in section 7.3 .1. 
The Mushroom microdosimeter was also irradiated at GHMC, however with a with a 
290 MeV/u 12C pencil beam with a 3.3 mm a and intensity of 106 particles/spill. An 
aluminium ripple filter, which is commonly used at this facility, was used to spread the 
range of the ions, which is used to effectively smearing energy layers together when 
multiple layers are used. An adjustable water column was used to adjust the effective 
depth of the microdosimeter by up to 0.1 mm increments, shown in figure 8.8a. The 
MicroPlus probe sheath was inserted into a PMMA block and placed directly under the 
water phantom in order to minimise the air-gap in between. In addition, the physical dose 
of the beam was measured using a parallel plate ionisation chamber, commonly used at 
this facility for QA. The uncertainty in microdosimeter and chamber position was much 
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less in this experiment due to the accuracy in which the phantom water level could be 
changed. 
In both cases, the lineal energy spectra was used to calculate microdosimetric quantities 
and derived RBE10 using the microdosimetric-kinetic model along the central axis of each 
beam. 
9.2.1.1 Results and Discussion 
290 MeV/u 12C Pencil Beam at GHMC 
The physical dose profile along the central axis of the beam was obtained using a parallel 
plate ionisation chamber, shown in figure 9.7. This data was obtained by varying the 
amount of water above the chamber, which was housed in a small PMMA block. A 
maximum physical dose occurred at a depth of 155.2 mm in water. The width of the 
Bragg peak is relatively broad due to the beam passing through the ripple filter. 
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Figure 9.7: Normalised depth-dose profile for the 290 MeV/u prisitne beam with ripple 
filter at GHMC. 
Figure 9.8 shows microdosimetric spectra obtained as a function of depth. Figure 9.8a 
clearly shows the progression of the 12C crosser peak shift from low lineal energy of~ 10 
keV/µm at 34.9 mm up to approximately ~35 keV/µm at a depth of 145 mm. As seen 
from the depth-dose profile in figure 9.7, the dose increases as the start of the Bragg peak 
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occurs after this point. Figure 9.8b shows the spectra within the Bragg peak. As the 12C 
ion LET increases with depth, the cross peak is continually seen to shift to deposit greater 
lineal energy within the microdosimeter. The effect of the ripple filter is observable from 
these spectra, as high LET 12C ions deposit large lineal energies over a relatively large 
range between 154 mm up to a depth of 158.4 mm. The 12C bump at ~600 keV/µm is 
evidence of 12C ions reaching their range and stopping within the microdosimeter sen-
sitive volume. After the distal edge, as seen in figure 9 .Sc, a large wide peak is seen at 
160.4 mm, created due to fragments generated upstream. This peak is persistent even up 
to 185 mm(~ 30 mm downstream of the distal edge), however with increasing lower 
lineal energy components from neutron interactions. 
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Figure 9.8: Microdosimetric spectra from the Mushroom microdosimeter in a 290 
MeV/u 12C pencil beam at GHMC. The yd(y) axis scale was changed between graphs to 
improve visualisation. 
The corresponding Yn distribution is shown in figure 9 .9. Entrance values of~ 13 ke V / µm 
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were observed, after increasing to ~37 keV/µmjust before the Bragg peak, and reaching 
a maximum of ~ 141 ke V / µm at ~ 157 .5 mm. Due to the ripple filter, this approximate YD 
value was recorded at 3 depths, between 157 mm and 158.4 mm. This is not surprising 
given the extremely similar microdosimetric spectra. Again, this is due to the effect of the 
ripple filter. These median of these 3 measurements was recorded at a distance of ~ 2.4 
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Figure 9.9: YD distribution obtained using the Mushroom microdosimeter in a pristine 






The corresponding RBE 10 distribution is shown in figure 9.10. The derived RBE 10 at 
entrance was ~1.12, increasing to ~1.61 at the start of the Bragg peak, reaching a maxi-
mum of ~2.37 at 156 mm. The spread of RBE10 values at the filtered Bragg peak is much 
less than seen in YD distribution due to the overkilling effect. In contrast with the maxi-
mum YD , the maximum RBE10 value was recorded just ~0.8 mm beyond the maximum 
physical dose. This shows a highly desirable and advantageous characteristic of 12C ions 
such that the maximum RBE value occurs extremely close to where maximum physical 
dose is deposited; the relative position of the maximum RBE compared to the Bragg peak 
decreases in depth with increasing atomic number of an ion[141]. 
290 MeV/u 12C Field (Passive Scattering) atlDMAC 
The microdosimetric spectra obtained in the passively scattered mono-energetic 290 Me V /u 
12C ion field at HIMAC is shown in figure 9 .11. As expected, at entrance and shallower 
depths the spectra is primarily comprised of the 12C ion crosser peak ~12 keV/µm, shift-
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Figure 9.10: RBE 10 distribution obtained using the Mushroom microdosimeter in a pris-
tine 290 MeV/u 12C ion pencil beam at GHMC. 
ing towards higher lineal energies as ion LET increases with depth. At a depth of 150 mm, 
the spectra is dominated by a wide plateau-like structure between ~200 - 800 keV/µm, 
due to high LET 12C ions reaching their range or nearing it; a small peak can be seen 
at the highest lineal energy where the ions have stopped within the detector. Most 12C 
ions were seen to stop within a distance of 2 mm between 149 mm and 151 mm. Beyond 
this, the spectra consists of a small number of higher lineal energy events from 12C ions, 
but is primarily made from boron and beryllium fragments which made up the wide ~25 
keV/µm peak, with helium and protons from neutron interactions producing the lower 
lineal energy shoulder [124]. 
The corresponding YD distribution is shown in figure 9.12. Note that the effective range 
of the passively scattered beam is shorter due to the beam modifying devices such as 
the 0.8 mm tantalum scatter used in the process of producing the 10 x 10 cm2 field. 
Unfortunately, the dose profile was not measured in this field. YD values the entrance 
were ~ 12 ke V / µm, increasing to ~ 30 ke V / µm just before the Bragg peak, then reaching 
a maximum of ~291 keV/µm. This is considerable higher than any other high energy 
beam measured in this thesis. As seen from the spectra, the lower lineal energy component 
is extremely small in comparison with the SOBP delivery, which is partly due to having 
minimal beam modifying devices that the ions interact. In addition, as the beam is mono-
energetic, there is less variance in the distribution of ion ranges, resulting in a decreased 
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spread of lineal energy events which results in a maximum measured YD value. 
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Figure 9.11: Microdosimetric spectra from the Mushroom microdosimeter in a 290 
Me V /u 12C pristine beam at HIMAC. The yd (y) axis scale was changed between graphs 
to improve visualisation. 
The derived RBE10 distribution for HSG tumour cells is shown in figure 9 .12b and expect-
edly shows a similar distribution as YD. The derived RBE10 value at entrance was ~1.13, 
increasing to ~ 1.48 just before the Bragg peak at 130 mm, then reaching a maximum of 
~2.95 at the Bragg peak. This maxima occurs 1 mm before the maximum YD value due 
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Figure 9.12: YD and derived RBE10 distributions obtained using the Mushroom micro-
dosimeter in a mono-energetic 290 Me V/u 12C beam at IIlMAC. 
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Comparison of 290 Me V /u Beams 
The YD values for each 290 MeV/u 12C ion beam is shown in figure 9.13, as well as for a 
290 MeV/u 12C ion SOBP field. Due to the differing ranges for each field, the depths of 
each distribution has been aligned to their respective maximum YD values. 
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Figure 9.13: YD distributions obtained using the Mushroom microdosimeter in a mono-
energetic 290 MeV/u 12C ion pencil beam, mono-energetic 290 MeV/u 12C ion field and 
290 MeV/u 12C ion SOBP field. The depth of each dataset has been normalised to the 
depth at which its maximum YD occurs. 
105 
At the entrance, all beam types have approximately the same YD values as the LET of the 
ions do not differ significantly at shallow depths. This can be seen in the very similar 
spectra obtained with all beams in figure 9.14a. The YD of the SOBP was seen to increase 
very slightly with depth, with a large increase at the start of the SOBP, where the lowest 
energy 12C ions come start to stop. As expected, the mono-energetic beams produce only 
very slight increases in YD values up until approximately 80% of their range, after which 
dramatic increases occur in the Bragg peak. The SOBP YD peak is somewhat less defined, 
however is wider than both of the 290 Me V /u fields due to the contribution of 12C ions 
which have stopped slightly upstream. 
Compared to the passively delivered mono-energetic field, the pencil beam has signifi-
cantly lower YD in the peak partly due to the beam modification performed by the ripple 
filter and due to the beam geometry. The ripple filter creates a broader 12C ion spectrum 
which is due to straggling only, ultimately reducing the measured maximum YD value. 
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At almost all locations at the end of the Bragg peak, there exists a significant fraction of 
lower lineal energy events from 12C ions which comprise the microdosimetric spectra, 
as exemplified in figure 9.14b. Without the ripple filter, the fractional contribution from 
high LET 12C ions close to the end of their range at the edge of the Bragg peak is higher, 
resulting in a high YD . The effect of the ripple filter can also be seen by the relatively 
wide YD peak in comparison with the sharp YD peak produced with the passively scattered 
beam. In all cases, energy spread, scatter and range straggling contribute to the finite 
width of the Bragg peak. 
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Figure 9.14: Microdosimetric spectra at entrance obtained using the Mushroom micro-
dosimeter in a mono-energetic 290 MeV/u 12C ion pencil beam, mono-energetic 290 
MeV/u 12C ion field and 290 MeV/u 12C ion SOBP field. 
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Some interesting differences were also observed in the microdosimetric spectra produced 
from neutron interactions and fragmentation, which can be seen in figure 9.14b. Regard-
less of the delivery technology, there is expected to fragments and neutrons produced 
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within the phantom used in each experiment, however significantly more is expected in 
beams which that use beam modifying devices. In each microdosimetric spectra, the pro-
portion of events produced from neutron interactions and fragments differs significantly. 
The fractional contribution in the microdosimetric spectra from heavier fragments such as 
boron and beryllium between~ 10 and ~70 keV/µm is quite different, and surprisingly 
highest when using the pencil beam at GHMC, which may be explained by its geometry. 
While the effect of Coulomb scattering on the trajectory of 12C ions is much less than 
for lighter ions, a higher fraction of the ions in the pencil beam which are near the end 
of the their range will not be detected due to lateral disequilibrium, which does not oc-
cur in large passively scattered fields. At the same time, the partial fraction of fragments 
and recoil protons from neutron interactions produced inside the phantom will not be re-
duced due to the much greater scattering potential of these particles. This results in an 
enhanced partial contribution from lower lineal energy events which also acts to reduce 
the YD value. In addition, the differences in lower lineal events may also be attributed in 
part to differences in secondary spectra, as a result of using the PMMA block to house the 
detector, located outside of the water phantom at GHMC. In contrast, at HIMAC with the 
passively delivered beams, the microdosimeter was housed only within a small PMMA 
sheath, which was placed within the water phantom. Increased YD beyond the distal edge 
was also observed within the PMMA phantom in section 7 .2.2. 
One of the main advantages of active scanning delivery is the production of the ion energy 
layers required to establish tumour coverage directly from the synchrotron, minimising 
the need for beam modifying devices in the bearnline. However in the pencil beam spec-
tra in this experiment, especially at the Bragg peak and distally, the lower lineal energy 
component is not insignificant. In fact, the proportion of neutron events and lighter frag-
ments, such as helium, differs greatly across the three fields. The SOBP beam, which has 
the greatest amount of beam modifying devices (ridge filter and scatterer), clearly shows 
a relatively large proportion of events produced by neutrons between 1-10 keV/µm, fol-
lowed by the pencil beam with ripple filter, then the passively delivered mono-energetic 
beam with very little neutron events. This is emphasised with comparison of the spectra 
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just beyond the distal edge, shown in figure 9.14c. 
The RBE10 of each field is quite different as can be seen in figure 9.15. Despite having 
a Yn approximately two times greater than the other beams, the RBE10 of the mono-
energetic passively delivered 290 MeV/u 12C beam is only ~1.2 times greater than the 
other beams. Again, this shows that substantially high Yn does not result in a proportion-
ally enhanced RBE10 value, due to overkilling above 150 keV/µm for the MKM. Max-
imum RBE10 occurs for the passively scattered beam due to a less varied lineal energy 
distribution from high LET 12C ions brought about due to minimal beam modification de-
vices. In all cases, the uncertainty becomes greatest in the Bragg peak, as the distribution 
of energy deposition events in the microdosimeter spans a wide range. This is especially 
true for events with high lineal energy, in which a lower number of events occur, which 
increases uncertainty dramatically. In addition, LQM parameters for HSG tumour cells 
obtained also play a large part in the uncertainty [122]. 
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Figure 9.15: RBE10 distributions obtained using the Mushroom microdosimeter in a 
mono-energetic 290 MeV/u 12C ion pencil beam, mono-energetic 290 MeV/u 12C ion 
field and 290 Me V /u 12C ion SOBP field. The depth of each dataset has been normalised 
to the depth at which its maximum YD occurs. 
9.3 Conclusion 
Measurement of low energy 70 MeV 12C ions was performed using the Bridge V2 mi-
crodosimeter at ANU HIAF. Significant changes in microdosimetric spectra were able to 
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be observed as the effective microdosimeter depth in LDPE was varied between O - 400 
µm. The 10 µm thick sensitive volume of the microdosimeter minimised beam perturba-
tion (due to thin over-layers) and volume-averaging effects. Measured YD values of up to 
473 kev/µm were obtained at a depth of 170 µm, decreasing to ~6 keV/µm due to the 
absence of neutrons and fragments, unlike in 12C therapy treatments. Using the MKM, 
maximum derived RBE10 values of 2.57 occurred at the entrance as the higb LET of the 
ions at great depths reduced they* , followed by RBE10 , due to the overkilling effect. 
These results truly showcase the potential for thin silicon microdosimetric devices to be 
used for the measurement of higb LET particles with high granularity. 
Measurements were also performed using the Mushroom microdosimeter in passively 
delivered mono-energetic 290 MeV/u 12C ion field and mono-energy 290 MeV/u pen-
cil beam with ripple filter, commonly used in active scanning delivery systems. In the 
passively delivered field, a maximum YD value of ~291 keV/µm was measured, corre-
sponding to a maximum derived RBE10 value of ~2.95. This was ~0.8 mm beyond the 
maximum physical dose measured with an ionisation chamber, expected due to the known 
relationship between Bragg peak depth and RBE for 12C ions. 
For the actively delivered field, a maximum YD of just ~141 keV/µm was measured, 
corresponding to a derived RBE10 of 2.37. These lower YD and RBE10 values were due to 
the effect of the ripple filter, which increased the variance of the lineal energy distribution 
at the Bragg peak. The effect of the ripple filter was also seen by a wider YD and RBE10 
peak in comparison with the passively delivered field. The partial contribution to the 
microdosimetric spectra of fragments and neutrons using the active delivery was relatively 
greater than that produced from the passively delivered beam, likely due to differences in 
beam geometry and small differences in experimental setup. Comparison of the distal 
spectra with those obtained in a passively delivered SOBP field revealed a much greater 
contribution of lower lineal energy events from neutron interactions in beam modifying 
materials such as the ridge filter, scatters, etc. 
These results from these various applications show that CMRP silicon microdosimeters 
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can be used for characterisation and RBE prediction in mono-energetic 12C ion fields of 
different energies, as well as those produced using the different beam delivery technolo-
gies in 12C ion therapy. 
Chapter 10 
Microdosimetric Application in Proton 
Therapy 
This chapter presents work resulting from utilisation of the Bridge V2 microdosimeter in 
clinical proton therapy beams. The Bridge V2 microdosimeter was utilised in the mea-
surement of microdosimetric quantities and distributions within the fields generated by 
a passively scattered proton delivery system and a proton pencil beam scanning (PBS) 
system at Massachusetts General Hospital (Boston, MA, USA). Measurement of quanti-
ties relevant to microdosimetry and radiation protection was also performed downstream 
and out-of-field using a modem proton PBS system at Mayo Clinic (Rochester, MN, 
USA). 
The work described in this chapter has been published in multiple journal articles [125, 
142] with data collection performed in collaboration with Dr. Linh Tran (CMRP, UOW), 
and simulations performed by Dr. David Bolst (CMRP, UOW). 
10.1 In-field Measurements in Passive Scattering and Pen-
cil Beam Scanning Fields 
As discussed in section 1.1.2, proton therapy provides highly conformal dose delivery 
to specific tumour types, reducing delivered dose to healthy tissue and critical structures 
near by. This is especially useful for organs at risk downstream of the Bragg peak, as 
186 
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there is no fragment tail. However, during a protons journey through the body, inelastic 
collisions can contribute to dose through the production of secondary protons, neutrons, 
light nuclei and nuclei recoils, the magnitude of which varies with depth [143]. These 
secondary particles often travel at more oblique angles and have lower energies, resulting 
higher LET. Despite this, the energy they can provide to the media is small in comparison 
to primary and secondary protons [24]. 
As with all particle therapy planning systems, the radiobiological effect is taken into ac-
count which comes about from an increased number of double strand breaks from the 
dense ionisations caused by high LET particles. Traditionally, the RBE value used for pro-
ton therapy treatments is planned using 1.1 which is based on measurements performed 
during the initial development of the technology. A comprehensive analysis of many stud-
ies found that for a typical proton SOBP field, this a reasonable and valid RBE value to 
use. However, values across many different cell lines showed average RBE values of up 
to ~1.35 at distal edge and ~1.7 in the distal fall-off [144], with small and highly mod-
ulated fields producing higher RBE values. Other studies have also shown that a value 
of 1.1 underestimates the effect of increased LET at depth and distal regions, as well as 
for fractionated treatment regimes beams [145]; in fact, RBE has been shown to increase 
with smaller fractions [146]. Despite the relatively small volume over which large RBE 
variations occur, these studies have led to support for in the inclusion of variable RBE 
treatment planning and for precision dosimetry. 
In treatment planning, a quantity that has been used for taking into account the variable 
biological effect of charged particles is the dose averaged LET, LETo [147]. As its name 
suggests, this quantity is calculated by weighting the LET of each particle as a function 
of the energy deposited within a volume of interest, and is calculated based using Monte 
Carlo simulations or analytical models; it cannot be measured. However, it is similar to 
the dose-mean lineal energy in cases where delta electron ranges are smaller than the SY 
size [148]. While there exists many QA tools that have been implemented in a clinical 
setting for measuring quantities such as fluence, proton range an absorbed dose [149-
151], there is yet to be a device implemented which can routinely measure the physical 
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microdosimetric characteristics of proton beams, such as YD . As introduced in section 
1.2.1, the TEPC is the gold standard for measuring microdosimetric quantities and has 
been applied in clinical fields [152], monoenergetic protons fields at HIMAC [123] as 
well as in-field and out-of-field measurements of monoenergetic fields of heavier ions 
[51, 153]. Despite attempts to miniaturise the TEPC [66, 67], it's physical size produces 
volume-averaging over the greatly changing regions of the proton Bragg peak. As such, 
experimental microdosimetric quantities of a proton PBS field have not been measured in 
this region with high spatial resolution. 
The Bridge Microdosimeter was utilised in a variety of proton fields in order to showcase 
its ability to characterise mixed radiation fields in proton therapy with high resolution. 
Both proton PBS and double scattering delivery systems were used to obtain lineal energy 
spectra and were used to calculate YD and derive estimated RBE using the MKM model. 
Geant4 simulations were conducted for validation. These measurements were performed 
at Massachusetts General Hospital (MGH), Boston, USA. 
10.1.1 Materials and Methods 
The MGH proton facility cyclotron produces a proton beam with an energy of 235 MeV, 
which is degraded and transported to the treatment room. This treatment room is either 
equipped with a PBS (active) or double scattering (passive) delivery system. For passive 
delivery, an IBA universal nozzle and range modulation is used to form a SOBP with a 
5 x 5 cm2 brass aperture placed as close to the patient as possible in order to reduce 
proton penumbra [154]. For PBS delivery, a relatively large pencil beam with a FWHM 
between 10 and 35 mm can be produced, with the cyclotron able to produce ions with a 
range between 7 - 32 cm in water. This beam is quite large in comparison to more modem 
facilities and is useful for the treatment of larger tumours [31]. 
Measurements in this study were performed using beam spot size (FWHM) of 25.9 mm 
at isocenter in air, with a range of R9!J of 124.6 mm (range at which the dose delivered 
is 90 % of the maximum dose) which corresponds to an energy of 131 Me V - this beam 
type is referred here as the "spot" beam. A beam current of less than 0.1 nA was used to 
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avoid pulse pile-up which would act to increase the lineal energy measured. In addition, 
measurements were performed using a 5 x 5 x 5 cm3 SOBP beam delivered using double 
scattering delivery - this plan is referred to as the "cube" plan which is shown in figure 
10.1 for reference. The dose delivered to the target cube was 1.82 Gy in the middle of 
the SOBP. It was the intention that measurements in the same field delivered using PBS 
would also be carried out, but due to the treatment planning system limitations, this plan 
could not be delivered with a low current; pile-up effects would have dominated the lineal 
energy spectra acquired. 
Figure 10.1: Treatment plan for the 5 x 5 x 5 cm3 proton PBS field at MGH. 
The Bridge V2 Microdosimeter (section 1.3.2) was used to measure selected character-
istics of these beams. Due to relatively low LET of protons used in proton therapy, the 
minimal low energy response of the Bridge V2 microdosimeter, as seen in section 4.3, 
made it the ideal candidate for measurement in a proton field. For all field types, the 
microdosimeter was placed inside the water tank described in section 6.3 and the motion 
stage was used to vary its depth within the water. The setup is shown in figure 10.2. 
Microdosimetric acquisitions were performed at many depths in the water tank, with in-
creased density in the Bragg peak. At each acquisition location, a lineal energy spectrum 
was obtained which was used to calculate Yn (equation 1.15. In addition, using the MKM-
based method (section 1.1.4), the lineal energy spectra was used to derive approximate 
RBE for the HSG cell line. However as the RBE for protons is lower, and is dependent 
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(a) PBS setup (b) Double scattering setup 
Figure 10.2: Experimental setup showing the PBS gantry and Microdosimeter in water 
tankatMGH 
on delivered dose, the general expression for RBE was used, shown in equation 10.1. 
Measured LQM parameter values were obtained from [123]. 
(10.1) 
where: 
DR = Dose delivered with 200-kV x-rays 
Dp = Dose delivered with protons = 1.82 Gy 
ap = Linear function of saturation-corrected dose-mean lineal energy (equation 1.21 
aR = LQM a parameter for HSG cells= 0.164 Gy- 1 
/3p = /3R = LQM /3 parameter for HSG cells = 0.05 Gy- 2 
In order for these quantities to be associated with biological effects, the response in silicon 
was converted to that of an equivalent tissue volume. This was performed by David Bolst 
(UOW), by simulating a 150 MeV PBS spot proton field and recording the response in 
different sized tissue and silicon microscopic volumes. The conversion factor is the ratio 
of the length of a microscopic tissue volume to that in a silicon volume which produced 
the same response in both materials. This factor was determined to be of 0.58 [58] and 
was fairly constant over the range of proton energies used in this study. 
In addition, the PBS delivery system was modelled using Geant 4 version 10.0, and was 
tuned using depth-dose data obtained in the beam with an IBA Zebra multilayer ioni-
sation chamber. The initial proton energy was modelled as Gaussian with 1 % <J. The 
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proton spot size was matched to the actual beam used (25.9 mm FWHM) and the phantom 
was modelled as a 30 x 30 x 30 cm3 cube placed 40 cm away from the beam nozzle. 
Calculation of Yn was used to verify experimental results. 
10.1.2 Results and Findings 
10.1.2.1 PBS Spot Measurements 
In order to provide context, the depth-dose profile of the PBS spot beam measured using 
an IBA Zebra ionisation chamber is shown in figurel0.3. The simulated beam is also 
shown. Very good agreement is seen between the simulated and measured profile. There 
exists some deviation between measured and simulated during the build up region (simu-
lation degraded response) which is most likely attributed to small differences between the 
physical setup and the modelled geometry. 
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Figure 10.3: PBS Spot beam depth-dose profile measured with a Zebra multilayer ioni-
sation chamber compared to simulated dose profile 
Figure 10.4 shows the microdosimetric spectra obtained at depths 22 mm to 150 mm in 
water. The shallowest depth of 22 mm is limited by the physical construction of the water 
phantom and waterproof sheath, with the maximum depth of 150 mm depth corresponding 
to ~25 mm downstream of the distal edge. Each of the in-field spectra shows a clear peak 
which is generated by protons depositing energy within the 10 µ.m thick microdosimeter 
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SV. As the depth is increased, this peak shifts to the right and becomes wider due to the 
decreasing energy of primary protons as well as neutron interactions and secondary proton 
production. Simulations also revealed that at these shallow depths, electrons provided 
small contributions to the higher energy tail between ~0.5 and ~3 ke V / µm up until ~ 120 
mm. The range of lineal energy events observed at entrance is between ~0.5 to ~5 
keV/µm, and increases up to ~0.6 to ~45 keV/mum at the distal edge of the BP. 
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Figure lOA: Microdosimetric spectra obtained using the Bridge Microdosimeter in the 
PBS Spot beam at MGH. The y-axis limits differ between the figures in order to visualise 
the spectra at greater depths, unfortunately at the cost of being able to directly compare 
between figures. 
A dramatic difference between microdosimetric spectra 129 mm and 137 mm exists due 
to this transition between locations near the distal edge and further downstream. While 
not represented in the spectra, the dose downstream is obviously much less than in the 
field, however at these downstream locations there particles with a range of lineal ener-
gies from ~0.4 keV/µm and up to ~200 keV µm. As the primary beam has stopped, it 
can be deduced that this spectra is generated from mainly secondary proton and helium 
production [124]. Higher lineal energy events can also be generated from oxygen and 
silicon recoils, as well as alpha particles from the Si(n, a) reaction. These high energy 
events can drastically change YD values and uncertainties which has been observed with 
TEPC measurements [123]. 
From the measured microdosimetric spectra, the YD distribution was calculated and is 
shown in figure 10.5. Simulated results are also shown for comparison, and the absorbed 
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dose, in order to provide a physical reference to the beam. YD values were seen to be ~2 
ke V / µm at the entrance with values slightly decreasing at around 90 mm, then increasing 
sharply starting from around 120 mm, near to the Bragg peak maximum. YD reached 
a maximum of ~10 keV/µm at a depth of 129 mm. Simulated results generally showed 
good agreement with measured results (within 3 - 10 % ). However a select few data points 
had large deviations between measured and simulated (within 15 - 30 % ) in the critical 
region near the Bragg peak. These deviations are likely due to the sharp YD gradient in 
this region and uncertainty in microdosimeter position, especially due to the relatively 
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Figure 10.S: Average dose-mean lineal energy YD distribution measured and simulated 
for the PBS Spot beam at MGH. 
Using the lineal energy spectra, equation 10.1 and the depth dose profile with maximum 
dose of 1.82 Gy, an the estimated RBE was derived as a function of depth, shown in figure 
10.6. Between the depths of 20 - 110 mm the RBE stayed constant at ~0.96. These low 
RBE values are due to reference 200-kV x-rays having ay* value of 4.34 keV/µm at these 
depths [51 ], which is greater than the measured value with protons. At a depth of 122 mm, 
corresponding to R90, the derived RBE was~ 1.04 and increased at a rate of ~0.06 mm- 1 
thereafter. The RBE reached ~ 1.57 in the distal falloff at 129 mm, corresponding to 13% 
of the maximum dose. This RBE increase is due to both an increase in proton LET but 
also due to decreasing dose at this depth, of which RBE is dependent. The importance 
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of microdosimetric measurement can be seen by comparing RBE values derived with the 
same dose e.g. in the leading edge of the Bragg peak at 123 mm and the distal edge at 126 
mm. The derived RBE values at these depths is ~1.1 and ~1.4, respectively, showing that 
that large changes in lineal energy spectra, and hence YD , can produce large variations in 
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Figure 10.6: Derived RBE obtained using the Bridge Microdosimeter in the PBS Spot 
beamatMGH. 
10.1.2.2 Double Scattering SOBP Measurements 
Figure 10.7 shows the microdosimetric spectra obtained at depths 22 mm to 150 mm in 
water for the passively delivered SOBP beam. The microdosimetric spectra at shallower 
depths is characterised by a quite narrow peak centred about ~0.7 keV/µm with a high 
energy tail which spans the lineal energies until ~10 keV/µm. As the microdosimeter is 
moved deeper within the phantom, this large peak naturally shifts towards higher lineal 
energies and broadens, however not significantly. Due to the stochastic nature of mi-
crodosimeter and the dose-weighting of yd (y) plots, high energy events can drastically 
change the shape of the spectra. This is seen in the spectrum obtained at 30 mm where 
a few events of lineal energy ~ 100 ke V / µm reduce the height of the main peak centred 
~0.7 keV/µm. 
For the first ~50 cm, the SOBP beam consists of protons of multiple different energies, 
however with very little variation in LET [24] which is seen by the very little change in 
microdosimetric spectra. However, once reaching the plateau of the SOBP ( ~70 cm), the 
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Figure 10.7: Microdosimetric spectra obtained using the Bridge Microdosimeter in the 
passive scattering SOBP beam at MGH. The y-axis limits differ between the figures in 
order to visualise the spectra at greater depths, unfortunately at the cost of being able to 
directly compare between figures. 
field starts to change as the low energy pristine beams reach deposit most of their energy 
in their Bragg peak. This can be seen in the spectra as the primary peak shifts towards 
higher lineal energies and their tail increases in width between the depths of 60 mm and 
110mm. 
Towards the end of the SOBP plateau, which has an R90 of 126 mm, the spectra are 
extremely similar to that of the PSB spot beam. The primary peak continues to increase 
in energy and significantly widen as the higher energy pristine beams start to reach their 
range. Past the distal edge the spectra are comprised from neutron interactions within the 
phantom as well as beam modifying devices upstream. 
The YD distributions for these spectra are shown in figure 10.8, plotted with the measured 
physical dose. The YD values are seen to start at just under 2 keV/µm which is expected 
for this beam. The YD value obtained at 30 mm, as previously mentioned, is larger than the 
surrounding points due to an increase in high lineal energy events which is thought to be 
produced from the stochastic nature of this measurement process, not due to unexpected 
physical phenomena. In addition to the higher YD value due to the greater weighting of 
these events, the uncertainty is also increased disproportionately. At 60 mm depth, where 
the SOBP plateau starts, a stepped increase of YD to ~2.4 keV/µm was observed. After 
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this point, YD increases gradually to ~2.9 keV/µm at 110 mm depth and then increases 
rapidly. This rapid increase is due to the measured spectra comprising almost entirely of 
higher LET protons from the highest energy layer. A maximum YD value of ~7 .2 ke V lµm 
was measured at 130 mm depth ( 4 mm past R90), which did not change drastically further 
downstream. 
The YD values at R90 is ~2.8 keV/µm less than that at the same respective R90 for the 
spot beam. An enhanced YD value in the spot beam generally could be due to effects 
associated with pileup, however current was reduced to extremely low levels to avoid 
this. The difference is more likely simply due to the difference between the beams, in 
particular more straggling with the double scattered beam, resulting in a wider lineal 
energy distribution and reduced YD . 
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Figure 10.8: Average dose-mean lineal energy YD distribution measured for the double 
scattered SOBP beam at MGH. 
Estimated RBE values were derived for the SOBP beam, shown in figure 10.9. Derived 
RBE values between depths of 22 mm and 110 mm remained relatively constant be-
tween values ~0.98 and ~1.02. At a depth of 126 mm, corresponding to R90, the RBE 
was ~1.12 and reached a maximum of ~1.41 at a depth of 140 mm. These values are 
slightly lower than the PBS spot beam which is not surprising given the YD values are also 
higher. 
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Figure 10.9: Derived RBE obtained using the Bridge Microdosimeter in the passively 
scattered SOBP beam at MGH. 
10.2 Out-of-field Measurements in Pencil Beam Scanning 
Fields 
Delivery of dose to out-of-field (OOF) healthy tissue is always detrimental to treatment 
outcome across all radiation therapy modalities, and naturally increases the risk of sec-
ondary malignancy, especially in children [155]. The ions used in charged particle ther-
apy undergo interactions with materials in the beam line, treatment head, beam-shaping 
devices and within the patient. Unlike most conventional photon therapies, these interac-
tions are both electronic and nuclear in nature. While most processes are due to multiple 
Coulomb scattering, reactions with target nuclei can generate neutrons and fragments that 
will deliver excess dose to both target and non-target regions distally and laterally within 
a patient [156]. Naturally, the absence of materials upstream of the patient reduces neu-
tron and fragment production and is one of many reasons why particle therapy modalities 
are moving from passive scattering to active scanning techniques to deliver and shape the 
beam to the target [31, 157]. 
Many studies with protons have been undertaken to measure the out-of-field dose deliv-
ered to tissue external to the target volume [57, 154, 158-160], however due to differing 
measuring techniques, beam geometries, proton energies and acquisition locations, it is 
difficult to compare them directly. Furthermore, most measurements are taken around 
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the room, far outside the patient which is not particularly relevant to treatment outcomes. 
Whilst there can be large differences in delivery systems and in-beam devices, most stud-
ies obtained similar dose-equivalent values up to the order of 10 mSv/Gy close to the 
field, and decreasing to minima of between 0.001 - 0.1 mSv/Gy at distances of 10-100 
cm lateral to the field. Due to the absence of beam modifying materials, active scanning 
systems produce less neutrons and as a result, lower dose-equivalent values, however the 
extent to which this is true has been disputed in the past [161, 162]. 
As discussed in section 1.1.3, microdosimetry is one technique that can be utilized to 
evaluate out-of-field and in-field quality of mixed radiation fields. It can be used for ra-
diation protection purposes to calculate dosimetric quantities such as the dose-equivalent. 
Previous work with silicon microdosimeters has been undertaken by the CMRP to mea-
sure microdosimetric quantities in-field [163] and out-of-field [57, 160] in passively scat-
tered proton fields, however studies have not been carried out using proton pencil beam 
scanning (PBS). This work demonstrates the usefulness of the SOI microdosimeters in 
assessing beam quality in proton PBS therapy systems. The dose-equivalent and other 
microdosimetric quantities have been determined in out-of-field locations using a spread-
out Bragg peak proton PBS field at Mayo Clinic, Rochester, USA. 
10.2.1 Materials and Methods 
The relatively new proton therapy facility uses intensity modulated PBS to deliver dose 
to patients without the use of patient-specific beam shaping devices. The plan that was 
chosen delivered a uniform dose of 2.2 Gy to a volume of 10 x 10 x 6 cm3 using intensity 
modulation between 40-100 mm (SOBP), with proton energy layers between 71.3 - 118.4 
Me V. The depth-dose profile along the central axis of the field and lateral dose profile at 
the field centre for the plan are shown in Fig. 10.lOa and 10.lOb, respectively. 
The Bridge V2 Microdosimeter (section 1.3.2) was used chosen to measure selected beam 
characteristics of this beam. Due to relatively low LET of protons used in proton therapy, 
the minimal low energy response of the Bridge V2 microdosimeter, as seen in section 4.3, 
made it the ideal candidate for measurement in a proton field. 
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Figure 10.10: Dose profiles of the SOBP proton beam, calculated using the Mayo Clinic 
Geant4 GPU treatment planning system. 
Due to the extremely high count rates associated with PBS delivery, out-of-field measure-
ments were performed to investigate radiation effects that would occur in healthy tissue 
surrounding a treatment volume. The out-of-field measurements were taken laterally at 
10, 30, 60 and 120 mm from the field edge at depths close to the beam entrance (25 mm) 
and on the plateau region of the SOBP (80 mm). In addition, two locations downstream 
of the SOBP distal edge of the SOBP (40 and 55 mm downstream), laterally in-field were 
also investigated. The phantom described in section 6.3 was used to hold and vary the 
lateral and axial position of the microdosimeter with respect to the beam isocenter. The 
acquisition locations can be seen schematically in figures 10.lla and 10.llb. 
At each acquisition location, the dose equivalent was determined using equations in sec-
tion 1.1.5. 
The PBS delivery at Mayo Clinic was modelled using Geant4 version 10.2p2, by David 
Bolst (UOW). The positional sigma of the beam was calculated based on the starting 
combination of energy and position, with the FWHM value ranging between 6-16.5 mm. 
The phantom was modelled as a slab of 40 x 40 x 30 cm3 water placed in air 80 cm away 
from the beam nozzle. The response of the bridge microdosimeter from being irradiated 
by the SOBP was simulated. 
Uncertainty in the spectra and associated quantities is based on the statistical error asso-
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Figure 10.11: Schematics showing acquisition locations with respect to the PBS field 
size. 
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ciated with the counts in each channel, dependent on a number of factors including de-
livered dose, detector area and acquisition time, which was varied between 5 - 15 minute 
per acquisition. Errors in YD and Q were determined using standard error propagation 
techniques described in Appendix A.1, and are again dependent on the counts in each 
channel in each spectrum. There is also assumed uncertainty of ~ 1 mm in depth and 
lateral position of the microdosimeter, based on the repeatability of movement, as well 
as uncertainty in measurement of the over-layers above the microdosimeter. There is an 
inherent uncertainty in the silicon-to-tissue conversion factor of ~2%. 
10.2.2 Results and Discussion 
10.2.2.1 Downstream of the SOBP 
Table 10.1 presents the dose-mean lineal energy YD, average quality factor Q and dose--
equivalent H from acquisitions located downstream at depths of 110 mm and 150 mm, 
with corresponding microdosimetric spectra shown in figure 10.12. 
Table 10.1: Microdosimetric quantities obtained at 110 and 150 mm depth, downstream 
of the SOBP field. 
Depth (mm) YD (keV/µm) Q H/Dose (mSv/Gy) 
110 21.9 ± 3.4 5.4 ± 0.6 0.99 ± 0.11 
150 27.2 ± 5.7 6.1 ± 0.9 0.62 ± 0.09 
The generation of higher LET particles is seen to be more prevalent at 150 mm as can 
be seen by higher YD and Q values, however H is lower, resulting in less dose delivered 
out-of-field from neutrons, per treatment Gy. In both spectra, high LET events above 100 
keV/µm are most likely from alpha particles produced through (n, a) inelastic reactions 
within the silicon, carbon and oxygen. Despite these events, the spectra are mainly dom-
inated by lower lineal energy events originating from recoil protons produced through 
elastic (n,p) reactions inside the water phantom. 
10.2.2.2 Lateral to the Field Edge 
Microdosimetric spectra produced from out-of-field acquisitions at each lateral location 
for depths 25 mm and 80 mm are shown in figure 10.13 and figure 10.14, respectively. 
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Figure 10.12: Microdosimetric spectra obtained downstream at depths 110 and 150 mm 
of a proton PBS SOBP field. 
For these acquisitions, the spectra are characterized by a low lineal energy peak with a 
higher lineal energy tail. For both depths, the microdosimetric spectra obtained at 10 
mm out-of-field spans a large range of lineal energies from approximately 0.7 keV/µm 
to 70 keV/µm, produced by laterally scattered primary protons due to the relatively wide 
penumbra. At a depth of 80 mm in water, the microdosimetric spectrum for 10 mm out-
of-field is naturally broader compared to that at 25 mm depth as the scattered protons have 
lower energy, and hence higher LET at greater depths. Moving further laterally from the 
field edge, at 30, 60 and 120 mm, the spectrum is dominated by recoil protons induced by 
neutrons and are extremely similar for both 25 mm and 80 mm depths. 
Figure 10.15 shows the YD distributions for out-of-field positions at 25 mm and 80 mm 
depths in water. Despite the detector being located at significantly different parts along 
the SOBP profile (see figure 10.11), the YD distributions are extremely similar. At 10 
mm from the field edge, YD increases from approximately 5.8 keV/µm and reaches a 
maximum of 7.5 and 7.8 keV/µm for 25 mm and 80 mm depths, respectively, followed 
by a gradual fall-off with distance. Overall, for each lateral location, the YD values at 80 
mm depth are greater than those at 25 mm depth by between 2 - 7%, however agree within 
experimental error. 
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Figure 10.13: Microdosimetric spectra obtained lateral to a proton PBS SOBP field at 
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Figure 10.14: Microdosimetric spectra obtained lateral to a proton PBS SOBP field at 
80 mm depth in water. 
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Figure 10.15: Dose-mean lineal energy and dose-equivalent distributions Microdosi-
metric obtained lateral to a proton PBS SOBP field at depths of 25 mm and 80 mm in 
water 
The dose-equivalents for each set of out-of-field acquisitions at 25 mm and 80 mm depths 
are also presented in figure 10.15. Maximum values were measured at 10 mm from the 
field edge, reaching values of 3.1 mSv/Gy and 5.3 mSv/Gy at depths 25 mm 80 mm, re-
spectively. For perspective, a total treatment of 60 Gy using this field would give a 300 
mSv dose-equivalent to a point of healthy tissue located 10 mm from the field edge. As 
expected, the dose-equivalent rapidly falls off with distance from the field edge, converg-
ing to approximately 0.04 mSv/Gy at 120 mm out-of-field for both depths. 
Similar treatment plans (Prostate and Medulloblastoma) have been investigated previ-
ously [154] which compared equivalent dose using active scanning and passive scattering 
at lateral locations at very similar depths to the microdosimetric acquisitions performed 
here (22.3 mm and 84 mm). The study unsurprisingly confirmed that active scanning de-
livery had decreased equivalent dose by around a factor of 10 for distances up to 60 cm 
from the field edge. While the experiment performed only sampled relatively close to the 
field edge (albeit clinically relevant) and used non-ideal SOBP beams, the microdosimet-
rically derived equivalent dose distribution found using the Bridge microdosimeter agrees 
well in both magnitude and shape. 
Figure 10.16 shows a comparison of the experimental and simulation results for 25 mm 
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and 80 mm depths. Good agreement between the experimental and simulation results was 
observed for 25 mm depth, however at 80 mm, the simulated YD values are slightly higher 
than the experimental results. This may be explained by a few high LET events which 
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Figure 10.16: Experimental and simulated dose-mean lineal energy distributions ob-
tained lateral to a proton PBS SOBP field at depths of 25 mm and 80 mm in water in 
experiments and simulation 
Figure 10.17 shows the simulated contributions from different particle types with respect 
to lateral position at both 25 mm and 80 mm depths in water. It can be seen that at 25 mm, 
there is a greater contribution from secondary protons which have greater LET. At 80 mm 
depth, a slightly higher contribution is seen from primary protons and less from secondary 
protons, however the primary beam has a higher LET from traversing at extra 55 mm of 
water. The balance of contributions between the primary beam and secondary protons 
keeps lateral YD distributions values at both depths relatively similar. Contributions from 
heavier ions remains minimal at both depths, with slight increases at lateral distances past 
80 mm from the central axis. 
10.2.3 Conclusion 
In-field measurements with the Bridge V2 microdosimeter were performed using a PBS 
beam and passively scattered proton field at Massachusetts General Hospital. With the 
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Figure 10.17: Simulated lateral dose particle-type contribution profiles for the Mayo 
Clinic SOBP proton PBS field at 25 mm and 80 mm depth. 
proton pencil beam, relatively constant YD values of~ 2 keV/µm were recorded for the 
majority of the protons journey, with a sharp increase to ~ 10 ke V / µm just after the max-
imum measured physical dose. With the passively scattered SOBP beam, the YD values 
continually increased from ~2 keV/µm due to the contribution of higher LET protons 
that stopped within the SOBP, reaching a maximum of ~7.2 keV/µm after the SOBP dis-
tal edge. Obtained RBE values in the PBS spot beam were ~0.96 in the build up region, 
reaching a maximum of ~ 1.57 slightly downstream of the Bragg peak. Obtained RBE 
values in the SOBP double scattered beam were ~1.0 in the build up, reaching maximum 
of ~1.4 after the distal edge of the SOBP. Comparison ofyD and RBE values derived us-
ing the microdosimetric-kinetic model showed good agreement with Geant4 simulations 
for pencil beam measurements. In both cases, the measurements pedormed in this work 
used to derive RBE for HSG tumour cells confirm the varying nature of proton beam RBE 
with depth as described in the literature. In addition, the thin sensitive volume of the mi-
crodosimeter enabled detailed measurements to be pedormed along the depth of a water 
phantom with minimal volume averaging effects. 
Out-of-field measurements with the SOI microdosimeter in a proton PBS field were car-
ried out for the first ti.me at Mayo Clinic, which revealed quite an interesting YD distribu-
tion laterally to the field at different depths. For both depths at 10 mm from the field edge, 
the microdosimetric spectra was dominated by laterally scattered primary protons, result-
ing in a relatively low YD . Moving further out between 30 mm - 120 mm from the field 
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edge, YD increased due to the fast neutron contribution (lower energy recoil protons), fol-
lowed by a gradual fall-off with distance. The measured YD distributions at 25 mm depth 
are in slightly better agreement with predicted Monte Carlo simulations than 80 mm depth 
due to possible lack of statistics that may affect neutron spectra and lead to slightly in-
creased probability of Si( n, a) events. Despite this, Geant4 simulations validated these 
microdosimetric measurements and gave confidence to the microdosimetric derivation of 
radiation protection related quantities. The dose-equivalent for proton PBS delivery sys-
tems showed significant decreases from other passive scattering systems and agreed well 
with studies performed at other facilities [154]. These studies allowed for measurement 
of quantities related to radiation protection as well as high resolution probing of proton 
Bragg peaks at which dramatic increase of dose and YD exists. 
These measurements show that for physical measurement of microdosimetric spectra is 
possible in PBS and passively delivered proton beams. Furthermore with the advance-
ment of smaller sensitive volume technology from CMRP, measurement of in-field PBS 
beams have also been performed [ 164]. The work performed here shows a glimpse of the 
possible role that solid state microdosimeters could play in proton therapy. The measure-
ment of YD and, with more comprehensive data sets, RBE derivation via the MKM model 
could be used in routine quality assurance to assess beam quality, or even routinely verify 
proton treatment plans, especially those with unique and challenging properties e.g. heav-
ily modulated beams, areas close to critical structures or organs at risk at the distal edge 
of the beam. Solid state microdosimeters enable the measurement of quantities relevant 
to the biological endpoint of cellular damage which ionisation chambers cannot provide. 
While silicon microdosimeters can not replace conventional QA equipment, these results 
certainly showcase the utility of a microdosimeter as a QA tool in proton therapy. 
Chapter 11 
Conclusion 
This thesis presented the characterisation of three new SOI microdosimeters and their 
utilisation in a variety of different proton and 12C ion therapy applications. 
As a way of fine tuning manufacturing process at SINTEF, the Etched Microdosimeter 
was fabricated, and its electrical, physical and charge collection properties were charac-
terised. Electrical characterisation showed very low leakage current and capacitance, with 
a very low depletion voltages, and SEM imaging showed seemingly successful fabrica-
tion results. However, charge collection studies revealed properties similar to previous 
generation devices, having poor charge collection on the periphery of each SY, as well as 
collection from unbiased arrays due to capacitance-resistive charge sharing. 
Meanwhile, with the etching issues that were encountered during Bridge Yl microdosime-
ter fabrication remedied, the Bridge Y2 microdosimeter was fabricated. This device was 
the first microdosimeter with the majority of silicon surrounding its SY s removed, us-
ing deep ion reactive etching, which allowed for electrode implantation processes to be 
performed on the SY walls, creating a 3D-like configuration. Electrical characterisation 
showed favourable properties and SEM imaging showed remarkable improvements from 
the Bridge Yl microdosimeter, with the complete removal of interstitial silicon between 
the SY s and bridges, exposing the buried oxide layer. Charge collection characterisation 
showed well-defined, isolated SY s and bridges, with high yield and the absence of a large 
low energy component that plagued previous generations. This allowed for true micro-
208 
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dosirnetric application in lower LET radiation fields such as proton beams, where low 
energy events are produced. 
The first revision of Mushroom rnicrodosimeters were fabricated, including numerous 
variants including a 18 or 30 µm diameter and two electrode configurations; one with 
the p+ and n+ 3D electrodes along the depth of the device with silicon removed in a 
central and outside trench and two (air-trench), and another with a planar n+ electrode 
with the outside trench filled with p-doped polysilicon to form the p+ electrode (poly­
trench). Electrical characterisation revealed greater differences in leakage current and 
capacitance over all samples, however this was somewhat expected due to the geometrical 
and design differences between the variants. Physical SEM measurements of the air­
trench device showed complete etching of the two annular trenches, producing a well­
defined nearly free-standing cylindrical SY with a small bridge to allow for n+ electrode 
connection. Charge collection characterisation results revealed good charge collection 
efficiency in most devices, however undesirable charge collection behaviour was were 
observed with the 30 µm air-trench variant, consisting of a large low energy component 
generated in between adjacent SVs. However dead regions in the central core and outer 
trenches were observed, confirming the complete removal of silicon during the etching 
process; this is an important process on which present and future 3D technology heavily 
relies. The 30 µm poly-trench device showed more favourable characteristics, however 
a low energy component was still observed, originating from a thin annulus around each 
SY. The 18 µm poly-trench device was also characterised, showing extremely poor yield, 
however the SY characteristics were the most favourable of any device, possessing well 
defined cylindrical SVs with minimal low energy components and no charge collection 
from SY s in the unbiased array. With the information learned from this characterisation, a 
new variant is planned to be developed, whereby complete trenches will be formed around 
the SV, filled with polysilicon and the surrounding silicon etched away and replaced with 
PMMA, creating a more tissue-equivalent substrate [76]. 
These rnicrodosirneters were put to the test with the aim of estimating RBE10 in 
12C ion 
therapy fields. The response of all rnicrodosirneters was measured in a 290 MeV/u 12C 
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to distinguish due to fast scanning speeds compared to target motion as well as their phase 
difference. These results show the importance of mitigating motion during treatment 
and provides insight into the impact of these effects through the microdosimetric spectra 
obtained. 
The Bridge V2 microdosimeters were also utilised in proton beams delivered via both 
double scattering and pencil beam scanning technology. Due to the removal of silicon 
in the Bridge V2 microdosimeter microdosimeter, it was possible to measurement micro-
dosimetric quantities in these low LET beams. Using the microdosimetric-kinetic model, 
the RBE distribution along the depth of a water phantom was derived for HSG cells irra-
diated by a PBS spot beam (assuming 1.82 Gy delivered). Values of ~0.95 were obtained 
for most of the protons journey, reaching a value of 1.57 just after the Bragg peak. For 
a double scattering SOBP proton beam, derived RBE values were ~ 1.0 for most of the 
proton range, increasing to up to ~1.4. In both cases, deviation from the value of ~1.1 
was observed, which is commonly used in proton therapy treatment planning. Radiation 
protection and microdosimetric quantities were also measured for out-of-field locations 
using pencil beam scanning proton fields. It was found that the dose-equivalent decreased 
rapidly moving laterally out of the field as expected, however Yn values actually peaked 
at 30 mm from the field edge at various depths, due to the contribution of secondary 
particles (scattered primary protons and recoil protons produced by neutrons) outside the 
field. 
The diverse range of work presented in this thesis has shown the versatility of SOI mi-
crodosimeters developed at CMRP, and their potential to be a used as a tool for quality 
assurance in proton and 12C ion therapy. 
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Appendix 
A.1 Uncertainties in Microdosimetric Quantities 
Error propagation of microdosimetric quantities is something that is overlooked as they 
are derived from spectra. This appendix analytically derives the uncertainties in all mi-
crodosimetric quantities, RBE10-related quantities, RBEn-related quantities and radiation 
protection-related quantities that are displayed in this thesis in the form of values or data 
points in graphs. Some uncertainty expressions become extremely long and due to for-
matting reasons the use of the square root operator and ½ exponent may be used inter-
changably within the same derivation. 
As a reminder, the general form of an uncertainty expression for the functional f (x, y, y) = 
xy / z where x, y and z are independent is: 
Af(x,y,z) = ( :x [.f(x,y,z)]Ax) 
2 
+ ( :x [.f(x,y,z)]Ay) 
2 
+ ( :x [.f(x,y,z)]Az) 
2 
(A.l) 
A.1.1 Uncertainty in Spectrum Counts 
The uncertainty for the counts C; in channel i of a spectrum is: 
(A.2) 
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A.1.2 Uncertainty in Spectrum Area 
The area under a spectrum with n channels is defined as: 
i=l (A.3) 
The uncertainty in this area is: 
(A.4) 
A.1.3 Uncertaintyin/(y) 
The normalised spectrum f(y) is defined as: 
(A.5) 
The contribution of uncertainty given by the area term below will be ignored it is generally 
<1 %. The uncertainty in f(y) is hence: 







A.1.4 Uncertainty in YF 
The frequency-mean lineal energy YF is defined as: 
(A.7) 
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The uncertainty in YF is hence: 
AyF = ( ( a f~y1) [y1f(y1)Ay] Af(y1)) 
2 




+ ( a f~Yn) [ynf(Yn)Ay] Af(Yn)) 
2
) ~ (A.8) 
= Ay✓(y1Af(Y1))2 + (y2Af(Y2))2 + ... + (y1Af(Y1))2 
where Ay is the width of the lineal energy hin. 
A.1.5 Uncertaintyind(y) 
The dose-mean lineal energy is defined as: 
d(y) = yf(y) = yf(y) 
YF J f(y)dy (A.9) 
The dose-mean lineal energy uncertainty is hence: 
Where <It(y)YF is the covariance between f(y) and YF · By definition, for a random variable 
X and constant c, <Icx = 0, so: 
(A.11) 
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A.1.6 Uncertainty in Yv 
The dose-mean average lineal energy is defined as: 




where Ay is the width of the lineal energy hin. 
The uncertainty in Yn is hence: 








+ ( ad~Yn) [ynd(yn)] M(yn)) 2) ~ 
= Ay✓(y1M(y1))2 + (y2M(y2))2 + ... + (ynM(yn))2 
A.1.7 Uncertainty in yd(y) 
The uncertainty in yd(y) is: 
a 






APPENDIX A. APPENDIX 237 
A.2 Uncertainties in RBE10-Related Quantities 
A.2.1 Uncertainty in y* 
The saturation-corrected dose-mean lineal energy y* is defined as: 
Therefore the uncertainty in y* is expressed as: 
Ay*= 
(A.16) 
A.2.2 Uncertainty in LQM parameter a 
The uncertainty for the LQM saturation-correct a parameter is defined as: 
(A.17) 
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The uncertainty expression for a is: 
(A.18) 
A.2.3 Uncertainty in RBE10 
The RBE 10 quantity is defined as: 
DR IO 2f3D10,R 
RBE10 = -'- = -----.==a==e======~-
D10 Ja 2 -4{31n(0.1)-a 
(A.19) 
The uncertainty expression for RBE10 used in this thesis stems from uncertainty in a 
alone: 
MUJE1 = ~ [ 2f3Drn,R ] Aa 0 
aa Ja 2 -4f31n(0.1)-a 
_ 2f3D10,R Aa 
-aJa 2 -4{31n(0.1) + a2 -4{31n(0.1) 
(A.20) 
A.3 Uncertainties in RBEv-Related Quantities 
A.3.1 Uncertainty in Dose to Silicon, Dsi 
The dose in silicon is calculated from MCA spectra and is defined as: 
(A.21) 
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The uncertainty for dose in silicon stems from spectrum counts alone: 
A.3.2 Uncertainty in Dose in Tissue, Dre 
The dose in tissue is calculating use tissue-equivalent convertion factor: 
The uncertainty expression is therefore: 
A.3.3 Uncertainty in Survival, S 
The survival S is defined as: 
-? -(11-0+_L_y•)n-Jl& 
S = e-aD-Jl,r = e ~ 
The survival uncertainty stems from the uncertainty of ao, rn and D: 






aao At7o + ard Ard + aDAD 




A.3.4 Uncertainty in RBEv 
The RBEn quantity is defined as: 
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as AS + ans MJs 
(A.28) 
A.4 Uncertainties in Radiation Protection-Related Quan-
tities 
A.4.1 Uncertainty in Q 
The average quality factor Q is defined as: 
(A.29) 
A.4.2 Uncertainty in Dose Equivalent H 
The Dose Equivalent H is defined as: 
(A.30) 
The uncertainty expression is hence: 
(A.31) 
